| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1001 |
Combined Analysis of Valproic Acid Induced MicroRNA and Gene Expression Changes in Acute Myeloid Leukemia.
|
Russ, Annika C.
|
|
|
110 |
11 |
p. 869
|
artikel
|
| 1002 |
Combined Antithrombotic Therapy but Not Single-Agent Therapy with Low-Dose Aspirin Deteriorated Platelet Activation in Patients with Antiphospholipid Syndrome (APS).
|
Yamazaki, Masahide
|
|
|
110 |
11 |
p. 4002
|
artikel
|
| 1003 |
Combined BIOMED-2 Clonality Assays for IGH and IGK and Assessment of t(14;18) on Formalin-Fixed, Paraffin Embedded Tissues Effectively Separates Primary Cutaneous B Cell Lymphomas from Reactive Cutaneous Lymphoid Hyperplasia.
|
Morales, Anjali V.
|
|
|
110 |
11 |
p. 2623
|
artikel
|
| 1004 |
Combined Chemotherapy and High Cut-Off Hemodialysis Improve Outcomes in Multiple Myeloma Patients with Severe Renal Failure.
|
Hutchison, Colin A.
|
|
|
110 |
11 |
p. 3610
|
artikel
|
| 1005 |
Combined Cyclophosphamide, Fludarabine, Alemtuzumab, and Rituximab (CFAR), an Active Frontline Regimen for High-Risk Patients with CLL.
|
Wierda, William G.
|
|
|
110 |
11 |
p. 628
|
artikel
|
| 1006 |
Combined Effects of a Pan-Aurora Kinase Inhibitor MK-0457 and Dasatinib Against T315I Mutant Form of BCR-ABL: In Vitro and In Vivo Studies.
|
Tauchi, Tetsuzo
|
|
|
110 |
11 |
p. 805
|
artikel
|
| 1007 |
Combined escBEACOPP-ABVD Therapy for Advanced Hodgkin's Lymphoma Patients with High IPS Score: An Effective Regimen and Low Positive Predictive Value of Early FDG-PET/CT Scan.
|
Avigdor, Abraham
|
|
|
110 |
11 |
p. 2319
|
artikel
|
| 1008 |
Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).
|
Montillo, Marco
|
|
|
110 |
11 |
p. 3133
|
artikel
|
| 1009 |
Combined Inhibition of CDK and PI3K/Akt Pathways Induces Apoptosis of Mantle Cell Lymphoma.
|
Mohapatra, Subhra
|
|
|
110 |
11 |
p. 1384
|
artikel
|
| 1010 |
Combined Tissue Factor Pathway Inhibitor (TFPI) and Thrombomodulin (TM) Deficiency Produces an Augmented Hypercoagulable State with Tissue Specific Fibrin Deposition.
|
Maroney, Susan A.
|
|
|
110 |
11 |
p. 265
|
artikel
|
| 1011 |
Combined Treatment of STI571 (Glivec) and Curcumin Synergistically Suppresses the Growth of K562 Cells Via Inhibition of Bcr-Abl Pathway.
|
Park, Juwon
|
|
|
110 |
11 |
p. 4537
|
artikel
|
| 1012 |
Combined VBM Chemotherapy and Involved Field (IF) Radiotherapy in Early Stage Hodgkin's Lymphoma (HL): A Single Centre Experience.
|
Cocorocchio, Emilia
|
|
|
110 |
11 |
p. 4463
|
artikel
|
| 1013 |
Common Gene Deletions and Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation.
|
Bradner, James
|
|
|
110 |
11 |
p. 37
|
artikel
|
| 1014 |
Common VWF Haplotypes in Normal African-Americans and Caucasians Recruited into the ZPMCB-VWD and Their Impact on VWF Laboratory Testing.
|
Flood, Veronica H.
|
|
|
110 |
11 |
p. 714
|
artikel
|
| 1015 |
Comorbidity Indexes and Allogeneic Stem Cell Transplantation (SCT).
|
Xhaard, Alienor
|
|
|
110 |
11 |
p. 1985
|
artikel
|
| 1016 |
Comorbidity, Lactate Dehydrogenase (LDH), and Chemosensitivity Are Independent Predictors of Mortality after Autologous Hematopoietic Cell Transplantation (HCT) for Patients (pts) with Lymphoma.
|
Sorror, Mohamed
|
|
|
110 |
11 |
p. 616
|
artikel
|
| 1017 |
Comparable Outcome after Allogeneic Hematopoietic Cell Transplantation from Matched Unrelated and Sibling Donors in Elderly Patients with Acute Myeloid Leukemia - Results of a Retrospective Analysis in 368 Patients.
|
Schetelig, Johannes
|
|
|
110 |
11 |
p. 172
|
artikel
|
| 1018 |
Comparable Outcomes in Secretory (SM) Versus Non-Secretory (NSM) Multiple Myeloma (MM) with Autologous Hematopoietic Stem Cell Transplantation (AuHCT).
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 944
|
artikel
|
| 1019 |
Comparable Outcomes of High-Resolution HLA-Matched Unrelated and HLA-Identical Sibling Donor Stem Cell Transplantation for Childhood Acute Myeloid Leukemia in First Remission.
|
Lee, Dae-Hyoung
|
|
|
110 |
11 |
p. 5079
|
artikel
|
| 1020 |
Comparable Survival between HIV+ and HIV- Hodgkin's Lymphoma (HL) and Non-Hodgkin's Lymphoma (NHL) Patients Undergoing an Autologous Peripheral Blood Stem Cell Transplantation (ASCT). A Retrospective Analysis of the EBMT Lymphoma Working Party.
|
Diez-Martin, Jose L.
|
|
|
110 |
11 |
p. 24
|
artikel
|
| 1021 |
Comparative Analysis of Coagulation System Proteins Distribution in Breast Cancer Primary Lesions and Lymph Node Metastases.
|
Wojtukiewicz, Marek
|
|
|
110 |
11 |
p. 3137
|
artikel
|
| 1022 |
Comparative Analysis of Downstream Genetic Targets of the Variant Acute Promyelocytic Leukemia Fusion Proteins NPM-RARA and NuMA-RARA.
|
Thomas, Mariam
|
|
|
110 |
11 |
p. 3166
|
artikel
|
| 1023 |
Comparative Analysis of Gene Expression Profiles between Diagnosis and Relapse of Childhood Acute Lymphoblastic Leukemia.
|
Szczepanski, Tomasz
|
|
|
110 |
11 |
p. 2809
|
artikel
|
| 1024 |
Comparative Gene Profiling of Acute Myeloid Leukemia (AML) and Malignant Melanoma (MEL) Cell Lines Exposed to the MEK Inhibitor PD0325901 Reveals Common Effectors of the MEK/ERK Kinase Module.
|
Milella, Michele
|
|
|
110 |
11 |
p. 3470
|
artikel
|
| 1025 |
Comparative High Resolution Array-Based CGH (aCGH) in B-Cell Malignancies.
|
Braggio, Esteban
|
|
|
110 |
11 |
p. 2479
|
artikel
|
| 1026 |
Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.
|
Sokolic, Robert
|
|
|
110 |
11 |
p. 501
|
artikel
|
| 1027 |
Comparative Single-Institute Analysis of Cord Blood Transplantation from Unrelated Donors with Unrelated Bone Marrow or Related Peripheral Blood Stem-Cell Transplants in Elderly Patients with Hematologic Diseases after Reduced Intensity-Conditioning Regimen.
|
Uchida, Naoyuki
|
|
|
110 |
11 |
p. 2011
|
artikel
|
| 1028 |
Comparative Study of French Unrelated Registered Stem Cell Donors and Cryopreserved Cord Blood Units.
|
Balere, Marie-Lorraine M.L.
|
|
|
110 |
11 |
p. 5068
|
artikel
|
| 1029 |
Comparative Transcriptome Analysis of Different Subsets of CD34+ Normal and Chronic Myeloid Leukemia Cells Identifies Novel Perturbations in the CML Stem Cell Population.
|
Zhao, Yun
|
|
|
110 |
11 |
p. 35
|
artikel
|
| 1030 |
Comparison between Intravenous Iron and Oral Iron Preparations for the Treatment of Anemia of Chronic Kidney Disease - A Systematic Review and Meta-Analysis
|
Gafter-Gvili, Anat
|
|
|
110 |
11 |
p. 3748
|
artikel
|
| 1031 |
Comparison of Allogeneic Hematopoietic Cell Transplantation (HCT) after Nonmyeloablative Conditioning with HLA-Matched Related (MRD), Unrelated (URD), and Related Haploidentical (Haplo) Donors for Relapsed or Refractory Hodgkin Lymphoma (HL).
|
Burroughs, Lauri
|
|
|
110 |
11 |
p. 173
|
artikel
|
| 1032 |
Comparison of Antigen and Activation Assays with a Probability Scoring Model for the Diagnosis of Heparin Induced Thrombocytopenia.
|
Scarvelis, Dimitrios
|
|
|
110 |
11 |
p. 3215
|
artikel
|
| 1033 |
Comparison of 200 cGy vs. 400 cGy Total Body Irradiation (TBI) When Used with Fludarabine for Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation (RIC AHSCT).
|
Sobecks, Ronald
|
|
|
110 |
11 |
p. 2003
|
artikel
|
| 1034 |
Comparison of Clinical Outcomes of Relapsed APL Patients Induced with ATO and Consolidated with Either an Autologous SCT or ATO Based Treatment Regimen.
|
Mathews, Vikram
|
|
|
110 |
11 |
p. 2880
|
artikel
|
| 1035 |
Comparison of Cyclosporine A and Mycophenolate Mofetil vs Cyclosporine A and Methotrexate in Reduced Intensity Conditioning HLA Sibling Allogeneic Stem Cell Transplantation. A Case-Match Single-Center Experience.
|
Piñana, Jose L.
|
|
|
110 |
11 |
p. 4994
|
artikel
|
| 1036 |
Comparison of Cytochemistry, Flow Cytometry and Immunohistochemistry for the Detection of Myeloperoxidase in Acute Myeloid Leukemia.
|
Saravanan, Linda
|
|
|
110 |
11 |
p. 4256
|
artikel
|
| 1037 |
Comparison of Different Chemotherapy Regimens in the Management of Acute Myeloid Leukaemia - 5 Years Experience from Pakistan.
|
Ullah, Khalil
|
|
|
110 |
11 |
p. 4349
|
artikel
|
| 1038 |
Comparison of Different Intravenous and Oral Dose Schedules on Clofarabine-Induced Hematological Toxicity in Male Rates.
|
Arthaud, Larry
|
|
|
110 |
11 |
p. 4524
|
artikel
|
| 1039 |
Comparison of Gene Expression between T Cells from CLL Patients, Myeloma Patients and Healthy Individuals.
|
Choudhury, Aniruddha
|
|
|
110 |
11 |
p. 4674
|
artikel
|
| 1040 |
Comparison of High Resolution HPLC with Capillary Zone Electrophoresis in Hemoglobin A2 Measurement.
|
Gallivan, Monica V.
|
|
|
110 |
11 |
p. 3832
|
artikel
|
| 1041 |
Comparison of Homeostatic Reticulocyte Aging between Normal and Belgrade Rats Using Flow Cytometry.
|
Wiczling, Pawel
|
|
|
110 |
11 |
p. 2682
|
artikel
|
| 1042 |
Comparison of ICE (Ifosfamide-Carboplatin-Etoposide) Versus DHAP (Cytosine Arabinoside-Cisplatin-Dexamethasone) as Salvage Chemotherapy in Patients with Relapsed or Refractory Lymphoma.
|
Urun, Yuksel
|
|
|
110 |
11 |
p. 4438
|
artikel
|
| 1043 |
Comparison of Imatinib, Dasatinib, Nilotinib and INNO-406 in Imatinib-Resistant Cell Lines.
|
Kimura, Shinya
|
|
|
110 |
11 |
p. 2952
|
artikel
|
| 1044 |
Comparison of Immune Reconstitution after Umbilical Cord Blood (UCB) and Allogenic Peripheral Blood Stem Cell (APBSC) Transplantation in Patients with Advanced Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML).
|
Meniane, Jean-Come
|
|
|
110 |
11 |
p. 5008
|
artikel
|
| 1045 |
Comparison of Immunohystochemical (IHC) Expression Profile and Prognosis in 98 Patients with Diffuse Large B Cell Non-Hodgkin's Lymphoma (DLBCL) with and without Human Immunodeficiency Virus (HIV) Infection.
|
Xicoy, Blanca
|
|
|
110 |
11 |
p. 4403
|
artikel
|
| 1046 |
Comparison of 12-Month Treatment Costs for Patients with Advanced Phase Chronic Myeloid Leukemia (CML) in China: Imatinib (IM) vs. Chemotherapy (Chemo) Plus Interferon-(IFN) in Accelerated Phase (AP) CML and IM vs. Chemo in Blast Crisis (BC) CML.
|
Chen, Zi
|
|
|
110 |
11 |
p. 5169
|
artikel
|
| 1047 |
Comparison of Outcomes of Bone Marrow and Umbilical Cord Blood Transplants from Unrelated Donors in Adult Patients with Acute Myeloid Leukemia/Myelodysplastic Syndrome.
|
Masuoka, Kazuhiro
|
|
|
110 |
11 |
p. 2010
|
artikel
|
| 1048 |
Comparison of PB CD34+ vs Hematopoietic Progenitor Cell Counts as Predictors of Successful PBPC Collections in Healthy Donors and Patients.
|
Barbosa, Isabel L.
|
|
|
110 |
11 |
p. 4914
|
artikel
|
| 1049 |
Comparison of Platelet Function and Bleeding in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura (ITP) and Chemotherapy-Induced Thrombocytopenia (CIT).
|
Psaila, Bethan
|
|
|
110 |
11 |
p. 2094
|
artikel
|
| 1050 |
Comparison of Prognostic Factors and Outcomes of Patients with Secondary Acute Myeloid Leukemia (AML) Following Myelodysplastic Syndromes (MDS), Myeloproliferative Disorders (MPD), or Therapy-Related AML (t-AML).
|
Mohan, Sanjay
|
|
|
110 |
11 |
p. 4292
|
artikel
|
| 1051 |
Comparison of Quality of Life across Adolescents with Cancer, Sickle Cell Disease and Hemophilia.
|
Sharma, Mukta
|
|
|
110 |
11 |
p. 5176
|
artikel
|
| 1052 |
Comparison of the Antithrombotic Effectiveness of the Direct Thrombin Inhibitor, Dabigatran Etexilate, and Two Factor Xa Inhibitors in an A-V Shunt Model of Thrombosis in Rabbits.
|
van Ryn, Joanne
|
|
|
110 |
11 |
p. 3154
|
artikel
|
| 1053 |
Comparison of the 2-Year Clinical Outcomes of VTE Prophylaxis Options in Medical Patients at Risk of VTE.
|
Deitelzweig, Steven B.
|
|
|
110 |
11 |
p. 1876
|
artikel
|
| 1054 |
Comparison of Three Minor-Mismatched Mouse Models of Chronic Graft Versus Host Disease.
|
Mueller, Antonia M.S.
|
|
|
110 |
11 |
p. 3237
|
artikel
|
| 1055 |
Comparison of 6586 Unrelated Bone Marrow Transplants (UBMT) and 2713 Unrelated Cord Blood Transplants (UCBT) in Japan.
|
Kato, Shunichi
|
|
|
110 |
11 |
p. 332
|
artikel
|
| 1056 |
Comparison of UVA and UVB Induced Lesions in Human Platelets Evaluated in an Animal Model.
|
Gelderman-Fuhrmann, Monique P.
|
|
|
110 |
11 |
p. 2883
|
artikel
|
| 1057 |
Comparison of YM150, an Oral, Direct Factor Xa Inhibitor, with Other Antithrombotic Agents in Rodent Venous and Arterial Thrombosis Models.
|
Saitoh, Minori
|
|
|
110 |
11 |
p. 3155
|
artikel
|
| 1058 |
Compartment-Specific Bioluminescence Imaging (CS-BLI): A High-Throughput Approach To Identify Novel Anti-Neoplastic Therapies That Overcome the Protection of Stromal Cells.
|
McMillin, Douglas W.
|
|
|
110 |
11 |
p. 536
|
artikel
|
| 1059 |
Compassionate Use Experience with Dasatinib Therapy in Patients after Imatinib and/or Nilotinib Failure.
|
Gunawardena, Bettina A.
|
|
|
110 |
11 |
p. 4561
|
artikel
|
| 1060 |
Compassionate Use of Nilotinib (AMN107) in Mexican Patients with Chronic Myeloid Leukemia (CML) Resistant or Intolerant to Imatinib.
|
Ayala, Manuel
|
|
|
110 |
11 |
p. 4578
|
artikel
|
| 1061 |
Complement Activation and Complement-Mediated Killing of B Cells Promoted by Anti-CD20 Monoclonal Antibodies (mAb) Rituximab and Ofatumumab Are Rapid, and Ofatumumab Kills Cells More Rapidly and with Greater Efficacy.
|
Taylor, Ronald P.
|
|
|
110 |
11 |
p. 2352
|
artikel
|
| 1062 |
Complement Activation and Resistance within the Cerebrospinal Fluid Following Intraventricular Administration of Anti-CD20 in the Treatment of Recurrent CNS Lymphoma.
|
Kadoch, Cigall
|
|
|
110 |
11 |
p. 3418
|
artikel
|
| 1063 |
Complementary JAK/STAT Signalling Is Required for the Pro-Inflammatory Effects of CD40 Ligation: Differential Effects in Human Myeloid and B Cells.
|
Conzelmann, Michael
|
|
|
110 |
11 |
p. 2413
|
artikel
|
| 1064 |
Complement Cascade (CC) Cleavage Fragments - C3a and C5a Anaphylatoxins - As New Unexpected Hypoxia-Related Stimulators of Erythropoiesis.
|
Ratajczak, Janina
|
|
|
110 |
11 |
p. 2220
|
artikel
|
| 1065 |
Complement System Activation after Allogeneic Bone Marrow Transplantation May Early Predict the Development of Acute Gastrointestinal GVHD.
|
Rubio, Marie T.
|
|
|
110 |
11 |
p. 2186
|
artikel
|
| 1066 |
Complete and Fast Hematologic Reconstitution with Non-Cryopreserved Stem Cell after a 5 Days BEAM Conditioning and Autologous Stem Cell Transplantation.
|
Karduss, Amado J.
|
|
|
110 |
11 |
p. 4926
|
artikel
|
| 1067 |
Complete Clinical and Molecular Remissions Due to Very Effective GVL Reactions after Allogeneic Blood Stem Cell Transplantation for Mantle Cell Lymphoma in First or Second Remission.
|
Schüler, Frank
|
|
|
110 |
11 |
p. 2187
|
artikel
|
| 1068 |
Complete Hematologic Response to Sunitinib in an Eosinophilia-Associated Chronic Myeloproliferative Disorder with an ETV6-FLT3 Fusion Gene.
|
Walz, Christoph
|
|
|
110 |
11 |
p. 3558
|
artikel
|
| 1069 |
Complete Remission Achievement during Long-Term Maintenance with Bortezomib Based Therapy in Multiple Myeloma: A Case Report.
|
Crescenzi, Sabrina Leonetti
|
|
|
110 |
11 |
p. 4815
|
artikel
|
| 1070 |
Complete Remission after Autologous Stem Cell Transplantation Does Not Impact Relapse or Survival in African Americans with Multiple Myeloma.
|
Khaled, Yasser
|
|
|
110 |
11 |
p. 5125
|
artikel
|
| 1071 |
Complete Remissions Observed in Acute Myeloid Leukemia Following Prolonged Exposure to SGN-33 (lintuzumab), a Humanized Monoclonal Antibody Targeting CD33.
|
Raza, Azra
|
|
|
110 |
11 |
p. 159
|
artikel
|
| 1072 |
Complete Remission Status at Autologous Transplantation Is an Important Prognostic Factor in Multiple Myeloma Patients Received Upfront Single Autologous Transplantation.
|
Kim, Jin Seok
|
|
|
110 |
11 |
p. 955
|
artikel
|
| 1073 |
Complex Karyotypic Abnormalities Detected by Conventional Cytogenetic Analysis More Strongly Predict Survival Than FISH, ZAP70, or IgVH Mutation Status for Previously Treated Patients with CLL.
|
Wierda, William G.
|
|
|
110 |
11 |
p. 2065
|
artikel
|
| 1074 |
Compliance with Imatinib Mesylate Associated with Lower Health Resource Utilization and Costs for Patients with CML and GIST.
|
Halpern, Rachel
|
|
|
110 |
11 |
p. 5159
|
artikel
|
| 1075 |
Composite Lymphoma: A Late Relapsing Primary Cutaneous B Cell Lymphoma Coexisting with Nodal Hodgkin's Lymphoma.
|
Pulini, Stefano
|
|
|
110 |
11 |
p. 4426
|
artikel
|
| 1076 |
Composite Nodular Sclerosis Hodgkin and Diffuse Large B Cell Non-Hodgkin Lymphoma Arising from the Thymus.
|
Sumoza, Luis D.
|
|
|
110 |
11 |
p. 4432
|
artikel
|
| 1077 |
Compositional Differences in the Oligosaccharide Components of Generic Versions of Enoxaparin and Dalteparin.
|
Jeske, Walter P.
|
|
|
110 |
11 |
p. 3999
|
artikel
|
| 1078 |
Comprehensive Analysis of BAFF Binding Receptor Profiles and Receptor Occupancy in B Cell Chronic Lymphocytic Leukemia: Identification of Discrete Phenotypic Subgroups.
|
Tschumper, Renee C.
|
|
|
110 |
11 |
p. 1135
|
artikel
|
| 1079 |
Comprehensive Analysis of Genetic Alterations in Acute Myeloid Leukemia According to the WHO Classification.
|
Ishikawa, Yuichi
|
|
|
110 |
11 |
p. 4311
|
artikel
|
| 1080 |
Comprehensive Antiphopholipid Antibody Testing in Children with Acute Thromboembolism: Preliminary Findings from a Prospective Inceptional Cohort Study.
|
Hathaway, Hannah
|
|
|
110 |
11 |
p. 1643
|
artikel
|
| 1081 |
Comprehensive Biomarker and Genomic Analysis Identifies p53 Status as the Major Determinant of Response to MDM2 Inhibitors in Chronic Lymphocytic Leukemia.
|
Malek, Sami N.
|
|
|
110 |
11 |
p. 224
|
artikel
|
| 1082 |
Comprehensive Genomic Copy Number and Sequence Analysis of 28 Chromosome 5q31.2 Candidate Genes in De Novo MDS.
|
Graubert, Timothy A.
|
|
|
110 |
11 |
p. 117
|
artikel
|
| 1083 |
Comprehensive Highly Multiplexed Single-Tube Liquid Bead Microarray Assay for Constitutively Activated Tyrosine Kinases in Chronic Myeloproliferative Disorders.
|
Roberts, Mark J.
|
|
|
110 |
11 |
p. 1551
|
artikel
|
| 1084 |
Comprehensive Molecular Characterization of Malignant and Microenvironmental Cells in Waldenstrom's Macroglobulinemia by Gene Expression Profiling.
|
Hatjiharissi, Evdoxia
|
|
|
110 |
11 |
p. 3174
|
artikel
|
| 1085 |
Comprehensive Risk Factor Analysis in 939 Adults with Acute Myeloid Leukemia Receiving Risk Stratified Post-Remission Therapy: Results of the Prospective Randomized AML96 Trial of the German Study Initiative Leukemia (DSIL).
|
Ehninger, Gerhard
|
|
|
110 |
11 |
p. 1847
|
artikel
|
| 1086 |
Concomitant Diagnosis of Chronic Myeloid Leukemia and B-Cell Chronic Lymphocytic Leukemia in a 57-Year-Old Female Patient, with Good Therapeutic Response Exclusively to Imatinib in Both Myeloid and Lymphoid Clones.
|
Moellmann-Coelho, Arthur
|
|
|
110 |
11 |
p. 4583
|
artikel
|
| 1087 |
Concordance of Assays Designed for the Quantitation of JAK2 1849G>T (V617F): A Multi-Centre Study.
|
Lippert, Eric
|
|
|
110 |
11 |
p. 2529
|
artikel
|
| 1088 |
Conditional Deletion of STAT5 in Non-Myeloablated Recipient Mice Promotes Donor Hematopoietic Stem Cell Engraftment.
|
Wang, Zhengqi
|
|
|
110 |
11 |
p. 178
|
artikel
|
| 1089 |
Conditioning with Fludarabine, BCNU, and Melphalan in Allogeneic Stem Cell Transplantation Results in Reduced Toxixcity and High Activity Against Advanced Hematologic Malignancies.
|
Marks, Reinhard
|
|
|
110 |
11 |
p. 3066
|
artikel
|
| 1090 |
Conditions Associated with Hyperferritinemia in HIV Positive Patients.
|
Kodali, Srinivas
|
|
|
110 |
11 |
p. 2288
|
artikel
|
| 1091 |
Confirmation of the Safety and Efficacy of the Kovacs 10 mg Warfarin Initiation Nomogram for Venous Thromboembolism and Derivation of a Rule To Predict the Weekly Maintenance Dose.
|
Monkman, Katherine J.
|
|
|
110 |
11 |
p. 1864
|
artikel
|
| 1092 |
Congenital Hypothyroidism Following Maternal Exposure throughout Pregnancy to Imatinib.
|
Leeksma, Onno C.
|
|
|
110 |
11 |
p. 4549
|
artikel
|
| 1093 |
Connectivity Mapping of BCL6 Targeted Therapy Guides Rational Design of Potent and Specific Non-Chemotherapy Combinatorial Regimens in DLBCL.
|
Cerchietti, Leandro
|
|
|
110 |
11 |
p. 523
|
artikel
|
| 1094 |
Connexin-43 Mediates Fcγ Receptor-Induced Calcium Signaling by Acting as an NAD/Cyclic ADP-Ribose Transporter.
|
Song, Eun-Kyung
|
|
|
110 |
11 |
p. 3853
|
artikel
|
| 1095 |
Conservative Whole Blood Extended Differential Method.
|
Paul, Ronald
|
|
|
110 |
11 |
p. 3846
|
artikel
|
| 1096 |
Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients in the EXCLAIM Study.
|
Tapson, Victor F.
|
|
|
110 |
11 |
p. 1863
|
artikel
|
| 1097 |
Consolidation Therapy Based on Conventional Chemotherapy and Corticoids Do Not Provide Therapeutic Advantage for Newly Diagnosed Patients after Autologous Transplantation.
|
Prof, Roman Hajek
|
|
|
110 |
11 |
p. 531
|
artikel
|
| 1098 |
Consolidation Therapy with Subcutaneous (SC) Alemtuzumab Results in Severe Infectious Toxicity in Previously Untreated CLL Patients Who Achieve a Complete Response (CR) after Fludarabine and Rituximab (FR) Induction Therapy: Interim Safety Analysis of the CALGB Study 10101.
|
Lin, Thomas S.
|
|
|
110 |
11 |
p. 755
|
artikel
|
| 1099 |
Consolidation with Bortezomib, Thalidomide and Dexamethasone Induces Molecular Remissions in Autografted Multiple Myeloma Patients.
|
Ladetto, Marco
|
|
|
110 |
11 |
p. 530
|
artikel
|
| 1100 |
Constitutional Loss-of-Function Mutations in Telomerase Are Genetic Risk Factors for Acute Myeloid Leukemia.
|
Calado, Rodrigo T.
|
|
|
110 |
11 |
p. 16
|
artikel
|
| 1101 |
Constitutive Activation of Ras and Mitogen-Activated Protein Kinase (MAPK/ERK) in LGL Leukemia Unrelated to Activating Mutations in N and KRas Genes.
|
Painter, Jeffrey S.
|
|
|
110 |
11 |
p. 3180
|
artikel
|
| 1102 |
Constitutive Activation of STAT5a in Myeloid Progenitors of Severe Congenital Neutropenia Patients Leads to Downregulation of LEF-1.
|
Skokowa, Julia
|
|
|
110 |
11 |
p. 663
|
artikel
|
| 1103 |
Constitutive Activation of the Canonical NF-κB Signaling Pathway and Expanded Populations of Splenic Marginal Zone B Cells Characterize Em-BCL10 Transgenic Mice.
|
Li, Zhaoyang
|
|
|
110 |
11 |
p. 1341
|
artikel
|
| 1104 |
Constitutive Activation of the Protein Tyrosine Kinase Syk in Chronic Lymphocytic Leukemia B-Cells.
|
Gobessi, Stefania
|
|
|
110 |
11 |
p. 1123
|
artikel
|
| 1105 |
Constitutive Chemokine Receptor Expression in B-Cell Non-Hodgkin's Lymphoma.
|
Bryson, Michelle S.
|
|
|
110 |
11 |
p. 3590
|
artikel
|
| 1106 |
Constitutive Expression of Lef-1 in Murine Hematopoietic Progenitors Causes Myeloid and Lymphoid Leukemias Propagated by a Leukemic Stem Cell Population with Lymphoid Characteristics.
|
Petropoulos, Konstantin
|
|
|
110 |
11 |
p. 2645
|
artikel
|
| 1107 |
Constitutive JAK3 Activation as a Mouse Model for Human Peripheral T-Cell Lymphoma.
|
Cornejo, Melanie G.
|
|
|
110 |
11 |
p. 1612
|
artikel
|
| 1108 |
Constitutively Activated STAT3 Promotes Cell Proliferation and Survival in the Activated B Cell Subtype of Diffuse Large B Cell Lymphomas.
|
Ye, Bihui Hilda
|
|
|
110 |
11 |
p. 1621
|
artikel
|
| 1109 |
Constitutively Serine Phosphorylated STAT3 Provides Chronic Lymphocytic Leukemia (CLL) Cells with Survival Advantage and Promotes Their Proliferation.
|
Hazan-Halevy, Inbal
|
|
|
110 |
11 |
p. 1132
|
artikel
|
| 1110 |
Contacts between Several ADAMTS13 Structural Domains and von Willebrand Factor Domain A2 Contribute to Substrate Cleavage.
|
Gao, Weiqiang
|
|
|
110 |
11 |
p. 1750
|
artikel
|
| 1111 |
Continued Expression of the NRAS(G12V) Oncogene Is Required for the Maintenance of Acute Myeloid Leukemia Induced in Cooperation with MLL-AF9.
|
Kim, Won-Il
|
|
|
110 |
11 |
p. 1615
|
artikel
|
| 1112 |
Continued Late Conversion to Complete Remission (CR/CRu) and Durability of Remission (DUR) in Pts with B-Cell Follicular Lymphoma (FL) Treated with Rituximab Followed by Mitumprotimut-T (Id-KLH, FavId®) Active Immunotherapy.
|
Koc, Omer N.
|
|
|
110 |
11 |
p. 3427
|
artikel
|
| 1113 |
Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment in All Cytogenetic Subgroups of Older AML Patients: Results of the FR00331 Multicenter Phase II Study.
|
Lübbert, Michael
|
|
|
110 |
11 |
p. 300
|
artikel
|
| 1114 |
Continuous Immuno-Chemotherapy Followed by High Dose and Autologous Cell Transplantation May Improve the Event-Free-Survival in Mantle Cell Lymphoma Patients. Experience at the European Institute of Oncology in Milan.
|
Bassi, Simona
|
|
|
110 |
11 |
p. 5116
|
artikel
|
| 1115 |
Continuous Improvement of Bone Mineral Density Two Years Post Zoledronic Acid Discontinuation in Patients with Thalassemia-Induced Osteoporosis: Long-Term Follow-Up of a Randomized, Placebo-Controlled Trial.
|
Voskaridou, Ersi
|
|
|
110 |
11 |
p. 2768
|
artikel
|
| 1116 |
Continuous Infusion of FLAG and Idarubicin for Patients Younger Than 60 Years with Resistant Acute Myeloid Leukemia; a Prospective, Multicenter Phase II Study.
|
Kim, Hawk
|
|
|
110 |
11 |
p. 4350
|
artikel
|
| 1117 |
Contribution of All-Trans Retinoic Acid to Improved Early Relapse-Free Outcome in Infant Acute Lymphoblastic Leukemia Comparing to the Chemotherapy Alone.
|
Fechina, Larisa
|
|
|
110 |
11 |
p. 2828
|
artikel
|
| 1118 |
Contributions of Phosphatidylserine Exposure on Leukemic Cells to Unregulated Procoagulant Activity in Acute Promyelocytic Leukemia.
|
Zhou, Jin
|
|
|
110 |
11 |
p. 2153
|
artikel
|
| 1119 |
Contributions of Residues in the 558-Loop of Factor VIIIa A2 Subunit to Interactions with Factor IXa in Factor Xase.
|
Ichikawa, H. Travis
|
|
|
110 |
11 |
p. 2688
|
artikel
|
| 1120 |
Control of Massive Bleeding in Dengue Hemorrhagic Fever with Severe Thrombocytopenia by Use of KhamRho IV Anti D®.
|
Yadav, Satya Prakash
|
|
|
110 |
11 |
p. 2086
|
artikel
|
| 1121 |
Control of Platelet Adhesion by Rigidity Sensing at the Surface of Fibrin Clot.
|
Podolnikova, Nataly P.
|
|
|
110 |
11 |
p. 3906
|
artikel
|
| 1122 |
Cooperating Molecular Mutations in AML1/RUNX1 Mutated AML Differ Dependent on the Cytogenetic Subgroup.
|
Schnittger, Susanne
|
|
|
110 |
11 |
p. 365
|
artikel
|
| 1123 |
Cooperative Calcium Signaling Mediated by Glycoprotein (GP) Ib-IX-V, GPVI and Integrin α2β1 during Platelet Adhesion to Collagen under Flow.
|
De Marco, Luigi
|
|
|
110 |
11 |
p. 3638
|
artikel
|
| 1124 |
Coordinate Interstitial Deletion of Retinoblastoma (RB1) and Neurobeachin (NBEA) Is a Recurring Event in Multiple Myeloma.
|
O'Neal, Julie
|
|
|
110 |
11 |
p. 2480
|
artikel
|
| 1125 |
Copper and Iron Status in Myelodysplastic Syndromes.
|
Saouli, Zoi
|
|
|
110 |
11 |
p. 4593
|
artikel
|
| 1126 |
Cord Blood (CB) CD34+ and CD3+ Cells with Decreasing Levels of Their Mitochondrial Potential Are Not Detectable with 7-AAD, Have Impaired Function and Ultrastructural Morphology Characteristic of Early Apoptosis.
|
Albano, Maria S.
|
|
|
110 |
11 |
p. 1208
|
artikel
|
| 1127 |
Cord Blood NK Cytotoxic Activity Can Be Selelctively Modulated by Accessory.
|
Xing, Dongxia
|
|
|
110 |
11 |
p. 3272
|
artikel
|
| 1128 |
Cord Blood Transplantation after Non Myeloablative Conditioning (Minneapolis Protocol): Impact on Transplant Outcomes in 112 Adults with Hematologic Malignancy. A French Multicentric Study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and Eurocord.
|
Rio, B.
|
|
|
110 |
11 |
p. 2029
|
artikel
|
| 1129 |
Cord Blood Transplantation from Unrelated Donors for Adults with Advanced Lymphoid Malignancies - A Eurocord-Netcord Group/EBMT-LWP Study.
|
Rodrigues, Celso A.
|
|
|
110 |
11 |
p. 2025
|
artikel
|
| 1130 |
Cord Blood Transplantation from Unrelated Donors for Children with Acute Lymphoblastic Leukemia in Japan: The Impact of Methotrexate on the Clinical Outcome.
|
Kato, Koji
|
|
|
110 |
11 |
p. 2023
|
artikel
|
| 1131 |
Corrected QT Interval Is Related to Markers of Hemolysis and Tricuspid Regurgitant Jet Velocity in a Young Cohort with Sickle Cell Disease.
|
Liem, Robert I.
|
|
|
110 |
11 |
p. 2258
|
artikel
|
| 1132 |
Correcting Flow Cytometric Blast Counts for Blood Contamination in Bone Marrow Aspirates.
|
Loken, Michael R.
|
|
|
110 |
11 |
p. 4613
|
artikel
|
| 1133 |
Correction of Anemia with Hematide™, a Synthetic Peptide-Based Erythropoiesis Stimulating Agent (ESA), in Oncology Patients Receiving Chemotherapy.
|
Pickering, Lisa M.
|
|
|
110 |
11 |
p. 3666
|
artikel
|
| 1134 |
Correction of the Skin Defect in Murine Recessive Dystrophic Epidermolysis Bullosa by Bone Marrow Derived SLAM Family Receptor Enriched Cells.
|
Tolar, Jakub
|
|
|
110 |
11 |
p. 435
|
artikel
|
| 1135 |
Correlates of Treatment Intensity for Initial Management of Follicular Lymphoma (FL) in the United States: Report from the National Lymphocare Study (NLCS).
|
Link, Brian K.
|
|
|
110 |
11 |
p. 2612
|
artikel
|
| 1136 |
Correlation between FOXP3 Gene Polymorphisms in Donors, and the Severity of Acute Graft-Versus-Host Disease in Patients after Related Allogeneic Stem Cell Transplantation.
|
Perfecto-Avalos, Yocanxochitl
|
|
|
110 |
11 |
p. 3233
|
artikel
|
| 1137 |
Correlation between High Expression of Natural Killer Related-Genes (NCAM/CD94) and Early Death during Induction in Children with Acute Myeloid Leukemia.
|
Nigro, Luca Lo
|
|
|
110 |
11 |
p. 4291
|
artikel
|
| 1138 |
Correlation between Immunoglobulin Gene Rearrangements and Chromosomal Abnormalities in Multiple Myeloma.
|
Piras, Giovanna
|
|
|
110 |
11 |
p. 4771
|
artikel
|
| 1139 |
Correlation between Intratumoral Cellular Microenvironment, Clinicopathological Parameters and Prognosis in Hodgkin Lymphoma.
|
Kamper, Peter
|
|
|
110 |
11 |
p. 2273
|
artikel
|
| 1140 |
Correlation between MRD and Chimerism Kinetics in CLL Patients after Myeloablative and Non-Myeloablative Allogeneic Hematopoïetic Stem Cell Transplantation.
|
Plesa, Adriana
|
|
|
110 |
11 |
p. 5048
|
artikel
|
| 1141 |
Correlation between TP53 Deletion and Protein Overexpression in Chronic Lymphocytic Leukaemia and Its Impact on Prognostic.
|
Martin, Paloma
|
|
|
110 |
11 |
p. 2076
|
artikel
|
| 1142 |
Correlation between Two ADAMTS-13 Activity Assays Based on Different Principles.
|
Geiter, Sabine
|
|
|
110 |
11 |
p. 3159
|
artikel
|
| 1143 |
Correlation of Clinical Features with the Mutational Status of GM-CSF Signaling Pathway-Related Genes in Children with Juvenile Myelomonocytic Leukemia
|
Yoshida, Nao
|
|
|
110 |
11 |
p. 1528
|
artikel
|
| 1144 |
Correlation of Clinical Response to Nilotinib with BCR-ABL Mutation Status in Advanced Phase Chronic Myelogenous Leukemia (CML-AP) Patients with Imatinib-Resistance or Intolerance.
|
Saglio, Giuseppe
|
|
|
110 |
11 |
p. 1940
|
artikel
|
| 1145 |
Correlation of IFNγ, CD107 and CD137 at the Single Cell Level Can Be Used To Monitor T Cell Responses in Patients after Immunotherapy.
|
Czerwinski, Debra K.
|
|
|
110 |
11 |
p. 2306
|
artikel
|
| 1146 |
Correlation of Multiparameter Flow Cytometry and Fluorescence In Situ Hybridization in Quantifying Malignant Cells at Low Frequencies in B-Cell Lymphoproliferative Diseases.
|
Kern, Wolfgang
|
|
|
110 |
11 |
p. 4428
|
artikel
|
| 1147 |
Correlation of New Method for Measuring Plasma Myeloperoxidase with Clinical Behavior in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
|
Abdool, Adam
|
|
|
110 |
11 |
p. 4321
|
artikel
|
| 1148 |
Correlation of Peripheral Blood Involvement Measured by Four-Color Flow Cytometry and the Achievement of Molecular Response in Mantle Cell Lymphoma Treated within the Prospectively Randomized Intergroup Trials of the European MCL Network
|
Pott, Christiane
|
|
|
110 |
11 |
p. 1284
|
artikel
|
| 1149 |
Correlation of Red Blood Cells and Platelets Parameters.
|
Saouli, Zoi
|
|
|
110 |
11 |
p. 3764
|
artikel
|
| 1150 |
Correlation of Serum Ferritin Levels and Liver Iron Concentration Determined by R2* MRI in Patients with Thalassemia Intermedia.
|
Taher, Ali
|
|
|
110 |
11 |
p. 3818
|
artikel
|
| 1151 |
Correlation of Thrombosis and Prothrombotic Markers with Outcome in Lung Adenocarcinoma Patients: A Prospective Study.
|
de Meis, Ernesto
|
|
|
110 |
11 |
p. 3985
|
artikel
|
| 1152 |
Corticosteroid Therapy Does Not Increase Relapse Rate after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogeneous Leukemia and Myelodysplastic Syndrome Overt Leukemia.
|
Imahashi, Nobuhiko
|
|
|
110 |
11 |
p. 1660
|
artikel
|
| 1153 |
Cost-Effectiveness Analysis (CEA) of Conventional Stem Cell Transplantation (CST) and Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with AML and MDS.
|
Imataki, Osamu
|
|
|
110 |
11 |
p. 3333
|
artikel
|
| 1154 |
Cost-Effectiveness Analysis in Canada of Dasatinib Versus Imatinib for the Treatment of Chronic Myelogenous Leukemia in Patients with Imatinib Resistance.
|
Sambrook, Jennifer C.
|
|
|
110 |
11 |
p. 3328
|
artikel
|
| 1155 |
Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients.
|
Schwarzinger, Michael
|
|
|
110 |
11 |
p. 4340
|
artikel
|
| 1156 |
Cost-Effectiveness of Posaconazole vs Fluconazole in the Prevention of Invasive Fungal Infections among Patients with Graft-Versus-Host Disease (GVHD) in the US.
|
O'Sullivan, Amy K.
|
|
|
110 |
11 |
p. 3336
|
artikel
|
| 1157 |
Cost-Effectiveness of Primary Prophylaxis with Pegfilgrastim Versus Filgrastim in Non-Hodgkin's Lymphoma Patients Receiving CHOP-21.
|
Kim, John
|
|
|
110 |
11 |
p. 5166
|
artikel
|
| 1158 |
Cost Effectiveness of Rituximab Maintenance (R-Maint) vs Autologous Stem Cell Transplant (ASCT) from a UK National Health Service (NHS) Perspective.
|
Millar, Douglas R.
|
|
|
110 |
11 |
p. 3321
|
artikel
|
| 1159 |
Cost-Effectiveness of Rituximab Post CVP Induction for the Treatment of Low-Grade NHL.
|
Hornberger, John C.
|
|
|
110 |
11 |
p. 4486
|
artikel
|
| 1160 |
Costimulatory Blockade (CSB) during Mixed Lymphocyte Reaction (MLR) Prevents IL27 Upregulation and Signalling.
|
Gorgun, Gullu
|
|
|
110 |
11 |
p. 4878
|
artikel
|
| 1161 |
Cost of Myelosuppression with the Second Generation Tyrosine Kinase Inhibitors (TKIs) in Imatinib Resistant/Intolerant Chronic Myelogenous Leukemia (CML): An Economic Analysis Using Global Literature.
|
Stephens, J.
|
|
|
110 |
11 |
p. 5177
|
artikel
|
| 1162 |
Cost of 90Y-Ibritumomab Tiuxetan Radioimmunotherapy Versus Cost of Standard Regimens for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma in Switzerland.
|
Frei, Andreas
|
|
|
110 |
11 |
p. 3320
|
artikel
|
| 1163 |
Co-Transplantation of HLA-Haploidentical, Bone Marrow Derived Mesenchymal Stem Cells Prevents Graft Failure and Improves Hematological Recovery in T-Cell Depleted Haploidentical Stem Cell Transplantation.
|
Ball, Lynne M.
|
|
|
110 |
11 |
p. 3073
|
artikel
|
| 1164 |
Cotransplantation of HLA-Identical Mesenchymal Stem Cells and Hematopoietic Stem Cells in Chinese Patients with Hematologic Diseases.
|
Zhang, Xiaoyan
|
|
|
110 |
11 |
p. 5061
|
artikel
|
| 1165 |
CpG Oligonucleotides Induce Anti-Leukemia Activity in a Syngeneic Murine Model of Acute Lymphoblastic Leukemia.
|
Seif, Alix E.
|
|
|
110 |
11 |
p. 2830
|
artikel
|
| 1166 |
CPI-17 Contributes to Calcium-Independent ADP-Induced Platelet Shape Change through P2Y1-Gq-PKC Pathways.
|
Getz, Todd M.
|
|
|
110 |
11 |
p. 3644
|
artikel
|
| 1167 |
C1q Complement Cascade Protein as a Novel Modulator of the SDF-1-CXCR4 Axis and Hematopoietic Stem/Progenitor Cell Trafficking.
|
Jalili, Ali
|
|
|
110 |
11 |
p. 1212
|
artikel
|
| 1168 |
Cranial Nerves Paralysis Revealing Two Cases of Histiocytic Sarcoma.
|
Galicier, Lionel
|
|
|
110 |
11 |
p. 4406
|
artikel
|
| 1169 |
C-Reactive Protein on Admission Predicts Transplant-Related Mortality in Recipients of Allogeneic Stem Cell Transplant.
|
Kew, Andrea K.
|
|
|
110 |
11 |
p. 3005
|
artikel
|
| 1170 |
CREB Plays a Critical Role in the Regulation of Normal and Malignant Hematopoiesis.
|
Cheng, Jerry C.
|
|
|
110 |
11 |
p. 1224
|
artikel
|
| 1171 |
Critical Role for CD81 in B Cell Activation.
|
Sanyal, Mrinmoy
|
|
|
110 |
11 |
p. 1342
|
artikel
|
| 1172 |
Critical Role of Neutrophils in Determining Antigen-Specific CD4+ T-Cell Tolerance In Vivo.
|
Cheng, Fengdong
|
|
|
110 |
11 |
p. 3294
|
artikel
|
| 1173 |
Crosslineage T-Cell Receptor Genes Rearrangements and Active Receptor Editing in B-Cell Acute Lymphoblastic Leukemia.
|
Makuch-Lasica, Hanna
|
|
|
110 |
11 |
p. 4259
|
artikel
|
| 1174 |
Crosstalk between Chronic Lymphocytic Leukemia (CLL) B-Cells and Marrow Stromal Cells: Implication for CLL B-Cell Activation and Survival.
|
Ding, Wei
|
|
|
110 |
11 |
p. 337
|
artikel
|
| 1175 |
Cross-Talk between c-Myb and GATA-1 Regulates the Entry into Megakaryocyte Differentiation.
|
Berlanga, Oscar
|
|
|
110 |
11 |
p. 1225
|
artikel
|
| 1176 |
Cryopreservation of Peripheral Blood Stem Cells (PBSC) with Hydroxyethylstarch (HES) and Dimethylsulfoxide (DMSO) Results in Faster Granulocyte Recovery Than Using Dimethylsulfoxide Alone.
|
Chan, Wai Shun
|
|
|
110 |
11 |
p. 3287
|
artikel
|
| 1177 |
CS1, a New Surface Target on Multiple Myeloma (MM) Cells, Protects Myeloma Cells from Apoptosis Via Regulation of ERK1/2, AKT and STAT3 Signaling Cascades.
|
Tai, Yu-Tzu
|
|
|
110 |
11 |
p. 109
|
artikel
|
| 1178 |
CtBP1 Is a Novel and Essential Corepressor for BCL6 Autoregulation.
|
Mendez, Lourdes M.
|
|
|
110 |
11 |
p. 3581
|
artikel
|
| 1179 |
CTCF and Nucleophosmin Participate in Long Distance Cyclin D1 Deregulation in Mantle Cell Lymphoma.
|
Epner, Elliot M.
|
|
|
110 |
11 |
p. 989
|
artikel
|
| 1180 |
CTL Exhaustion in Persistent HTLV-1 Infection and ATLL Is Restored through PD-1/PD-L1 Pathway.
|
Kozako, Tomohiro
|
|
|
110 |
11 |
p. 511
|
artikel
|
| 1181 |
CTL Responses Against Tumor Associated Antigens Are Part of the Graft Versus Leukemia-Effect and Protect from Relapse after Allogeneic Hematopoetic Stem Cell Transplantation.
|
Kapp, Markus
|
|
|
110 |
11 |
p. 3231
|
artikel
|
| 1182 |
C3435T Polymorphism of MDR1 Gene Is Not Associated with p-Glycoprotein Function of Leukemic Blasts and Clinical Outcomes in Patients with Acute Myeloid Leukemia.
|
Lee, Michael Jinpyo
|
|
|
110 |
11 |
p. 2381
|
artikel
|
| 1183 |
Cucurbitacin D Upregulates Fetal Hemoglobin Expression in K562 Cells and Human Erythroid Progenitors.
|
Xing, Hongtao
|
|
|
110 |
11 |
p. 3833
|
artikel
|
| 1184 |
Cucurbitacin I (JSI-124) Has Potent Anti-Myeloma Effects Independent of Its Inhibition of JAK2-Induced STAT3 Activation.
|
Ma, Huihui
|
|
|
110 |
11 |
p. 2521
|
artikel
|
| 1185 |
Cul4A Is Required for Cell Viability and Its Deficiency in Hematopoietic Cells Causes Apoptosis and Is Fatal.
|
Chun, Kristin T.
|
|
|
110 |
11 |
p. 639
|
artikel
|
| 1186 |
Curcumin Downregulates NF-kB and Related Genes in Patients with Multiple Myeloma: Results of a Phase I/II Study.
|
Vadhan-Raj, Saroj
|
|
|
110 |
11 |
p. 1177
|
artikel
|
| 1187 |
Cure of Murine Medulloblastoma by Adoptive Transfer of Tumor-Specific T Cells.
|
Nicholson, Cameron L.
|
|
|
110 |
11 |
p. 4904
|
artikel
|
| 1188 |
Current Models for Predicting Warfarin Maintenance Dose Do Not Work in an Ambulatory Venous Thromboembolism Patient Population.
|
Wells, Philip
|
|
|
110 |
11 |
p. 302
|
artikel
|
| 1189 |
Current Staging Systems Are Inadequate Predictors of Treatment Failure after Autologous Hematopoietic Stem Cell Transplants (AuHCT) in Multiple Myeloma (MM).
|
Hari, Parameswaran
|
|
|
110 |
11 |
p. 938
|
artikel
|
| 1190 |
CXCL12 and CXCL13 Levels in Cerebrospinal Fluid (CSF) of Patients with CNS Lymphoma.
|
Fischer, Lars
|
|
|
110 |
11 |
p. 1576
|
artikel
|
| 1191 |
CXCR4 and CD62L Down-Regulation Following B-Cell Receptor Ligation Is Restricted to Progressive Chronic Lymphocytic Leukemia (CLL) Cases.
|
Vlad, Amalia
|
|
|
110 |
11 |
p. 1122
|
artikel
|
| 1192 |
CXCR4 Signals Regulate Neutrophil Release from the Bone Marrow but Not Clearance from the Circulation.
|
Eash, Kyle J.
|
|
|
110 |
11 |
p. 3297
|
artikel
|
| 1193 |
Cyclic ADP-Ribose Increases Human Mesenchymal Stem Cells Proliferation through the Modulation of Spontaneous Ca2+ Oscillation.
|
Tao, Rong
|
|
|
110 |
11 |
p. 4061
|
artikel
|
| 1194 |
Cyclic AMP-Dependent Protein Kinase Mediates Glycoprotein Ibα Shedding from Platelet.
|
Dai, Kesheng
|
|
|
110 |
11 |
p. 3653
|
artikel
|
| 1195 |
Cyclic Neutropenia Is Not Associated with Transformation to MDS and AML.
|
Dale, David C.
|
|
|
110 |
11 |
p. 3306
|
artikel
|
| 1196 |
Cyclin C Regulates the Quiescence of Human CD34+CD38- Hematopoietic Stem Cells.
|
Miyata, Yasuhiko
|
|
|
110 |
11 |
p. 1273
|
artikel
|
| 1197 |
Cyclin-Dependent Kinase Phosphorylation of RUNX1/AML1 on Three Sites Increases Trans-Activation Potency and Stimulates Cell Proliferation.
|
Friedman, Alan D.
|
|
|
110 |
11 |
p. 3351
|
artikel
|
| 1198 |
Cyclin D1 Overexpression Increases Chemosensitivity Via Prolonged S-Phase and TRAIL Signal in Myeloma Cell.
|
Kuroda, Yoshiaki
|
|
|
110 |
11 |
p. 3530
|
artikel
|
| 1199 |
Cyclin D1 Polymorphisms as Predictive and Prognostic Molecular Markers in 90 Mantle Cell Lymphoma Patients Treated with R-HyperCVAD.
|
Thompson, Michael A.
|
|
|
110 |
11 |
p. 1581
|
artikel
|
| 1200 |
Cyclophosphamide Overcomes the Suppressive Effect of LenalidomideTherapy on Stem Cell Collection in Preparation for Autologous Stem Cell Transplantation for Multiple Myeloma.
|
Mark, Tomer
|
|
|
110 |
11 |
p. 3024
|
artikel
|
| 1201 |
Cyclosporine A (CSA) Significantly Reduces the Cytotoxic Effects of In Vitro Expanded NK Cells: Implications for Adoptive NK Cell Therapy in the Setting of Allogeneic Hematopoietic Stem Cell Transplantation (HCT).
|
Yokoyama, Hisayuki
|
|
|
110 |
11 |
p. 4899
|
artikel
|
| 1202 |
Cyclosporine A without or with Thalidomide for the Treatment of Patients with Myelodysplastic Syndromes.
|
Xiao, Zhijian
|
|
|
110 |
11 |
p. 4599
|
artikel
|
| 1203 |
Cyclosporine Versus Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis after Matched Related and Unrelated Minimal Intensity Allotransplantation.
|
Nelson Jr., Robert P.
|
|
|
110 |
11 |
p. 5014
|
artikel
|
| 1204 |
Cystatin-C Is a Sensitive Marker of Renal Impairment with an Independent Predictive Value for Survival in Multiple Myeloma; Reduction Post Bortezomib Monotherapy.
|
Terpos, Evangelos
|
|
|
110 |
11 |
p. 1484
|
artikel
|
| 1205 |
Cytarabine, Daunorubicin and Etoposide (ADE) Chemotherapy in Acute Myeloid Leukemia (AML) Patients ≥60 Years (CALGB 9720).
|
Baer, Maria R.
|
|
|
110 |
11 |
p. 296
|
artikel
|
| 1206 |
Cytogenetic and Molecular Genetic Aberrations in Bone Marrow Mesenchymal Stroma Cells from Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.
|
Blau, Olga
|
|
|
110 |
11 |
p. 985
|
artikel
|
| 1207 |
Cytogenetic Findings and Pattern of Clonal Evolution Determine Survival in Patients with Primary or Secondary Myelofibrosis
|
Tam, Constantine S.
|
|
|
110 |
11 |
p. 1543
|
artikel
|
| 1208 |
Cytogenetic/Molecular Findings and Treatment Outcome of Childhood Acute Megakaryoblastic Leukemia. Possible Favorable Effect of High Dose Cytarabine and Stem Cell Transplantation.
|
Kato, Keisuke
|
|
|
110 |
11 |
p. 4255
|
artikel
|
| 1209 |
Cytogenetic Response in Relation to the Adherence to Treatment with Imatinib Mesylate: A Case Control Study.
|
Doti, Carlos
|
|
|
110 |
11 |
p. 4553
|
artikel
|
| 1210 |
Cytogenetic-Specific Heterogeneity in the Kinetics of Minimal Residual Disease (MRD) Clearance in Childhood Acute Lymphoblastic Leukaemia (ALL).
|
Moorman, Anthony V.
|
|
|
110 |
11 |
p. 1426
|
artikel
|
| 1211 |
Cytogenetic Studies at Diagnosis in Polycythemia Vera: Clinical and JAK2V617F Allele Burden Correlates.
|
Gangat, Naseema
|
|
|
110 |
11 |
p. 2545
|
artikel
|
| 1212 |
Cytokine-Dependent Imatinib Resistance in Mouse Bcr-Abl(+), Arf-Null Lymphoblastic Leukemia.
|
Williams, Richard T.
|
|
|
110 |
11 |
p. 2632
|
artikel
|
| 1213 |
Cytokine Patterns and Lymphocyte Subsets in Patients with Chronic GVHD after Allogeneic Stem Cell Transplantation with Reduced Intensity Conditioning.
|
Skert, Cristina C.
|
|
|
110 |
11 |
p. 3239
|
artikel
|
| 1214 |
Cytokine Production Signatures Are Intrinsically Associated with Human T Cell Maturation Stages.
|
Komanduri, Krishna V.
|
|
|
110 |
11 |
p. 1337
|
artikel
|
| 1215 |
Cytokine Response and Genotype Frequencies in ITP of Childhood.
|
Imfeld, Karen
|
|
|
110 |
11 |
p. 569
|
artikel
|
| 1216 |
Cytomegalovirus (CMV) Reactivation after T-Cell Replete Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT) Correlates with Donor KIR Genotype.
|
Sobecks, Ronald
|
|
|
110 |
11 |
p. 2974
|
artikel
|
| 1217 |
Cytoprotective Effect of Palifermin on Gastrointestinal Mucous Membrane Enabled Non-Myeloablative Chemotherapy Administration in ALL Patient with High Risk of Gastrointestinal Toxicity.
|
Foryciarz, Kajetana
|
|
|
110 |
11 |
p. 4332
|
artikel
|
| 1218 |
Cytosolic Phospholipase A2α (cPLA2α) Functions at the Nexus of Bidirectional Integrin Signaling in Platelets.
|
Prevost, Nicolas
|
|
|
110 |
11 |
p. 136
|
artikel
|
| 1219 |
Cytotoxic Effects of CML28 Specific T Cells on Acute Leukemia Cells In Vitro.
|
Mao, Hanwen
|
|
|
110 |
11 |
p. 4886
|
artikel
|
| 1220 |
Cytotoxicity Assessment of Quassinoids Neosergeolide and Isobrucein B toward Hematopoietic and Solid Malignancies Identifies STAT3 Activation To Be Predictive of Antitumor Response.
|
Hiwatari, Mitsuteru
|
|
|
110 |
11 |
p. 1394
|
artikel
|
| 1221 |
Cytotoxicity of Genetically Engineered Fusion Protein with CD154 Peptide Mimetic (OmpC-CD154p) on B-NHL Cell Lines.
|
Martinez-Miguel, Bernardo
|
|
|
110 |
11 |
p. 4525
|
artikel
|
| 1222 |
Cytotoxicity of the Type 4 Phosphodiesterase Inhibitor CD160130 for Freshly Isolated Human CLL Cells In Vitro.
|
Weinberg, J. Brice
|
|
|
110 |
11 |
p. 3129
|
artikel
|
| 1223 |
Cytotoxic T-Lymphocyte Harnessing CML66 Can Kill Human Myeloid Leukemia Cells, In Vitro.
|
Suemori, Koichiro
|
|
|
110 |
11 |
p. 2746
|
artikel
|
| 1224 |
DAAM2 Polymorphism and Allogeneic Hematopoietic Stem Cell Transplantation.
|
Yi, Hyeon Gyu
|
|
|
110 |
11 |
p. 2986
|
artikel
|
| 1225 |
Dabigatran Inhibits Both Clot-Bound and Fluid Phase Thrombin In Vitro: Effects Compared to Heparin and Hirudin.
|
van Ryn, Joanne
|
|
|
110 |
11 |
p. 3998
|
artikel
|
| 1226 |
Dalteparin Thromboprophylaxis in Critically Ill Patients with Severe Renal Insufficiency: The Direct Study.
|
Douketis, James
|
|
|
110 |
11 |
p. 304
|
artikel
|
| 1227 |
Damage to Aging Thymic Stroma and De Novo T Cell Development.
|
Prockop, Susan
|
|
|
110 |
11 |
p. 3264
|
artikel
|
| 1228 |
Daptomycin Use in Cancer Patients with Neutropenia.
|
Rolston, Kenneth V.I.
|
|
|
110 |
11 |
p. 2289
|
artikel
|
| 1229 |
Darbepoetin alfa Administered Every 3 Weeks Is Effective in Correcting Hemoglobin and Reducing Transfusion Requirements in Anemic Patients with Hematological Malignancies Receiving Chemotherapy: A Retrospective Observational Study Reflecting Real-World Clinical Practice in Europe.
|
Coiffier, Bertrand
|
|
|
110 |
11 |
p. 4085
|
artikel
|
| 1230 |
Darbepoetin Alfa for the Treatment of Anemia in Patients with Myelofibrosis with Myeloid Metaplasia (MMM). Results from a Danish Multicenter Study.
|
Hannestad, Kathrine
|
|
|
110 |
11 |
p. 4641
|
artikel
|
| 1231 |
Darbepoetin 500 mcg Q3W, Alone or in Combination with Peg-Filgrastim, in Low/Int1 IPSS Risk Myelodysplastic Syndromes Unresponsive to Recombinant Erythropoietin.
|
Villani, Oreste
|
|
|
110 |
11 |
p. 4606
|
artikel
|
| 1232 |
Darbepoietin in Autologous Peripheral Blood Stem Cell Transplantation (ASCT): A Pilot Study.
|
Chierichini, Anna
|
|
|
110 |
11 |
p. 5101
|
artikel
|
| 1233 |
Dasatinib as Front-Line Monotherapy for the Induction Treatment of Adult and Elderly Ph+ Acute Lymphoblastic Leukemia (ALL) Patients: Interim Analysis of the GIMEMA Prospective Study LAL1205.
|
Foa, Robert
|
|
|
110 |
11 |
p. 7
|
artikel
|
| 1234 |
Dasatinib Can Be Administered Orally with or without a Meal.
|
Kaul, Sanjeev
|
|
|
110 |
11 |
p. 4569
|
artikel
|
| 1235 |
Dasatinib-Induced Platelet Dysfunction.
|
Quintas-Cardama, Alfonso
|
|
|
110 |
11 |
p. 2941
|
artikel
|
| 1236 |
Dasatinib Induces Apoptosis in Chronic Lymphocytic Leukemia and Enhances the Activity of Rituximab and Fludarabine.
|
Aguillon, Robier A.
|
|
|
110 |
11 |
p. 1116
|
artikel
|
| 1237 |
Dasatinib Inhibits Multiple Myeloma Growth by Blocking PDGF-Rb and c-Src Activity in Patient-Derived Tumor and Endothelial Cells.
|
Coluccia, Addolorata M.L.
|
|
|
110 |
11 |
p. 550
|
artikel
|
| 1238 |
Dasatinib Inhibits the Growth of Neoplastic Human Eosinophils (EOL-1) through Targeting of FIP1L1-PDGFRα.
|
Baumgartner, Christian
|
|
|
110 |
11 |
p. 3559
|
artikel
|
| 1239 |
Dasatinib or High-Dose Imatinib for Patients with Chronic-Phase Chronic Myeloid Leukemia Resistant to Standard-Dose Imatinib: 2-Year Follow-Up Data from START-R (CA180-017).
|
Kantarjian, Hagop M.
|
|
|
110 |
11 |
p. 736
|
artikel
|
| 1240 |
Dasatinib Resistance in CML Patients. Identification of Novel BCR-ABL Kinase Domain Mutation.
|
Krijanovski, Yelena
|
|
|
110 |
11 |
p. 1957
|
artikel
|
| 1241 |
Dasatinib (SPRYCEL®) in Children and Adolescents with Relapsed or Refractory Leukemia: Preliminary Results of the CA180018 Phase I/II Study from the ITCC Consortium.
|
Zwaan, Christian M.
|
|
|
110 |
11 |
p. 1049
|
artikel
|
| 1242 |
Data from the Registry of the Patients with Myelodysplastic Syndrome of a Romanian Single Center. III Analysis of the Group under 50 Years Old.
|
Gologan, Radu B.
|
|
|
110 |
11 |
p. 4601
|
artikel
|
| 1243 |
Data Mining of Hematopoietic Stem Cell Microarray Studies Reveals a Novel Stem Cell Gene Expression Signature and Demonstrates Feasibility of Integrating Data from Different Labs and Different Microarray Platforms.
|
Sohal, D.
|
|
|
110 |
11 |
p. 4073
|
artikel
|
| 1244 |
Day 15 Dendritic Cell Recovery Predicts Overall Survivial after Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma.
|
Siddiqui, Mustaqeem A.
|
|
|
110 |
11 |
p. 5009
|
artikel
|
| 1245 |
Day Hospital Approach to Uncomplicated Vaso-Occlusive Crises in Children with Sickle Cell Disease.
|
Raphael, Jean L.
|
|
|
110 |
11 |
p. 5172
|
artikel
|
| 1246 |
Daytime Steady-State Hemoglobin Desaturation Is a Risk Factor for Overt Stroke Children with Sickle Cell Anemia.
|
Sargent, James W.
|
|
|
110 |
11 |
p. 431
|
artikel
|
| 1247 |
DCC-2036: A Novel Switch Pocket Inhibitor of ABL Tyrosine Kinase with Therapeutic Efficacy Against BCR-ABL T315I In Vitro and in a CML Mouse Model.
|
Van Etten, Richard A.
|
|
|
110 |
11 |
p. 463
|
artikel
|
| 1248 |
DCEP (Dexamethasone, Cyclophosphamide, Etoposide, Cisplatin) Followed by High-Dose G-CSF Is a Highly Efficient and Safe Regimen for Stem Cell Mobilization for Multiple Myeloma.
|
Gonsky, Jason P.
|
|
|
110 |
11 |
p. 3284
|
artikel
|
| 1249 |
D-DImer Dosing for Risk Prediction of Central Venous Catheter Thrombosis (The DIReCT Trial).
|
Doucet, Stephane
|
|
|
110 |
11 |
p. 3980
|
artikel
|
| 1250 |
Death Associated Protein 5 (DAP5/p97/NAT1) Contributes to Retinoic Acid-Induced Granulocytic Differentiation and Arsenic Trioxide Induced Apotosis through Inhibition of PI3K/Akt/mTOR Pathway in Acute Promyelocytic Leukemia Cells: A Novel Mechanism.
|
Ozpolat, Bulent
|
|
|
110 |
11 |
p. 2836
|
artikel
|
| 1251 |
Deciphering JunB Function in Regulating Hematopoietic Stem Cell Functions.
|
Santaguida, Marianne
|
|
|
110 |
11 |
p. 777
|
artikel
|
| 1252 |
Decisional Flow with a Score System To Start Platelet-Lowering Treatment in Patients with Essential Thrombocythemia (ET): Long-Term Results.
|
Latagliata, Roberto
|
|
|
110 |
11 |
p. 4636
|
artikel
|
| 1253 |
Decision Criteria for the Futility of Intensive Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML).
|
Dombret, Hervé
|
|
|
110 |
11 |
p. 2861
|
artikel
|
| 1254 |
Decitabine Improves Clinical Outcomes in Severely Ill Sickle Cell Disease Patients Who Have Exhausted Standard of Care Options.
|
Saunthararajah, Yogenthiran
|
|
|
110 |
11 |
p. 3792
|
artikel
|
| 1255 |
Decreased Bone Mineral Density among Patients with Hemophilia.
|
Gerstner, Gregory
|
|
|
110 |
11 |
p. 1153
|
artikel
|
| 1256 |
Decreased Expression of Membrane-Bound Proteinase 3 by a GPI-Deficient Granulocytes May Contribute to Thrombophilic Propensity in PNH.
|
Jankowska, Anna M.
|
|
|
110 |
11 |
p. 3673
|
artikel
|
| 1257 |
Decreased Expression of the Histone Methyltransferase SUV39H1 in AML Cells Reactivates Hypermethylated Tumor Suppressor p15INK4B in the Absence of Promoter Demethylation.
|
Lakshmikuttyamma, Ashakumary
|
|
|
110 |
11 |
p. 4150
|
artikel
|
| 1258 |
Decreased Hepcidin Level in Iron Deficiency Anemia after Successful Helicobacter pylori Eradication Therapy: A Preliminary Data.
|
Cho, Yo-Han
|
|
|
110 |
11 |
p. 2678
|
artikel
|
| 1259 |
Decreased Incidence of Clonal Evolution to Myelodysplastic Syndrome/Acute Myeloid Leukemia with Monosomy 7 in Children with Aplastic Anemia Following Reduced Use of G-CSF.
|
Takahashi, Yoshiyuki
|
|
|
110 |
11 |
p. 1696
|
artikel
|
| 1260 |
Decreased Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma (MM) Treated with Zoledronic Acid (ZA) after Application of Preventive Measures.
|
Dimopoulos, Meletios Athanasios
|
|
|
110 |
11 |
p. 3609
|
artikel
|
| 1261 |
Decreased Megakaryocytepoiesis and No Excess of Platelet Destruction in Myelodysplastic Syndrome Patients.
|
Murai, Kazunori
|
|
|
110 |
11 |
p. 4616
|
artikel
|
| 1262 |
Decreased MHC-II Expression and Immune Dysfunction by Mesenchymal Stem Cells in the Bone Marrow of Patients with Myeloproliferative Disorders.
|
Castillo, Marianne D.
|
|
|
110 |
11 |
p. 4647
|
artikel
|
| 1263 |
Decreased Numbers of Tregs in Aplastic Anemia Is Detected by Immunohistochemistry and Flow Cytometry.
|
Serio, Bianca
|
|
|
110 |
11 |
p. 1703
|
artikel
|
| 1264 |
Decreased Proliferation of Myeloid Leukemia Cells through Down-Regulating LYL1 Expression with Small Interference RNA.
|
Meng, Yuesheng
|
|
|
110 |
11 |
p. 4158
|
artikel
|
| 1265 |
Defective Activation of Phospholipase Cγ2 by Collagen in Platelets Lacking the Semaphorin Family Member, Sema4D.
|
Zhu, Li
|
|
|
110 |
11 |
p. 417
|
artikel
|
| 1266 |
Defective Circulating CD25 Regulatory T Cells in Patients with Chronic Immune Thrombocytopenic Purpura.
|
Yu, Jin
|
|
|
110 |
11 |
p. 570
|
artikel
|
| 1267 |
Defective Expression of ANKHD1 Transcript Variant 3 in Myelodysplastic Cells and Its Role in Apoptosis.
|
Duarte, Adriana S.S.
|
|
|
110 |
11 |
p. 2432
|
artikel
|
| 1268 |
Defective Expression of Neutrophil Serine Proteases in Myeloid Progenitors of Congenital Neutropenia Patients Carrying Either ELA2 or HAX1 Mutations.
|
Skokowa, Julia
|
|
|
110 |
11 |
p. 3299
|
artikel
|
| 1269 |
Deferasirox (ICL670; Exjade®) Reduces Serum Ferritin (SF) and Labile Plasma Iron (LPI) in Patients with Myelodysplastic Syndromes (MDS).
|
List, Alan F.
|
|
|
110 |
11 |
p. 1470
|
artikel
|
| 1270 |
Deferasirox Might Induce Immunosuppression Comparable to Deferoxamine.
|
Jeong, Dae-Chul
|
|
|
110 |
11 |
p. 3755
|
artikel
|
| 1271 |
Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).
|
Maggio, Aurelio
|
|
|
110 |
11 |
p. 575
|
artikel
|
| 1272 |
Defibrotide Counteracts the Modifications of Anti-Thrombotic Phenotype of Endothelial Cells Induced by Thalidomide.
|
Echart, Cinara
|
|
|
110 |
11 |
p. 2502
|
artikel
|
| 1273 |
Defibrotide for the Treatment of Veno-Occlusive Disease Post SCT: Preliminary Results of EU Compassionate Use Program in 332 Patients Confirm Promising Activity and Manageable Toxicity.
|
Carreras, Enric
|
|
|
110 |
11 |
p. 613
|
artikel
|
| 1274 |
Defibrotide Low-Dose Continuous Infusion from Day +1 Until Day +21 after Allogeneic Stem Cell Transplantation as Prophylaxis of Veno-Occlusive Disease (VOD) of the Liver. A Single Centre Experience.
|
Bonini, Alessandro
|
|
|
110 |
11 |
p. 4927
|
artikel
|
| 1275 |
Deficiency in GATA-4 or GATA-6 Diminishes Definitive Hematopoiesis in Murine Embryonic Stem Cell Derived Embryoid Bodies.
|
Pierre, Monique S.
|
|
|
110 |
11 |
p. 2230
|
artikel
|
| 1276 |
Deficiency of the VWF-Cleaving Protease ADAMTS13 Results in Increased Leukocyte Rolling and Adhesion in Mice.
|
Chauhan, Anil K.
|
|
|
110 |
11 |
p. 290
|
artikel
|
| 1277 |
Deficient Th-1 Responses from TNFα-Matured Dendritic Cells.
|
Decker, William K.
|
|
|
110 |
11 |
p. 3839
|
artikel
|
| 1278 |
Defining Complete Response in Multiple Myeloma: Role of the Serum Free Light Chain Assay and Multiparameter Flow Cytometry.
|
Owen, Roger G.
|
|
|
110 |
11 |
p. 1479
|
artikel
|
| 1279 |
Defining the Leukemia Epigenome: Distinct Genome Wide Histone H3 Modification Patterns Exist in AML, ALL and Healthy Hematopoietic Progenitor Cells.
|
Muller-Tidow, Carsten
|
|
|
110 |
11 |
p. 2124
|
artikel
|
| 1280 |
Defining the Role of Monocytes in Heparin-Induced Thrombocytopenia (HIT): Insights from a Murine HIT Model.
|
Rauova, Lubica
|
|
|
110 |
11 |
p. 280
|
artikel
|
| 1281 |
Degrasyn-Induced Trafficking of BCR-ABL as a Novel Mechanism of Kinase Inactivation.
|
Donato, Nicholas
|
|
|
110 |
11 |
p. 1003
|
artikel
|
| 1282 |
Deguelin, a Novel Hsp90 Inhibitor, Suppresses STAT3 and STAT5 Activity and Induces Apoptosis in the Human T-Cell Leukemia Virus Type 1-Transformed Cells.
|
Ito, Shigeki
|
|
|
110 |
11 |
p. 1387
|
artikel
|
| 1283 |
Delayed Intensification (DI) Enhances Event-Free Survival (EFS) of Children with B-Precursor Acute Lymphoblastic Leukemia (ALL) Who Received Intensification Therapy with Six Courses of Intravenous Methotrexate (MTX): POG 9904/9905: A Childrens Oncology Group Study (COG).
|
Winick, Naomi
|
|
|
110 |
11 |
p. 583
|
artikel
|
| 1284 |
Delayed Platelet Engraftment and Outcome of Stem Cell Transplant for Multiple Myeloma: Possible Microenvironment Effect?.
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 939
|
artikel
|
| 1285 |
Delayed Response to Lenalidomide in International Prognostic Scoring System (IPSS) Low Risk Myelodysplastic Syndrome (MDS).
|
Tubb, Erev E.
|
|
|
110 |
11 |
p. 1447
|
artikel
|
| 1286 |
Deletion of HoxA Genes Inhibits Proliferation and Differentiation of Myeloid Progenitors.
|
Bijl, Janetta J.
|
|
|
110 |
11 |
p. 1271
|
artikel
|
| 1287 |
Deletion of Murine Kininogen Gene 1 (mKNG1) Causes Loss of Plasma Kininogen and Delays Thrombosis.
|
Merkulov, Sergei
|
|
|
110 |
11 |
p. 3625
|
artikel
|
| 1288 |
Deletion of Pro1648-Leu1650 in VWF73, the Conservative Substrate for ADAMTS13, Causes von Willebrand Disease.
|
Su, Jian
|
|
|
110 |
11 |
p. 3939
|
artikel
|
| 1289 |
Deletion 13q in B-CLL: Interphase FISH Reveals More 13q- Than Does CpG Stimulation.
|
Van Dyke, Daniel L.
|
|
|
110 |
11 |
p. 2070
|
artikel
|
| 1290 |
Deletion 5q in WHO-Defined Myeloproliferative Neoplasms: A Clinicopathological Description.
|
Santana-Davila, Rafael
|
|
|
110 |
11 |
p. 2552
|
artikel
|
| 1291 |
Deletions Adjacent to BCR and ABL Breakpoints Occur in a Substantial Minority of Chronic Myeloid Leukaemia Patients with Masked Philadelphia Rearrangements.
|
De Melo, Valeria A.
|
|
|
110 |
11 |
p. 2929
|
artikel
|
| 1292 |
Delineation of a KIT-Independent Oncogenic Pathway in Neoplastic Mast Cells That Involves Lyn and Btk, and Can Be Disrupted by the KIT/Lyn/Btk-Targeting Drug Dasatinib
|
Gleixner, Karoline V.
|
|
|
110 |
11 |
p. 1541
|
artikel
|
| 1293 |
Delineation of Canonical and Non-Canonical NF-κB Pathways in Multiple Myeloma: Therapeutic Implications.
|
Hideshima, Teru
|
|
|
110 |
11 |
p. 670
|
artikel
|
| 1294 |
Delivery of mRNA into Dendritic Cells Using Novel Transfer Peptides Leads to Prolonged Antigen Expression and Potent Immune Responses In Vivo.
|
Woan, Karrune
|
|
|
110 |
11 |
p. 4884
|
artikel
|
| 1295 |
del(17p13.1) in Chronic Lymphocytic Leukemia Confers Poor Prognosis Even at Low Percentage Involvement and Increases Proportionately with Increase in Clonal Involvement.
|
Andritsos, Leslie A.
|
|
|
110 |
11 |
p. 2073
|
artikel
|
| 1296 |
Del(6)(q22) and BCL6 Rearrangements in Primary Central Nervous System Lymphoma (PCNSL) Are Indicators of an Aggressive Clinical Course.
|
Cady, Francois M.
|
|
|
110 |
11 |
p. 1557
|
artikel
|
| 1297 |
Delta Like 4 Expressing Bone Marrow-Derived Endothelial Progenitor Cells Regulate Tumour Angiogenesis
|
Real, Carla
|
|
|
110 |
11 |
p. 3728
|
artikel
|
| 1298 |
Dematin and Adducin Provide a Critical Link between the Spectrin Cytoskeleton and the Erythrocyte Membrane Via Glucose Transporter-1.
|
Khan, Anwar A.
|
|
|
110 |
11 |
p. 1719
|
artikel
|
| 1299 |
Demographic Risk Factors for Low Hematocrit (HCT) Deferral in Regular Whole Blood Donors.
|
Mast, Alan E.
|
|
|
110 |
11 |
p. 2888
|
artikel
|
| 1300 |
Dendritic Cell Reconstitution Following Autologous Stem Cell Transplant with GM-CSF Support for Multiple Myeloma.
|
Schlueter, Annette J.
|
|
|
110 |
11 |
p. 951
|
artikel
|
| 1301 |
Dendritic Cells as a Novel Target for Erythropoietin: Studies in a Human System.
|
Sagiv, Sari Prutchi
|
|
|
110 |
11 |
p. 316
|
artikel
|
| 1302 |
Dendritic Cells as a Novel Target for Erythropoietin: Studies in Murine Models.
|
Lifchitz, Lilach
|
|
|
110 |
11 |
p. 2417
|
artikel
|
| 1303 |
Denileukin Diftitox (ONTAK) Plus CHOP Chemotherapy in Patients with Peripheral T-Cell Lymphomas (PTCL), the CONCEPT Trial.
|
Foss, Francine
|
|
|
110 |
11 |
p. 3449
|
artikel
|
| 1304 |
De Novo CD5+ Diffuse Large B-Cell Lymphoma: Result of a Detail Morphologic Evaluation and Long-Term Follow Up of 128 Patients.
|
Yamaguchi, Motoko
|
|
|
110 |
11 |
p. 1564
|
artikel
|
| 1305 |
De Novo Expression of ATP Binding Cassette C1 (ABCC1) on T-ALL Cells Confers Resistance to Vincristine Independent of an MDR1 Phenotype.
|
Winter, Stuart S.
|
|
|
110 |
11 |
p. 2374
|
artikel
|
| 1306 |
Deoxycytidine Kinase Genotype Influences Leukemia Cell Concentration of Cytarabine 5′-Triphosphate in Pediatric AML Patients.
|
Lamba, Jatinder
|
|
|
110 |
11 |
p. 225
|
artikel
|
| 1307 |
Dependency of Survival on Additional Karyotype Anomalies and Bone Marrow Blast Count in Patients Suffering from Myelodysplastic Syndromes with 5q Deletion.
|
Knipp, Sabine
|
|
|
110 |
11 |
p. 2459
|
artikel
|
| 1308 |
Depletion and Restoration of the Intravascular Nitrite (NO2-) Reserve Modulate Susceptibility to Liver Vaso-Occlusive Infarction in Sickle Cell Transgenic Mice.
|
Hsu, Lewis L.
|
|
|
110 |
11 |
p. 841
|
artikel
|
| 1309 |
Depot Formulation of Interleukin-2 as an Immunotheraphy for B-Cell Lymphoma.
|
Grille, Sofia
|
|
|
110 |
11 |
p. 1398
|
artikel
|
| 1310 |
Deregulation of RARγ and RARγ-Specific miRNAs in AML.
|
Barrett, Angela N.
|
|
|
110 |
11 |
p. 3182
|
artikel
|
| 1311 |
Der(20)idic(20)(p11)del(20)(q11q13) Is Seen Not Only in Myeloid Disorders but Also in Lymphoid Disorders: A Report of Further Seven Cases.
|
Li, Tianyu
|
|
|
110 |
11 |
p. 4126
|
artikel
|
| 1312 |
Derivation and Validation of a Prediction Tool for Venous Thromboembolism: A VERITY Registry Study.
|
Arya, Roopen
|
|
|
110 |
11 |
p. 697
|
artikel
|
| 1313 |
Derivation, Characterization, and In Vitro Differentiation of Canine Embryonic Stem Cells.
|
Ramakrishnan, Aravind
|
|
|
110 |
11 |
p. 4059
|
artikel
|
| 1314 |
Description of a Large Duplication in F8 Gene Responsible for Severe Hemophilia A.
|
Vinciguerra, Christine
|
|
|
110 |
11 |
p. 1149
|
artikel
|
| 1315 |
Design and Development of Small Molecules for Specific Targeted Therapy of Diffuse Large B-Cell Lymphoma.
|
Da Silva, Gustavo F.
|
|
|
110 |
11 |
p. 799
|
artikel
|
| 1316 |
Design of an Ongoing Phase I/II Open-Label, Dose-Escalation Trial Using the Oral Chelator Deferasirox To Treat Iron Overload in HFE-Related Hereditary Hemochromatosis (HH).
|
Pietrangelo, A.
|
|
|
110 |
11 |
p. 2680
|
artikel
|
| 1317 |
Detecting Apoptotic Blocks and Sensitvity to ABT-737 and Conventional Chemotherapy Via BH3 Profiling.
|
Letai, Anthony
|
|
|
110 |
11 |
p. 4523
|
artikel
|
| 1318 |
Detecting Drugs That Cause Thrombocytopenia: A Comparison of Three Methods: Tests for Drug-Dependent Anti-Platelet Antibodies (DDab), Published Case Reports, and Data Mining of the US FDA Adverse Event Reporting System (AERS) Database.
|
Li, Xiaoning
|
|
|
110 |
11 |
p. 2087
|
artikel
|
| 1319 |
Detection and Follow Up of BCR/ABL Translocation by Cromogen In Situ Hibridization with ABL Centromeric and Telomeric (T/C) Probe Pair. Molecular, Accurate and Inexpensive Assay.
|
Barragan, Carlos Sergio
|
|
|
110 |
11 |
p. 4528
|
artikel
|
| 1320 |
Detection and Production of Haptoglobin within Acute Myeloid Leukemic Blasts.
|
Lingamfelter, Daniel
|
|
|
110 |
11 |
p. 4305
|
artikel
|
| 1321 |
Detection and Treatment of Molecular Relapse in Acute Myeloid Leukemia with RUNX1, CBFB or MLL Gene Translocations. Frequent Quantitative Monitoring of Molecular Markers in Different Compartments and Correlation with WT1 Gene Expression.
|
Doubek, Michael
|
|
|
110 |
11 |
p. 4356
|
artikel
|
| 1322 |
Detection of ADAMTS13 Autoantibodies and Elevated ADAMTS13/fXI Complex in Lupus Anticoagulant Positive Plasmas Suggest a Potential Role for ADAMTS13 in Antiphospholipid Syndrome.
|
Guinto, Enriqueta R.
|
|
|
110 |
11 |
p. 3627
|
artikel
|
| 1323 |
Detection of Dysplastic Features by Multiparameter Flow Cytometry in Myelodysplastic Syndromes in Relation to Cytomorphology and Cytogenetics.
|
Kern, Wolfgang
|
|
|
110 |
11 |
p. 2461
|
artikel
|
| 1324 |
Detection of Genomic Lesions in Childhood Precursor-B Cell ALL in Diagnosis and Relapse Samples Using High Resolution Genomic Profiling.
|
Kuiper, Roland P.
|
|
|
110 |
11 |
p. 995
|
artikel
|
| 1325 |
Detection of Herpesvirus and Adenovirus Infections in Patients Undergoing Stem Cell Transplantation: Looking Below the Tip of the Iceberg with the Microarray Technology.
|
Ditzen, Anette
|
|
|
110 |
11 |
p. 4977
|
artikel
|
| 1326 |
Detection of Hypoxia-Inducible Gene Manipulation.
|
Imagawa, Shigehiko
|
|
|
110 |
11 |
p. 3662
|
artikel
|
| 1327 |
Detection of JAK2 Exon 12 Mutations in 10 Patients (10.1%) of V617F Negative PV: A Study of 211 Cases with PV or Suspected PV.
|
Schnittger, Susanne
|
|
|
110 |
11 |
p. 2541
|
artikel
|
| 1328 |
Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.
|
Buccisano, Francesco
|
|
|
110 |
11 |
p. 4242
|
artikel
|
| 1329 |
Detection of Nucleophosmin Gene Mutations in Plasma from Patients with Acute Myeloid Leukemia: Clinical Significance and Implications.
|
Ma, Wanlong
|
|
|
110 |
11 |
p. 2855
|
artikel
|
| 1330 |
Detection of p57KIP2 Gene Methylation Is Useful Marker for Minimal Residual Disease in Diffuse Large B Cell Lymphoma.
|
Hagiwara, Kazumi
|
|
|
110 |
11 |
p. 4415
|
artikel
|
| 1331 |
Detection of Recurrent Uniparental Disomy and Cryptic Chromosomal Abnormalities in MDS/MPD-U and MDS/MPD-Derived Secondary AML
|
Gondek, Lukasz P.
|
|
|
110 |
11 |
p. 1542
|
artikel
|
| 1332 |
Detection of the mRNA Transcription Level of Several Genes of the HIF and NO Metabolic Pathways in PBMCs of Sickle Cell Disease Patients Using Quantitative RT-PCR Assay.
|
Ammosova, Tatyana
|
|
|
110 |
11 |
p. 844
|
artikel
|
| 1333 |
Detection of the V617F Mutation of JAK2 Using a Novel Fully Automated SNP Super-Rapid Detector.
|
Tanaka, Ruriko
|
|
|
110 |
11 |
p. 4640
|
artikel
|
| 1334 |
Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients.
|
Schnittger, Susanne
|
|
|
110 |
11 |
p. 2546
|
artikel
|
| 1335 |
Detection of Th1/Th2 Cytokines Is Useful for the Quick and Early Diagnosis of Hemophagocytic Syndrome in Children.
|
Tang, Yongmin
|
|
|
110 |
11 |
p. 4079
|
artikel
|
| 1336 |
Detection of Varicella Zoster Virus Specific CD8 T Cells in Patients after T Cell Depleted Allogeneic Stem Cell Transplantation by a Novel Epitope Screening Technology.
|
van der Heiden, P.L.J.
|
|
|
110 |
11 |
p. 1060
|
artikel
|
| 1337 |
Determination of ADAMTS13 Antigen and Activity Levels in Patients with Acute Myocardial Infarction and Acute Ischemic Stroke.
|
Dong, Ningzheng
|
|
|
110 |
11 |
p. 3987
|
artikel
|
| 1338 |
Determination of BCR-ABL Overexpression by Correlating qRT-PCR and IP-FISH in Imatinib Treated CML Patients.
|
Bianchini, Michele
|
|
|
110 |
11 |
p. 1958
|
artikel
|
| 1339 |
Determination of the Role and Mechanism of the Transcription Factor NF-Y in Murine Hematopoietic Stem Cell Biology.
|
Bungartz, Gerd
|
|
|
110 |
11 |
p. 2234
|
artikel
|
| 1340 |
Determining the Extent of Disease with Magnetic Resonance Imaging of the Bone Marrow (BM-MRI) in Patients with Multiple Myeloma (MM).
|
Ailawadhi, Sikander
|
|
|
110 |
11 |
p. 1483
|
artikel
|
| 1341 |
Determining the Mechanism of Transformation of Follicular Lymphoma into Diffuse Large B Cell Lymphoma.
|
Carlotti, Emanuela
|
|
|
110 |
11 |
p. 181
|
artikel
|
| 1342 |
Determining the Optimal Timing of Initiation for Venous Thromboembolism (VTE) Anticoagulant (AC) Prophylaxis (proph) after Orthopedic Surgery (OS).
|
Lazo-Langner, Alejandro
|
|
|
110 |
11 |
p. 305
|
artikel
|
| 1343 |
Developing a Multidimensional Prognostic Test for Follicular Lymphoma.
|
Foster, Cheryl J.
|
|
|
110 |
11 |
p. 2610
|
artikel
|
| 1344 |
Developing In Vivo Model for Studying Mechanisms of Osteoblast Suppression in Multiple Myeloma.
|
Hong, Chang-Sook
|
|
|
110 |
11 |
p. 4731
|
artikel
|
| 1345 |
Developmental Differences in Megakaryocytopoeisis: The Role of GATA-1 Short.
|
Poterjoy, Brandon S.
|
|
|
110 |
11 |
p. 4069
|
artikel
|
| 1346 |
Development and Characterization of a Novel CD34 Monoclonal Antibody That Identifies Sheep Hematopoietic Stem/Progenitor Cells.
|
Porada, Christopher D.
|
|
|
110 |
11 |
p. 4909
|
artikel
|
| 1347 |
Development and Performance of the GTI Diagnostics ADAMTS-13 Activity Assay (ATS-13™) and ADAMTS-13 Inhibitor Assay (ATS-13™ INH).
|
Pressman, Melissa A.
|
|
|
110 |
11 |
p. 2159
|
artikel
|
| 1348 |
Development and Validation of a Novel, High-Throughput Colony-Forming Assay That Allows Simultaneous Detection and Quantitation of Seven Primitive Sheep Hematopoietic Populations.
|
Porada, Christopher D.
|
|
|
110 |
11 |
p. 1221
|
artikel
|
| 1349 |
Development and Validation of a Pediatric Severity Index for Sickle Cell Patients.
|
van den Tweel, Xandra W.
|
|
|
110 |
11 |
p. 3391
|
artikel
|
| 1350 |
Development as Anti-Leukemic Agents, a Novel Synthesis of Phospha Sugar Derivatives in Therapy for Leukemias, and Analysis of Their Characterizations.
|
Nakamura, Satoki
|
|
|
110 |
11 |
p. 4174
|
artikel
|
| 1351 |
Development of a Cell Based Vaccine for the Immunotherapy of Acute and Chronic Leukemia by the Use of Autologous Dendritic Cells Loaded with Monoclonal Antibody Treated or Irradiated Leukemia Cells.
|
Duncan, Caroline J.
|
|
|
110 |
11 |
p. 4889
|
artikel
|
| 1352 |
Development of a Genetic Tool Based on BCR-ABL Transgenic Drosophila Melanogaster for Identification of Genes Involved in CML Progression and Drug Testing.
|
Cilloni, Daniela
|
|
|
110 |
11 |
p. 468
|
artikel
|
| 1353 |
Development of Allosteric Inhibitors of the Interaction of AML1 and CBFβ for the Treatment of Leukemia.
|
Douvas, Michael G.
|
|
|
110 |
11 |
p. 653
|
artikel
|
| 1354 |
Development of a New Fully Human Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies.
|
Bornstein, Gadi Gazit
|
|
|
110 |
11 |
p. 2349
|
artikel
|
| 1355 |
Development of a PML-RARα-IL-2 Recombinant Plasmid DNA for APL.
|
Zhou, Yubing
|
|
|
110 |
11 |
p. 4881
|
artikel
|
| 1356 |
Development of Computer Based System To Aid Pathologists in Histological Grading of Follicular Lymphomas.
|
Kong, Jun
|
|
|
110 |
11 |
p. 3318
|
artikel
|
| 1357 |
Development of Efficent Gene Therapy for the Treatment of Erythrocyte Pyruvate Kinase Deficiency.
|
Meza, Nestor W.
|
|
|
110 |
11 |
p. 2584
|
artikel
|
| 1358 |
Development of Megakaryocyte-Specific Lentiviral Vectors for Gene Therapy of Platelet Disorders.
|
De Waele, Liesbeth
|
|
|
110 |
11 |
p. 5143
|
artikel
|
| 1359 |
Development of Osteonecrosis Is Associated with Difference in Upregulation of Antithrombin, Protein C and Protein S after Four Weeks of Dexamethasone during Induction Treatment in Childhood Acute Lymphoblastic Leukemia.
|
te Winkel, Mariel L.
|
|
|
110 |
11 |
p. 862
|
artikel
|
| 1360 |
Development of Pulmonary Sarcoidosis during Lymphoma Treatment: A Diagnostic Dilemma.
|
Campos-Gines, Angel F.
|
|
|
110 |
11 |
p. 4443
|
artikel
|
| 1361 |
Development of RAD51 as Biomarker for Sensitivity to the Histone Deacetylase (HDAC) Inhibitor PCI-24781 in Lymphoma.
|
Balasubramanian, Sriram
|
|
|
110 |
11 |
p. 1377
|
artikel
|
| 1362 |
Development of Renal Calculi and Imatinib Therapy in CML: Is There an Association?.
|
Saikia, Tapan
|
|
|
110 |
11 |
p. 4551
|
artikel
|
| 1363 |
Development of Small Molecule Inhibitors of the AML1-ETO and CBFβ-SMMHC Oncoproteins.
|
Grembecka, Jolanta E.
|
|
|
110 |
11 |
p. 1591
|
artikel
|
| 1364 |
Development of Tools for T Cell Repertoire Analysis (TCRB Spectratyping) for the Canine Model of Hematopoietic Cell Transplantation.
|
Kiianitsa, Konstantin
|
|
|
110 |
11 |
p. 4873
|
artikel
|
| 1365 |
Development & Validation of Hemophilia Treatment Regimen Specific Adherence Scales.
|
Duncan, Natalie A.
|
|
|
110 |
11 |
p. 966
|
artikel
|
| 1366 |
Dexamethasone Dose Adjustments Seem To Result in Better Efficacy and Improved Tolerability in Patients with Relapsed/Refractory Multiple Myeloma Who Are Treated with Lenalidomide/Dexamethasone (MM009/010 Sub-Analysis).
|
Miguel, Jesus F. San
|
|
|
110 |
11 |
p. 2712
|
artikel
|
| 1367 |
Dexamethasone Induced Apoptotic Mechanisms in Myeloma Cells by Analysis of Mutant Glucocorticoid Receptors.
|
Sharma, Sanjai
|
|
|
110 |
11 |
p. 2492
|
artikel
|
| 1368 |
3D Grown Human Placental-Derived Mesenchymal Stromal Cells (PLX-I) Support and Potentiate the Engraftment of Human Cord Blood Unfractionated (UFCBC) and Fractionated CD34+ Cells (hCD34+) in Irradiated NOD/SCID Mice.
|
Burger, Ora
|
|
|
110 |
11 |
p. 4104
|
artikel
|
| 1369 |
3,4-Diarylmaleimides Effectively Inhibit Proliferation of FLT3-ITD-Positive Leukemic Cells, Induce Apoptosis and Show Additive Effects in Combination with Chemotherapeutic Drugs.
|
Heidel, Florian H.
|
|
|
110 |
11 |
p. 1605
|
artikel
|
| 1370 |
Dietary Products Induce Apoptosis in CLL B Cells and Reveal Potential as a Therapeutic Combination That Can Overcome Stromal Cell Mediated Protection.
|
Ghosh, Asish K.
|
|
|
110 |
11 |
p. 3130
|
artikel
|
| 1371 |
Difference of Drug-Resistance between Single-Factor Resistance Cell Line K562/MDR1 Transfected with mdr1 Gene and Multi-Factor Resistance Cell Line K562/A02 Induced by Doxorubicin.
|
Gong, Yuping
|
|
|
110 |
11 |
p. 4179
|
artikel
|
| 1372 |
Differences in BCL-2 Protein and t(14;18) in Patients with Primary Rituximab/Chemotherapy Refractory Diffuse Large B-Cell Lymphoma (DLBCL).
|
Ailawadhi, Sikander
|
|
|
110 |
11 |
p. 4433
|
artikel
|
| 1373 |
Differences in Cyto- and Molecular Genetic Abnormalities between Children <2 Years and Older Children with Acute Myeloid Leukemia.
|
Balgobind, Brian V.
|
|
|
110 |
11 |
p. 1830
|
artikel
|
| 1374 |
Differences in Regulatory T Cell Function in Alloimmunized Versus Non-Alloimmunized Mice Following Multiple Red Cell Transfusions.
|
Yu, Jin
|
|
|
110 |
11 |
p. 452
|
artikel
|
| 1375 |
Differences in Survival Rates for Patients with Hodgkin Lymphoma, Who Were Treated Inside vs. Outside Therapy Optimisation Protocols in Germany.
|
Brillant, Corinne
|
|
|
110 |
11 |
p. 2321
|
artikel
|
| 1376 |
Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.
|
Robertus, Jan-Lukas
|
|
|
110 |
11 |
p. 3586
|
artikel
|
| 1377 |
Differences in the Transcriptomes of Highly Purified Fetal Liver and Adult Bone Marrow Hematopoietic Stem Cells Revealed by Long Serial Analysis of Gene Expression (LongSAGE)
|
Kent, David
|
|
|
110 |
11 |
p. 1277
|
artikel
|
| 1378 |
Different Cooperating Mutation Patterns of Receptor Tyrosine Kinases/Ras/JAK2 between De Novo AML1-ETO and CBFβ-MYH11 Acute Myeloid Leukemia.
|
Liang, Der-Cherng
|
|
|
110 |
11 |
p. 3487
|
artikel
|
| 1379 |
Different FLT3 Inhibitors Display Limited, Non-Overlapping Profiles of Specific FLT3-ITD Resistance Mutations in a Cell-Based Screen.
|
von Bubnoff, Nikolas
|
|
|
110 |
11 |
p. 870
|
artikel
|
| 1380 |
Different Hemoglobin Switching Pattern of β-Thalassemia Mutations at the Proximal and Distal Human β-Globin CACCC Box.
|
Marongiu, Maria F.
|
|
|
110 |
11 |
p. 1780
|
artikel
|
| 1381 |
Differential Ability of the Notch Ligands Jagged2, Delta1, and Delta4 To Accelerate Development of Human CD34+ Hematopoietic Progenitor Cells (HPCs) into Killer Inhibitory Receptor (KIR)-Negative NK Cells with Cytotoxic Activity.
|
Beck, Rose
|
|
|
110 |
11 |
p. 1326
|
artikel
|
| 1382 |
Differential Expression and Re-Localization of Potential Cell Fate Determinants in Hematopoietic and Leukemia Stem Cells.
|
Ting, Stephen B.
|
|
|
110 |
11 |
p. 93
|
artikel
|
| 1383 |
Differential Expression of ERG Isoforms in Acute Myeloid and T-Lymphoblastic Leukemia Is Regulated by DNA-Methylation.
|
Baldus, Claudia D.
|
|
|
110 |
11 |
p. 2126
|
artikel
|
| 1384 |
Differential Expression of Genes Related to JAK-STAT Pathway Activation or Megakaryocyte Differentiation/Maturation in CD34+ Cells from Patients with Refractory Anemia with Ringed Sideroblasts and Thrombocytosis (RARS-T).
|
Malcovati, Luca
|
|
|
110 |
11 |
p. 397
|
artikel
|
| 1385 |
Differential Expression of miRNAs in Polycythemia Vera Peripheral Blood Cells.
|
Bruchova, Hana
|
|
|
110 |
11 |
p. 262
|
artikel
|
| 1386 |
Differential Gene Signature and Signaling Pathways in Childhood Burkitt (BL) vs Diffuse Large B-Cell Lymphoma (DLBCL).
|
Day, Nancy S.
|
|
|
110 |
11 |
p. 4142
|
artikel
|
| 1387 |
Differential hMLH1 Gene Expression after Temozolomide Selection Linked to Microsatellite Instability in a Subset of Hematopoietic Stem/Progenitor Cells in Old Versus Young and Cancer Versus Normal Patient Samples.
|
Kenyon, Jonathan
|
|
|
110 |
11 |
p. 509
|
artikel
|
| 1388 |
Differential Impact of Host Derived Interleukin-18 on Regulatory and Conventional T Cell Expansion Following Murine Allogeneic Hematopoietic Cell Transplantation.
|
Zeiser, Robert
|
|
|
110 |
11 |
p. 3262
|
artikel
|
| 1389 |
Differential Iron Loading of R2* Pancreas in Children with Thalassemia Major and Sickle Cell Disease.
|
Papudesi, Jhansi L.
|
|
|
110 |
11 |
p. 3817
|
artikel
|
| 1390 |
Differential Localization and Conditioned Release of Pro- and Anti-Angiogenic Cytokines from Resting and Stimulated Platelets.
|
Brill, Alex
|
|
|
110 |
11 |
p. 3707
|
artikel
|
| 1391 |
Differential Modulation of Erythrogenic Effects of EPO by Prolonged Administration of Glucocorticoids.
|
He, Zili
|
|
|
110 |
11 |
p. 1733
|
artikel
|
| 1392 |
Differential Procoagulant Phenotype of Pancreatic and Breast Cancer Cells Related to Different Tissue Factor Activity.
|
Gerotziafas, Grigoris T.
|
|
|
110 |
11 |
p. 3992
|
artikel
|
| 1393 |
Differential Regulation of Granzyme B and C Expression in Murine Cytotoxic T and NK Cells.
|
Cai, Sheng F.
|
|
|
110 |
11 |
p. 2291
|
artikel
|
| 1394 |
Differential Role of the Transcription Factor ZBP-89 in Hemangioblast Fate Determination: ZBP-89 Is a Direct Regulator of SCL.
|
Li, Xiangen
|
|
|
110 |
11 |
p. 1253
|
artikel
|
| 1395 |
Differential Transactivation Activities of Sumoylated CCAAT Enhancer Binding Protein alpha (C/EBPα) p42 Versus p30 May Contribute in Part, to Aberrant C/EBPα Activity in Acute Leukemias.
|
Khanna-Gupta, Arati
|
|
|
110 |
11 |
p. 1231
|
artikel
|
| 1396 |
Differentiation Hotspots on a Cell Cycle Related Continuum.
|
Colvin, Gerald A.
|
|
|
110 |
11 |
p. 3703
|
artikel
|
| 1397 |
Differentiation of Highly Conserved Host and Transgene mRNA in HO-1 Gene Therapy.
|
Bruzzone, Carol M.
|
|
|
110 |
11 |
p. 2266
|
artikel
|
| 1398 |
Differentiation of Mesenchymal Stem Cells from Rat Bone Marrow into Dopaminergic Neuron-Like Cells In Vitro.
|
Chen, Li
|
|
|
110 |
11 |
p. 4067
|
artikel
|
| 1399 |
Different IGH Rearrangement and Somatic Hypermutation Patterns in Hairy-Cell Leukemia, Hairy-Cell Leukemia Variant and Splenic Marginal Zone Lymphoma.
|
Hockley, Sarah L.
|
|
|
110 |
11 |
p. 2082
|
artikel
|
| 1400 |
Different Number of AML1/ETO Transcripts in Single Leukemic Cell, Estimated by Combined Measurement of MRD by FISH and Real-Time PCR, Is a Powerful Predictor of Relapse.
|
Maeba, Hideaki
|
|
|
110 |
11 |
p. 4257
|
artikel
|
| 1401 |
Different Patterns of AML1 Mutations between De Novo Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia.
|
Shih, Lee-Yung
|
|
|
110 |
11 |
p. 2442
|
artikel
|
| 1402 |
Diffuse Large B-Cell Lymphoma (DLBCL) with Central Nervous System (CNS) Relapse: Prognosis and Risk Factors by Retrospective Analysis from Single Center Experience.
|
Shimazu, Yutaka
|
|
|
110 |
11 |
p. 3436
|
artikel
|
| 1403 |
Diffuse Large B-Cell Lymphomas of the Waldeyer's Ring Frequently Have a Germinal Center-Like Phenotype: A Clinico-Pathological Study of 209 Patients from the Groupe d'Etude des Lymphomes de L'Adulte (GELA).
|
de Leval, Laurence
|
|
|
110 |
11 |
p. 1561
|
artikel
|
| 1404 |
Direct and Enhanced Cytotoxicity of the Bcl-2 Family Inhibitor GX15-070 on Rituximab-Sensitive and Rituximab-Resistant B-NHL Clones.
|
Martinez-Paniagua, Melisa A.
|
|
|
110 |
11 |
p. 1402
|
artikel
|
| 1405 |
Direct and Natural Killer Cell-Mediated Anti-Tumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma.
|
Krusch, Matthias
|
|
|
110 |
11 |
p. 4181
|
artikel
|
| 1406 |
Direct Comparison of G-CSF Receptor and M-CSF Receptor Signaling Leading to AP-1 and STAT Induction and Identification of Novel Signaling Pathways.
|
Jack, Graham
|
|
|
110 |
11 |
p. 2206
|
artikel
|
| 1407 |
Directed De Novo DNA Methylation of a Genomic Locus Leads to Heritable Transcriptional Repression.
|
Ford, Kevin G.
|
|
|
110 |
11 |
p. 343
|
artikel
|
| 1408 |
Direct Evidence That the MHC Class Ib Antigen Qa-2 Regulates the Fetal Immune Response to Prenatal Allotransplantation.
|
Durkin, Emily T.
|
|
|
110 |
11 |
p. 1200
|
artikel
|
| 1409 |
Direct Inhibition of the Notch Transactivation Complex with Synthetic Constrained Peptides in T-Cell Acute Lymphoblastic Leukemia.
|
Moellering, Raymond
|
|
|
110 |
11 |
p. 2819
|
artikel
|
| 1410 |
Direct Interaction of G-CSF-Stimulated-Neutrophils and HUVECs Are Necessary for Production of IL-8 in Endothelial Cells.
|
Okamoto, Yasuhiro
|
|
|
110 |
11 |
p. 4038
|
artikel
|
| 1411 |
Direct Intra-Bone Injection of Unrelated Cord Blood Cells Overcomes the Problem of Delayed Engraftment and Improves the Feasibility of Hematopoietic Transplant in Adult Patients.
|
Ibatici, Adalberto
|
|
|
110 |
11 |
p. 334
|
artikel
|
| 1412 |
Discovery and Preclinical Characterization of INCB018424, a Selective JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.
|
Fridman, Jordan
|
|
|
110 |
11 |
p. 3538
|
artikel
|
| 1413 |
Discovery and Validation of STAT-3 and ERK1/2 Phosphorylation as Critical for the Function of Alloactivated T Cells in Acute Graft-Versus-Host-Disease Via a Novel Technique for Drug Discovery.
|
Lu, Sydney X.
|
|
|
110 |
11 |
p. 3236
|
artikel
|
| 1414 |
Discrimination and Quantification of Spectrally Similar Near-Infrared Probes by Time-Domain (TD) Optical Imaging in Acute Myeloid Leukemia Mouse Models.
|
McCormack, Emmet
|
|
|
110 |
11 |
p. 4319
|
artikel
|
| 1415 |
Discrimination Indices as Screening Tests for Beta-Thalassemic Trait.
|
Ntaios, George
|
|
|
110 |
11 |
p. 3815
|
artikel
|
| 1416 |
Disease and Comorbidity Status Predict Outcome after Nonmyeloablative Allografting for Advanced Haematological Malignancies.
|
Sorasio, R.
|
|
|
110 |
11 |
p. 4930
|
artikel
|
| 1417 |
Disease Burden of Chronic Lymphocytic Leukemia within the European Union.
|
Watson, Louise
|
|
|
110 |
11 |
p. 5151
|
artikel
|
| 1418 |
Disease-Related Symptoms Reported across a Broad Population of Patients with Paroxysmal Nocturnal Hemoglobinuria.
|
Meyers, Gabrielle
|
|
|
110 |
11 |
p. 3683
|
artikel
|
| 1419 |
Disease Severity in Sickle Cell Disease: Understanding Impairment in Health-Related Quality of Life.
|
Panepinto, Julie A.
|
|
|
110 |
11 |
p. 957
|
artikel
|
| 1420 |
Disparities of Minor Histocompatibility Antigens in Unrelated Allo-HCT.
|
Markiewicz, Miroslaw
|
|
|
110 |
11 |
p. 3070
|
artikel
|
| 1421 |
Disruption of Bcl-2 Heterodimerization by the BH3 Mimetic ABT-737 Restores Spontaneous Apoptosis and Induces Differentiation in High Risk MDS and AML.
|
Ades, L.
|
|
|
110 |
11 |
p. 398
|
artikel
|
| 1422 |
Disruption of the Osteoblast Niche by G-CSF Induces Hematopoietic Stem Cell Quiescence and Loss of Long-Term Repopulating Activity.
|
Gopalan, Priya K.
|
|
|
110 |
11 |
p. 2217
|
artikel
|
| 1423 |
Dissecting Karyotypic Patterns in Non Hyperdiploid Multiple Myeloma: An Overview on the Karyotypic Evolution.
|
Jimenez-Zepeda, Victor H.
|
|
|
110 |
11 |
p. 2491
|
artikel
|
| 1424 |
Dissection of Bcr-abl Structural Domains Relating to Kinase Auto-Inhibition Using a Forward Mutational Screen with the Non-ATP Competitive Inhibitor GNF-2.
|
Powers, John T.
|
|
|
110 |
11 |
p. 1021
|
artikel
|
| 1425 |
Dissection of the Role of Connexin-43 in Hematopoietic Progenitors and Stromal Cells Unveils Distinct Hematopoietic Intrinsic and Extrinsic Regulatory Functions.
|
Li, Lina
|
|
|
110 |
11 |
p. 607
|
artikel
|
| 1426 |
Dissociating GVT from GVHD in Murine BMT Models through TNFα Dependent CD4+ T Cell Mediated GVHD and IFNγ Dependent CD8+ T Cell Mediated Anti-Tumor Effects.
|
Murphy, William J.
|
|
|
110 |
11 |
p. 69
|
artikel
|
| 1427 |
Dissociation of Systemic and Local Anti-Tumor Immunity Following Depletion of Regulatory T Cells Limits Therapeutic Activity in Established Tumors.
|
Peggs, Karl S.
|
|
|
110 |
11 |
p. 286
|
artikel
|
| 1428 |
Distinct Clinical Syndromes Are Defined by ADAMTS13 Activity in Idiopathic TTP: Results of the SERF-TTP Study.
|
Zakarija, Anaadriana
|
|
|
110 |
11 |
p. 1320
|
artikel
|
| 1429 |
Distinct Expression Patterns of microRNAs in Activated B Cell (ABC) and Germinal Center B (GC) Subtypes of Diffuse Large B Cell Lymphoma (DLBLC).
|
Bastie, Jean-Noel
|
|
|
110 |
11 |
p. 562
|
artikel
|
| 1430 |
Distinct Functional Conformations of von Willebrand Factor A1 Domain in Support of Platelet-Surface or Platelet-Platelet Interactions.
|
Podda, Gianmarco
|
|
|
110 |
11 |
p. 5182
|
artikel
|
| 1431 |
Distinct Genetic Aberrations in Molecular Subtypes of Diffuse Large B Cell Lymphoma Detected by Array CGH.
|
Lenz, Georg
|
|
|
110 |
11 |
p. 2631
|
artikel
|
| 1432 |
Distinctive IgVH Gene Segments Usage and Mutation Status in Chinese Patients with Chronic Lymphocytic Leukemia.
|
Chen, Lijuan
|
|
|
110 |
11 |
p. 4708
|
artikel
|
| 1433 |
Distinctive Integration Profile of Avian Sarcoma Leukosis Virus Vectors in Rhesus Long-Term Repopulating Cells.
|
Hu, Jingqiong
|
|
|
110 |
11 |
p. 198
|
artikel
|
| 1434 |
Distinct Methylation Patterns among Infants with MLL Rearranged Acute Lymphoblastic Leukemia.
|
Stumpel, Dominique J.P.M.
|
|
|
110 |
11 |
p. 2794
|
artikel
|
| 1435 |
Distinct Role for Fyn-Kinase in αIIbß3-Mediated Signaling.
|
Reddy, Kumar B.
|
|
|
110 |
11 |
p. 3652
|
artikel
|
| 1436 |
Distribution and Pathology Characteristics of Non Hodgkin Lymphoma in Peru: A Study of 1014 Cases Using WHO Classification of Lymphoid Neoplasm.
|
Beltran, Brady
|
|
|
110 |
11 |
p. 4419
|
artikel
|
| 1437 |
Distribution of Hypercoagulation Laboratory Diagnoses among Patients with History of Thromboembolic Disease.
|
Bern, Murray M.
|
|
|
110 |
11 |
p. 3952
|
artikel
|
| 1438 |
Disturbed Sleep in Adult Patients with Sickle Cell Disease Assessed by the Pittsburgh Sleep Quality Index.
|
Harrison, Jonathan
|
|
|
110 |
11 |
p. 2265
|
artikel
|
| 1439 |
DKK1-Specific Cytotoxic T Lymphocytes Are Potent Effector Cells for the Treatment of Multiple Myeloma in SCID-hu Model.
|
Qian, Jianfei
|
|
|
110 |
11 |
p. 668
|
artikel
|
| 1440 |
DMT1 Expression Is Regulated by DMT1 Associated Protein (DAP) in K562 Cells.
|
Okazaki, Yasumasa
|
|
|
110 |
11 |
p. 2661
|
artikel
|
| 1441 |
DNA-Based Measurement of BCR-ABL in Chronic Myeloid Leukemia (CML).
|
Morley, Alexander
|
|
|
110 |
11 |
p. 2946
|
artikel
|
| 1442 |
DNA Damage Induced Sumoylation of p53 in Multiple Myeloma: Implications for Cell Proliferation and Apoptosis.
|
Driscoll, James J.
|
|
|
110 |
11 |
p. 112
|
artikel
|
| 1443 |
DNA Methylation Analysis of 807 Genes in Chronic Myeloid Leukemia and Acute Promyelocytic Leukemia.
|
Byun, Hyang-Min
|
|
|
110 |
11 |
p. 2122
|
artikel
|
| 1444 |
DNA Methyltransferase 1 Contributes to Epigenetic Signatures and Biological Phenotype during Normal B-Cell Differentiation and Lymphomagenesis.
|
Shaknovich, Rita
|
|
|
110 |
11 |
p. 685
|
artikel
|
| 1445 |
DNA Methyltransferases Modulate the Bystander Effect in Mouse Embryonic Stem Cells.
|
Rugo, Rebecca E.
|
|
|
110 |
11 |
p. 4154
|
artikel
|
| 1446 |
3D Nuclear Organization of Telomeres in Hodgkin and Reed-Sternberg Cells.
|
Knecht, Hans
|
|
|
110 |
11 |
p. 382
|
artikel
|
| 1447 |
Documenting the Effectiveness of Hydroxyurea (HU) To Treat Sickle Cell Disease (SCD) in the Community Setting.
|
Lanzkron, Sophie
|
|
|
110 |
11 |
p. 956
|
artikel
|
| 1448 |
Does FDG-PET/CT Obviate the Need for Standard Diagnostic Contrast-Enhanced CT in Patients with Lymphoma?.
|
Elstrom, Rebecca L.
|
|
|
110 |
11 |
p. 2329
|
artikel
|
| 1449 |
Does Imatinib Change the Outcome in Philapdelphia Chromosome Positive Acute Lymphoblastic Leukaemia in Adults? Data from the UKALLXII/ECOG2993 Study.
|
Fielding, Adele K.
|
|
|
110 |
11 |
p. 8
|
artikel
|
| 1450 |
Does Thrombocytosis Alter the Prognosis of Myelodysplastic Syndromes (MDS) and MDS/Myeloproloferative Syndromes (MDS/MPD)? A Matched Case-Control Analysis of Outcomes.
|
Kodali, Dhatri
|
|
|
110 |
11 |
p. 2469
|
artikel
|
| 1451 |
Dominant-Negative Inhibition of MCT-1 Oncogene Attenuates a Malignant Phenotype through Translational Repression.
|
Hagner, Patrick
|
|
|
110 |
11 |
p. 4168
|
artikel
|
| 1452 |
Donor-Cell Derived Aplastic Anemia (AA) with a Small Population of CD55−CD59− Blood Cells after Allogeneic Stem Cell Transplantation: Evidence for the Immune System Attack Against Normal Hematopoietic Stem Cells in AA.
|
Sugimori, Chiharu
|
|
|
110 |
11 |
p. 3682
|
artikel
|
| 1453 |
Donor Chimerism Is a Key Predictor of Graft Failure and the Response of Adoptive Immunotherapy Following Allogeneic Hematopoietic Stem Cell Transplantation.
|
Tang, Xiaowen
|
|
|
110 |
11 |
p. 4939
|
artikel
|
| 1454 |
Donor-Derived Squamous Cell Carcinoma after Allogeneic Bone Marrow Transplantation.
|
Janin, Anne
|
|
|
110 |
11 |
p. 831
|
artikel
|
| 1455 |
Donor-Derived T Cells Can Be Rendered Hyporesponsive to Alloantigen without Loss of Pathogen or Tumor Immune Responses.
|
Davies, Jeff
|
|
|
110 |
11 |
p. 771
|
artikel
|
| 1456 |
Donor Lymphocyte Infusion for Mixed Chimerism or Residual Disease after Reduced-Intensity T Cell Depleted Stem Cell Transplantation Results in Conversion to Full Donor Chimerism Combined with Graft Versus Tumor Responses and Limited GVHD.
|
von dem Borne, Peter A.
|
|
|
110 |
11 |
p. 1652
|
artikel
|
| 1457 |
Donor Lymphocytes Stimulated with CMV pp65 Gene Modified Dendritic Cells for Prophylaxis of CMV Following Allogeneic Haemopoietic Stem Cell Transplantation.
|
Micklethwaite, Kenneth P.
|
|
|
110 |
11 |
p. 2989
|
artikel
|
| 1458 |
Donor Response to G-CSF Is the Best Predictive Factor of Extensive Chronic Graft-Versus-Host Disease after Non Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation.
|
Dhedin, N.
|
|
|
110 |
11 |
p. 2188
|
artikel
|
| 1459 |
Donor T Cells from B Cell Deficient Mice Inhibit B Cell Development in Normal Recipients after Hematopoietic Cell Transplantation.
|
Mueller, Antonia M.S.
|
|
|
110 |
11 |
p. 3265
|
artikel
|
| 1460 |
Dose Attenuation of R-CHOP for the Treatment of Elderly Patients with Diffuse Large B Cell Lymphoma.
|
Choi, Young Jin
|
|
|
110 |
11 |
p. 4458
|
artikel
|
| 1461 |
Dose Definition for Intravenous Cyclophosphamide in Combination with Bortezomib/Dexamethasone for Remission Induction in Patients with Newly Diagnosed Multiple Myeloma.
|
Kropff, Martin
|
|
|
110 |
11 |
p. 3599
|
artikel
|
| 1462 |
Dose Dense and Dose Intense ABVD (dd-di ABVD) in Advanced and Intermediate-Stage Hodgkin's Lymphoma (HL).
|
Russo, Filippo
|
|
|
110 |
11 |
p. 2324
|
artikel
|
| 1463 |
Dose-Dense CHOP Plus Rituximab (R-CHOP14) Seems To Overcome, in Large B Cell Lymphoma, the Negative Prognostic Significance of B Cell Origin.
|
Rigacci, Luigi
|
|
|
110 |
11 |
p. 4401
|
artikel
|
| 1464 |
Dose-Dense Rituximab Improves Outcome of Elderly Patients with Poor-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
|
Pfreundschuh, Michael
|
|
|
110 |
11 |
p. 789
|
artikel
|
| 1465 |
Dose-Dependent Antithrombotic Effects of Apixaban, an Oral Direct Factor Xa Inhibitor, in Prevention and Treatment of Thrombosis in Rabbit Models of Arteriovenous-Shunt and Venous Thrombosis at Doses That Preserve Hemostasis.
|
Wong, Pancras C.
|
|
|
110 |
11 |
p. 933
|
artikel
|
| 1466 |
Dose-Escalated Low Molecular Weight Heparin Provides Effective Anticoagulation for Women with Mechanical Heart Valves during Pregnancy: A Single-Centre Experience.
|
Quinn, John
|
|
|
110 |
11 |
p. 1873
|
artikel
|
| 1467 |
Dose Escalation Study To Evaluate Dose Limiting Toxicity (DLT), Maximum Tolerated Dose (MTD) and Safety of Alemtuzumab for Consolidation Therapy in Patients with Chronic Lymphoycytic Leukemia: Phase I/II Trial of the German CLL Study Group (GCLLSG).
|
Fischer, Kirsten
|
|
|
110 |
11 |
p. 2053
|
artikel
|
| 1468 |
Dose Finding in Human Trials of TLR9 Agonists: Induction of Interferon-α Inducible Genes in Blood Mononuclear Cells as a Measure of Biologic Activity of 1018 ISS.
|
Lowder, James N.
|
|
|
110 |
11 |
p. 3844
|
artikel
|
| 1469 |
Dose-Reduced Conditioning Followed by Allogeneic Stem Cell Transplantation in Patients with Myelofibrosis. Results from a Multicenter Prospective Trial of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
|
Kroeger, Nicolaus
|
|
|
110 |
11 |
p. 683
|
artikel
|
| 1470 |
Dosimetric Analysis of 90Y-Ibritumomab Tiuxetan (Zevalin®) Given as Consolidation of First Remission in Patients with Advanced-Stage Follicular Lymphoma in the International Phase 3 First-Line Indolent Trial (FIT).
|
Bischof-Delaloye, Angelika
|
|
|
110 |
11 |
p. 3415
|
artikel
|
| 1471 |
Double Cord Blood Transplantation in Bone Marrow Failure Syndromes.
|
de Latour, Regis Peffault
|
|
|
110 |
11 |
p. 2018
|
artikel
|
| 1472 |
Double Umbilical Cord Blood Transplantation with Reduced Intensity Conditioning and Sirolimus-Based GVHD Prophylaxis.
|
Cutler, Corey
|
|
|
110 |
11 |
p. 2016
|
artikel
|
| 1473 |
Down-Modulation of Shp1 and Hsp70 Provides a Survival Advantage to the Ph+ Cells of CML Patients Additive to That Related to the Oncogenic BCR/ABL Protein and May Account for Resistance to Ima Treatment.
|
Esposito, Nicola
|
|
|
110 |
11 |
p. 1014
|
artikel
|
| 1474 |
Downregulation of a Candidate Myeloid Tumor Suppressor Gene Isolated from 7q21 Induces Abnormal Mitosis Due to Insufficient Centrosome Maturation.
|
Asou, Hiroya
|
|
|
110 |
11 |
p. 2638
|
artikel
|
| 1475 |
Down Regulation of CXC Chemokine Receptor 3 Impedes the Ability of Anti-CXCR3 Antibody To Block Graft-Versus-Host Disease.
|
He, Shan
|
|
|
110 |
11 |
p. 3235
|
artikel
|
| 1476 |
Down Regulation of GATA-2 and the Inversely-Correlated Expression of Adipogenic Specific Gene-PPARγ in Mesenchymal Stem Cells from Patients with Aplastic Anemia.
|
Xu, Yinyan
|
|
|
110 |
11 |
p. 1414
|
artikel
|
| 1477 |
Downregulation of Mpl Marks the Transition to Lymphoid-Primed Multipotent Progenitors with Gradual Loss of Granulocyte-Monocyte Potential.
|
Luc, Sidinh
|
|
|
110 |
11 |
p. 2227
|
artikel
|
| 1478 |
Downregulation of Peroxiredoxin III Contributes to Arsenic Trioxide-Induced Apoptosis in APL.
|
Vivas-Mejia, Pablo
|
|
|
110 |
11 |
p. 4322
|
artikel
|
| 1479 |
Doxorubicin, Vinblastine and Gemcitabine (AVG), a Novel Regimen Excluding Bleomycin for the Treatment of Early Stage Hodgkin Lymphoma (HL): Results of CALGB 50203.
|
Straus, David
|
|
|
110 |
11 |
p. 214
|
artikel
|
| 1480 |
Drug-Associated Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS): Frequency, Presenting Features, and Clinical Outcomes.
|
Saste, Vaishali V.
|
|
|
110 |
11 |
p. 1315
|
artikel
|
| 1481 |
Drug Metabolism Gene Polymorphisms and the Risk of Hepatic Sinusoidal Obstruction Syndrome in Children with Inherited Diseases Receiving Haematopoietic Stem Cell Transplantation.
|
Fernandes, Juliana F.
|
|
|
110 |
11 |
p. 1980
|
artikel
|
| 1482 |
Drug Resistance Gene Therapy by Simultaneous Lentiviral Overexpression of MDR1 in Combination with the MGMT P140K Mutant in Human Hematopoietic Stem Cells.
|
Spier, Isabel
|
|
|
110 |
11 |
p. 5146
|
artikel
|
| 1483 |
Drug Utilization and Cost Considerations of Erythropoiesis-Stimulating Agents in Patients with Myelodysplastic Syndromes.
|
Laliberté, François
|
|
|
110 |
11 |
p. 4611
|
artikel
|
| 1484 |
Drug Utilization Patterns and Cost Considerations for Erythropoiesis Stimulating Agents in Cancer Chemotherapy Patients in a Managed Care Setting.
|
Mandel, Alyson
|
|
|
110 |
11 |
p. 5157
|
artikel
|
| 1485 |
Dual Epigenetic Control of CCAAT/Enhancer Binding Protein α (C/EBPα) Expression in Acute Myeloid Leukemia.
|
Hackanson, Bjoern
|
|
|
110 |
11 |
p. 2116
|
artikel
|
| 1486 |
Durable Complete Responses Following Therapy with Epratuzumab Plus Rituximab: Final Efficacy Results of a Multicenter Study in Recurrent Indolent Non-Hodgkin's Lymphoma (NHL).
|
Leonard, John P.
|
|
|
110 |
11 |
p. 3419
|
artikel
|
| 1487 |
Durable Responses to Lenalidomide (Revlimid®) in Patients with AL Amyloidosis: Follow Up of a Phase II Trial.
|
Seldin, David C.
|
|
|
110 |
11 |
p. 192
|
artikel
|
| 1488 |
Durable Responses with Bortezomib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (MCL): Updated Time-to-Event Analyses of the Multicenter PINNACLE Study.
|
Goy, Andre
|
|
|
110 |
11 |
p. 125
|
artikel
|
| 1489 |
Duration of Immunosuppressive Therapy for Chronic Graft-vs.-Host Disease (cGVHD) Following Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation (HCT).
|
Rezvani, Andrew R.
|
|
|
110 |
11 |
p. 1071
|
artikel
|
| 1490 |
Duration of Initial Admission and Subsequent Readmission in the First 100 Days Following Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation.
|
Dungarwalla, Moez
|
|
|
110 |
11 |
p. 1999
|
artikel
|
| 1491 |
Dynamic Imaging of Fibrin Network Formation Correlated with Other Measures of Polymerization.
|
Weisel, John W.
|
|
|
110 |
11 |
p. 1757
|
artikel
|
| 1492 |
Dynamic In Vivo Imaging Reveals That Leukemia-Induced Changes in the Bone Marrow Microenvironment Alter Mechanisms of Metastasis.
|
Colmone, Angela
|
|
|
110 |
11 |
p. 2805
|
artikel
|
| 1493 |
Dynamic Mitochondrial Responses to Oxidative Stress in Primary AML Cells Involve Structural Damage and Repair Activity.
|
Shin, Myung-Geun
|
|
|
110 |
11 |
p. 4139
|
artikel
|
| 1494 |
Dynamics of BCR-ABL1 Transcripts during Dasatinib Therapy in Patients with Chronic Myeloid Leukemia (CML).
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 2962
|
artikel
|
| 1495 |
Dynamics of BCR-ABL1 Transcripts during Nilotinib Therapy in Patients with Chronic Myeloid Leukemia (CML).
|
Quintás-Cardama, Alfonso
|
|
|
110 |
11 |
p. 2961
|
artikel
|
| 1496 |
DYRK3 Encodes an Inhibitor of Erythroid Differentiation and Is Expressed at High Levels in Patients with Anemia.
|
Steensma, David P.
|
|
|
110 |
11 |
p. 3661
|
artikel
|
| 1497 |
Dyskeratosis Congenita: Low Regimen-Related Toxicity Following Hematopoietic Cell Transplantation (HCT) Using a Reduced Intensity Conditioning Regimen.
|
Tolar, Jakub
|
|
|
110 |
11 |
p. 2005
|
artikel
|
| 1498 |
Dysregulated Signaling Networks in Chronic Myeloproliferative Disorders: Co-Operation of JAK2 and Src Family Kinases (SFK)
|
Schade, Andrew E.
|
|
|
110 |
11 |
p. 1539
|
artikel
|
| 1499 |
Dysregulation of Frizzled 6 Is a Critical Component of B Cell Leukemogenesis in a Mouse Model of Chronic Lymphocytic Leukemia.
|
Wu, Qingli
|
|
|
110 |
11 |
p. 347
|
artikel
|
| 1500 |
Early Absolute Lymphocyte Count Recovery after Autologous Peripheral Hematopoietic Stem Cell Transplantation Depends on the Pre-Mobilization Absolute Lymphocyte Count and the Lymphocyte Dose in the Autograft.
|
Atta, Elias H.
|
|
|
110 |
11 |
p. 4973
|
artikel
|
| 1501 |
Early and Risk-Adapted Therapy with Fludarabine in High-Risk Binet Stage A CLL Patients Prolongs Progression Free Survival but Not Overall Survival: Results of the CLL1 Protocol of the German CLL Study Group (GCLLSG).
|
Bergmann, Manuela A.
|
|
|
110 |
11 |
p. 2038
|
artikel
|
| 1502 |
Early Biomarkers for the Anti-Angiogenic and Anti-Tumor Activity of the Superoxide Dismutase 1 (SOD1) Inhibitor Tetrathiomolybdate.
|
Braunstein, M.J.
|
|
|
110 |
11 |
p. 4214
|
artikel
|
| 1503 |
Early Deficiency of Endogenous Proteins Inhibiting LPS-Induced TNF-α Production Correlates with Acute Graft vs Host Disease (aGVHD) after Myeloablative Stem Cell Transplantation (SCT).
|
Levy, Ofer
|
|
|
110 |
11 |
p. 1058
|
artikel
|
| 1504 |
Early Evaluation of Bone Marrow Minimal Residual Disease by Flowcytometry on Day 15 Is Feasible on a Multicenter Basis and Bears Strong Prognostic Value in Childhood Acute Lymphoblastic Leukemia. The AIEOP-BFM Experience.
|
Basso, Giuseppe
|
|
|
110 |
11 |
p. 1423
|
artikel
|
| 1505 |
Early Febrile Infection after Allogeneic Stem Cell Transplantation of Acute Leukemia Is Associated with a Reduced Risk of Leukemic Relapse.
|
Kim, Sung-Yong
|
|
|
110 |
11 |
p. 4991
|
artikel
|
| 1506 |
Early Fludarabine Treatment of TCL-1 Transgenic Mice Promotes Drug Resistance through a Mechanism Not Involving p53 Mutations: Implications for Patients with Chronic Lymphocytic Leukemia (CLL).
|
De Lay, Michael D.
|
|
|
110 |
11 |
p. 3095
|
artikel
|
| 1507 |
Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.
|
Orlowski, Robert
|
|
|
110 |
11 |
p. 2735
|
artikel
|
| 1508 |
Early Onset of Acute Graft-Versus-Host Disease Indicating a Worse Prognosis in Terms of Chronic Graft-Versus-Host Disease and Survival Compared to Late Onset.
|
Sohn, Sang Kyun
|
|
|
110 |
11 |
p. 4979
|
artikel
|
| 1509 |
Early Peripheral Blood Blast Clearance during Induction Chemotherapy for Acute Myeloid Leukemia (AML) Predicts Superior Relapse-Free Survival.
|
Elliott, Michelle A.
|
|
|
110 |
11 |
p. 1848
|
artikel
|
| 1510 |
Early Post-Transplant Administration of Recombinant Erythropoietin Decreases Transfusion Needs and Hastens Haemoglobin Reconstitution in Reduced Intensity Conditioned (RIC) Allogeneic Stem Cell Transplantation (ASCT) for Non-Myeloid Malignancies.
|
Ivanov, Vadim
|
|
|
110 |
11 |
p. 2997
|
artikel
|
| 1511 |
Early Recovery of Absolute Lymphocyte Count (ALC) Is a Predictor of Long-Term Outcome Following Related Allogeneic Peripheral Blood Stem Cell Transplantation in Adults with AML/MDS.
|
Popradi, Gizelle
|
|
|
110 |
11 |
p. 1102
|
artikel
|
| 1512 |
Early Reduction of Serum Free Light Chain Can Predict Therapeutic Responses in Multiple Myeloma.
|
Nakorn, Thanyaphong Na
|
|
|
110 |
11 |
p. 4742
|
artikel
|
| 1513 |
Early Relapses in Primary CNS Lymphoma (PCNSL) without Intraventricular Treatment.
|
Schmidt-Wolf, Ingo G.H.
|
|
|
110 |
11 |
p. 4440
|
artikel
|
| 1514 |
Early Response to Therapy Is Significantly Associated with Genetic Subtype of Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group.
|
Loh, Mignon L.
|
|
|
110 |
11 |
p. 758
|
artikel
|
| 1515 |
Early Results of a Clinical Trial Using Targeted Oncolytic Virotherapy in Kaposi Sarcoma Herpes Virus (KSHV) Associated Multicentric Castleman's Disease (MCD).
|
O'Mahony, Deirdre
|
|
|
110 |
11 |
p. 514
|
artikel
|
| 1516 |
Early Results of a Phase II Trial Testing Low Dose Total Body Irradiation (LTBI) after Chemoimmunotherapy in Elderly High Risk Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
|
Safwat, Akmal
|
|
|
110 |
11 |
p. 1296
|
artikel
|
| 1517 |
Early Results of Pentostatin, Cytoxan, Rituximab (PCR) Followed by CAMPATH-H (CA) for the Treatment of Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) in ECOG Protocol E2903.
|
Kempin, Sanford
|
|
|
110 |
11 |
p. 3109
|
artikel
|
| 1518 |
Early Role of NFKB2 on the Myeloid Differentiation of CD34+ Hematopoietic Cells
|
Molfetta, Greice A.
|
|
|
110 |
11 |
p. 1276
|
artikel
|
| 1519 |
Early Stage Diffuse Large B Cell Lymphoma (DLBCL) in the CHOP-R Era: Does Involved Field Radiation Therapy (IFRT) Impact Outcome?.
|
Sikder, Manzurul A.
|
|
|
110 |
11 |
p. 3433
|
artikel
|
| 1520 |
Early T Cell Recovery of Thymus-Derived Naive T Cells and NK Cells in Pediatrics Patients after T-Cell Depleted HLA-Haploidentical Stem Cell Transplantation for Thalassemia.
|
Isgro', Antonella
|
|
|
110 |
11 |
p. 3816
|
artikel
|
| 1521 |
Early Treatment Intensification in High Risk (HR)-AML Patients Using Allogeneic Hematopoietic Stem Cell Transplantion in a Randomized Multicenter Setting.
|
Illmer, Thomas
|
|
|
110 |
11 |
p. 3018
|
artikel
|
| 1522 |
Early vs Standard Intervention with an Extended Epoetin alfa (EPO) Dose Regimen of 120,000 Units (U) Every 3 Weeks (Q3W) in Chemotherapy (CT)-Induced Anemia: Results for Elderly vs. Younger Patients in a Randomized Clinical Trial.
|
Charu, Veena
|
|
|
110 |
11 |
p. 3769
|
artikel
|
| 1523 |
EBV-Associated Follicular Dendritic Cell Tumor of the Spleen.
|
Fekrazad, M. Houman
|
|
|
110 |
11 |
p. 4509
|
artikel
|
| 1524 |
EBV-Associated Post-Transplant Lymphoproliferative Disorder after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
|
Yoo, Keon Hee
|
|
|
110 |
11 |
p. 4980
|
artikel
|
| 1525 |
EBV-Related Lymphoproliferative Disease Complicating Therapy with Siplizumab, a Novel Anti-CD2 Mediated T- and NK-Cell Depleting Agent, in Patients with T-Cell Malignancies.
|
O'Mahony, Deirdre
|
|
|
110 |
11 |
p. 3565
|
artikel
|
| 1526 |
EBV-Specific Cytotoxic T Lymphocytes by LMP2a- and EBNA3a-Specific T Cell Receptor Gene Transfer for Adoptive Therapy in EBV-Associated Hodgkin's Disease and Post-Transplant Lymphoma.
|
Nguyen, Tuan D.
|
|
|
110 |
11 |
p. 2334
|
artikel
|
| 1527 |
ECOG Performance Status Affects Efficacy, but Not Safety, of Lenalidomide/Dexamethasone in Relapsed/Refractory Multiple Myeloma (MM009/010 Sub-Analysis).
|
Chanan-Khan, Asher A.
|
|
|
110 |
11 |
p. 2721
|
artikel
|
| 1528 |
Economic Burden of Sickle Cell Disease among Children and Adults.
|
Hartzema, Abraham G.
|
|
|
110 |
11 |
p. 958
|
artikel
|
| 1529 |
Economic Evaluation of Posaconazole Versus Standard Azole Prophylaxis in High Risk Neutropenic Patients in The Netherlands.
|
Stam, Wiro B.
|
|
|
110 |
11 |
p. 3335
|
artikel
|
| 1530 |
Ectopic Expression of CDX2 Perturbs HOX Gene Expression in Murine Progenitors Depending on Its N-Terminal Transactivation Domain and Is Closely Correlated with Deregulated HOX Gene Expression in Human Acute Myeloid Leukemia.
|
Rawat, Vijay P.S.
|
|
|
110 |
11 |
p. 2125
|
artikel
|
| 1531 |
Ectopic Expression of HDAC9 in Murine Lymphoid System Leads to Altered Lymphocyte Numbers and Proliferation as Well as Predisposition to Tumorigenesis.
|
Gil, Veronica S.
|
|
|
110 |
11 |
p. 376
|
artikel
|
| 1532 |
Ectopic Expression of Human FIX in Mouse Platelets Can Store Releasable FIX in Platelets and May Be a Potential Strategy for Gene Therapy of Hemophilia B.
|
Zhang, Guowei
|
|
|
110 |
11 |
p. 196
|
artikel
|
| 1533 |
Ectopic Expression of Mer on Jurkat Cells and Its Anti-Apoptosis Effect.
|
Fan, Lei
|
|
|
110 |
11 |
p. 4098
|
artikel
|
| 1534 |
Ectopic Overexpression of C/EBP-alpha in Primary Human Mesenchymal Stem Cells Is Sufficient To Induce Preadipocyte Determination but Not Terminal Differentiation without Hormonal Enhancement.
|
Theurich, Sebastian
|
|
|
110 |
11 |
p. 4116
|
artikel
|
| 1535 |
Effective Factor VIII Endocytosis Is under Conformational Control of von Willebrand Factor.
|
Meijer, Alexander B.
|
|
|
110 |
11 |
p. 1767
|
artikel
|
| 1536 |
Effective Induction of Apoptosis in Chronic Myeloid Leukemia CD34+ Cells by the Histone Deacetylase Inhibitor LAQ824 in Combination with Imatinib.
|
Strauss, Adam C.
|
|
|
110 |
11 |
p. 1031
|
artikel
|
| 1537 |
Effectiveness of Management of Suspected Deep Vein Thrombosis in General Practice Based on a Clinical Decision Rule Including a Point of Care D-dimer Test.
|
Cate-Hoek, Arina ten
|
|
|
110 |
11 |
p. 967
|
artikel
|
| 1538 |
Effective Telomerase Inhibition Via Expression of Dominant-Negative HTERT Leads to Altered Growth Kinetics, Elevated Apoptosis and Increased Radiosensitivity of Bcr-Abl-Positive K562 Cells In Vitro.
|
Brassat, Ute
|
|
|
110 |
11 |
p. 2935
|
artikel
|
| 1539 |
Effect of Acute Inflammation Induced by Prolonged Exercise on Circulating Stem/Progenitor Cells That Mediate Tissue Repair.
|
Papassotiriou, Ioannis
|
|
|
110 |
11 |
p. 3902
|
artikel
|
| 1540 |
Effect of Anemia and Red Blood Cell Transfusion in Acute Myocardial Infarction.
|
Xenocostas, Anargyros
|
|
|
110 |
11 |
p. 454
|
artikel
|
| 1541 |
Effect of Dasatinib on BCR-ABL and Src Mediated Growth Signaling in Primary CML Hematopoietic Progenitors.
|
Konig, Heiko
|
|
|
110 |
11 |
p. 2944
|
artikel
|
| 1542 |
Effect of Deferasirox on Midazolam Pharmacokinetics.
|
Arrowsmith-Bensasson, Caroline
|
|
|
110 |
11 |
p. 3826
|
artikel
|
| 1543 |
Effect of Dioxin (TCDD) on Gene Transcription of Human CD34+ Hematopoietic Cells.
|
Fracchiolla, Nicola S.
|
|
|
110 |
11 |
p. 4033
|
artikel
|
| 1544 |
Effect of Disease Stage and Time Since Diagnosis on Time to Progression for Pegylated Liposomal Doxorubicin + Bortezomib vs Bortezomib Alone in Relapsed or Refractory Multiple Myeloma.
|
Sutherland, Heather J.
|
|
|
110 |
11 |
p. 2740
|
artikel
|
| 1545 |
Effect of FMS-Like Tyrosine Kinase-3 Mutations on Prognosis in Acute Myeloid Leukemia: A Single Institution Experience between 2000 and 2007.
|
Ghanem, Hady A.
|
|
|
110 |
11 |
p. 3489
|
artikel
|
| 1546 |
Effect of Graft Engineering and Post-Transplantation Immunosuppression Regimen on Immunophenotypic Recovery in Recipients of Unrelated Donor Bone Marrow (T-Cell Depletion Trial) in a Multicenter Randomized Phase II-III Trial.
|
Lamb, Lawrence S.
|
|
|
110 |
11 |
p. 1067
|
artikel
|
| 1547 |
Effect of HLA-Matching on Outcome of Hematopoietic Stem Cell Transplantation from Unrelated Donors: A IBMDR-GITMO Study.
|
Crocchiolo, Roberto
|
|
|
110 |
11 |
p. 3052
|
artikel
|
| 1548 |
Effect of Hypoxia on the Expression of BRIT1 in K562 Cell Line: Implication for Resistance to Imatinib.
|
Giallongo, Cesarina
|
|
|
110 |
11 |
p. 4530
|
artikel
|
| 1549 |
Effect of Inhibition of Grb2 Expression on BCR-ABL Mediated Transformation of Primary Human Hematopoietic Cells.
|
Modi, Hardik
|
|
|
110 |
11 |
p. 1020
|
artikel
|
| 1550 |
Effect of Interventions for Relapse or Progression Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience of 93 Patients.
|
Kurosawa, Saiko
|
|
|
110 |
11 |
p. 1648
|
artikel
|
| 1551 |
Effect of Mesenchymal Stem Cells on the Viability, Proliferation and Differentiation of B Lymphocytes.
|
Tabera, Soraya
|
|
|
110 |
11 |
p. 3880
|
artikel
|
| 1552 |
Effect of Pax3 Overexpression on the Engraftment of Mesenchymal Stem Cells in Dystrophic Mice.
|
Gang, Eun Ji
|
|
|
110 |
11 |
p. 1924
|
artikel
|
| 1553 |
Effect of Rituximab and/or High-Dose Therapy with Autotransplant at Time of Relapse in Patients with Follicular Lymphoma.
|
Coiffier, Bertrand
|
|
|
110 |
11 |
p. 386
|
artikel
|
| 1554 |
Effect of Staphylococcal Enterotoxin A on the Distribution and Clonal Expansion of TCR Vβ Subfamilies and the Cytotoxicity of T Cells Stimulated by PML-RARα Peptid.
|
Lin, Chen
|
|
|
110 |
11 |
p. 3871
|
artikel
|
| 1555 |
Effect of Storage on Levels of Nitric Oxide Derivatives in Blood Components.
|
Rizzatti, Fabiola G.
|
|
|
110 |
11 |
p. 2884
|
artikel
|
| 1556 |
Effect of Synthetic Peptides Derived from Human Apo(a) on Cell Proliferation, VEGF Production, and Angiogenesis in Cancer Cells and Vascular Endothelial Cells.
|
Bao, Bin
|
|
|
110 |
11 |
p. 3904
|
artikel
|
| 1557 |
Effect of T Cell Recovery on Overall Survival (OS) Following Pentostatin Conditioning for Nonmyeloablative Allogeneic Stem Cell Transplantation (NST).
|
Talmadge, James E.
|
|
|
110 |
11 |
p. 2994
|
artikel
|
| 1558 |
Effect of the Percent Decrease in Monoclonal Protein with Induction Therapy on the Outcome after Autologous Stem Cell Transplantation in Patients with IgG and IgA Multiple Myeloma.
|
Reece, Donna E.
|
|
|
110 |
11 |
p. 950
|
artikel
|
| 1559 |
Effect of Thrombotic Events on Overall Survival in Patients with Newly Diagnosed Myeloma: Analysis from a Randomized Phase III Trial of Thalidomide Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma (E1A00).
|
Kumar, Shaji
|
|
|
110 |
11 |
p. 2734
|
artikel
|
| 1560 |
Effect of Umbilical Cord Blood Hematopoietic Stem Cells on Formation of Angiogenic Structures.
|
Victor, Aaron
|
|
|
110 |
11 |
p. 4054
|
artikel
|
| 1561 |
Effects and Mechanisms of FTI-277 Inhibiting Proliferation of Myeloid Leukemia Cells and Enhancing Apoptosis Induced by As2O3.
|
Qiao, Zhenhua
|
|
|
110 |
11 |
p. 4177
|
artikel
|
| 1562 |
Effects of Anemia on the Rehabilitation Outcomes in Elderly Patients in the Post-Acute Care Setting.
|
Witkos, Maciej
|
|
|
110 |
11 |
p. 5158
|
artikel
|
| 1563 |
Effects of a Novel, Selective Jak2 Inhibitor, AZ60, on STAT5 Signaling and Cellular Growth in Jak2 V617F Cell Lines.
|
Gozgit, Joseph M.
|
|
|
110 |
11 |
p. 3549
|
artikel
|
| 1564 |
Effects of Celecoxib on Human Acute Promyelocytic Leukemia Cell Line and Its Mechanism.
|
Xu, Yun
|
|
|
110 |
11 |
p. 2851
|
artikel
|
| 1565 |
Effects of c-Src Overexpression in CD40-Activated Human B Lymphocytes.
|
Jung, Daniel
|
|
|
110 |
11 |
p. 3868
|
artikel
|
| 1566 |
Effects of Cyclosporine A on Lentiviral Transduction of Mouse Hematopoietic Stem Cells and Transplantation Using Nonmyeloablative Conditioning.
|
Sutherland, Nadia D.
|
|
|
110 |
11 |
p. 5147
|
artikel
|
| 1567 |
Effects of Dabigatran, a Direct Thrombin Inhibitor, as Compared to the Direct Factor Xa Inhibitors, Rivaroxaban and Apixaban, on Tissue Factor-Induced Human Platelet Aggregation in Platelet Rich Plasma.
|
van Ryn, Joanne
|
|
|
110 |
11 |
p. 1884
|
artikel
|
| 1568 |
Effects of Direct Factor Xa Inhibitor, YM150, on Clot Formation and Clot Lysis In Vitro Compared with Other Anticoagulants.
|
Kaku, Seiji
|
|
|
110 |
11 |
p. 3153
|
artikel
|
| 1569 |
Effects of G-CSF vs. No G-CSF on Outcomes Post-Autologous Stem Cell Transplant - A Two-Centre Retrospective Study.
|
Bergstrom, Debra J.
|
|
|
110 |
11 |
p. 5133
|
artikel
|
| 1570 |
Effects of Graft Compositions on Hematopoietic Reconstitution and Graft-Versus-Host Disease in Related Donor Peripheral Blood Stem Cell Transplantation.
|
Feng, Ru
|
|
|
110 |
11 |
p. 5045
|
artikel
|
| 1571 |
Effects of Integrin-Linked Kinase (ILK) Inhibitor QLT0267 on Multiple Myeloma Cells and Evaluation of ILK as a Therapeutic Target in Multiple Myeloma.
|
Stühmer, Thorsten
|
|
|
110 |
11 |
p. 3529
|
artikel
|
| 1572 |
Effects of Intravenous Immunoglobulins (IVIG) on Cell-Derived Microparticles in Patients with ITP.
|
Fontana, Vincenzo
|
|
|
110 |
11 |
p. 3134
|
artikel
|
| 1573 |
Effects of Leucine Administration in Diamond-Blackfan Anemia Patients.
|
Pospisilova, Dagmar
|
|
|
110 |
11 |
p. 1686
|
artikel
|
| 1574 |
Effects of Naturally Occurring Mutations in CUB-1 Domain on ADAMTS-13 Synthesis, Stability and Activity.
|
Zhou, Zhou
|
|
|
110 |
11 |
p. 710
|
artikel
|
| 1575 |
Effects of “Primary Prophylaxis” and “On-Demand” Therapy on the Clinical Expression of Severe Hemophilia A in Children - Results of a Multicenter Study.
|
Schobess, Rosemarie
|
|
|
110 |
11 |
p. 3146
|
artikel
|
| 1576 |
Effects of Recipients' Body Weight on Engraftment after Unrelated Bone Marrow Transplantation: Analysis of Clinical Data of 4065 Patients from the Database of the Japan Marrow Donor Program.
|
Yamashita, Takuya
|
|
|
110 |
11 |
p. 5083
|
artikel
|
| 1577 |
Effects of Recombinant Factor VIIa (NovoSeven®) on Restoring Thrombin Generation in Patients with Hemophilia A and Antibodies to Factor VIII.
|
Eichinger, Sabine
|
|
|
110 |
11 |
p. 1161
|
artikel
|
| 1578 |
Effects of Serotonin on Proplatelet Formation and F-actin Reorganization in Human Megakaryocytes.
|
Cheng, Yuan Shan
|
|
|
110 |
11 |
p. 2108
|
artikel
|
| 1579 |
Effects of Sodium Valproate on Proliferation and Apoptosis of Human Myelodysplastic Syndromes Cell Line MUTZ-1.
|
Chen, Bao-An
|
|
|
110 |
11 |
p. 4090
|
artikel
|
| 1580 |
Effects of Soluble Domain 1 of Apolipoprotein ER2′ (BD1 apoER2′) on Pathogenic Effects of a Dimer of β2glycoprotein I (β2GPI) In Vivo.
|
Pierangeli, Silvia S.
|
|
|
110 |
11 |
p. 3620
|
artikel
|
| 1581 |
Effects of Steroid Treatment on Childhood ALL Stem Cells.
|
Cox, Charlotte V.
|
|
|
110 |
11 |
p. 3462
|
artikel
|
| 1582 |
Effects of Temperature on the Change of HSP and the Viability of Mobilized Hematopoietic Stem Cells.
|
Kim, Hawk
|
|
|
110 |
11 |
p. 4044
|
artikel
|
| 1583 |
Effects of the Homeodomain Gene Pitx2 on Self-Renewal of Hematopoietic Stem Cells.
|
Zhang, Hui Z.
|
|
|
110 |
11 |
p. 95
|
artikel
|
| 1584 |
Efficacy and Long Term Survival of Genetically Modified T Cells Targeting CD19 in a Syngeneic Immune Competent Transgenic Murine Tumor Model Is Dependent on Prior Lymphodepleting Chemotherapy.
|
Lee, James
|
|
|
110 |
11 |
p. 2754
|
artikel
|
| 1585 |
Efficacy and Safety of a New Intravenous Immunoglobulin Product in Patients with Chronic Immune Thrombocytopenic Purpura.
|
Robak, Tadeusz
|
|
|
110 |
11 |
p. 1307
|
artikel
|
| 1586 |
Efficacy and Safety of a Single-Course of Yttrium-90 Ibritumomab Tiuxetan for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma after/not Appropriate for Autologous Stem Cell Transplantation - Final Analysis of a Phase II Trial of the European MCL Network.
|
Weigert, Oliver
|
|
|
110 |
11 |
p. 4501
|
artikel
|
| 1587 |
Efficacy and Safety of Bosutinib (SKI-606) among Patients with Chronic Phase Ph+ Chronic Myelogenous Leukemia (CML).
|
Cortes, J.
|
|
|
110 |
11 |
p. 733
|
artikel
|
| 1588 |
Efficacy and Safety of Colistin for the Treatment of Infections Caused by Multidrug-Resistant Isolates of Pseudomonas Aeruginosa Sensitive to Colistin in Patients with Haematological Malignancy; a Matched-Pair Analysis.
|
Durakovic, Nadira
|
|
|
110 |
11 |
p. 2283
|
artikel
|
| 1589 |
Efficacy and Safety of Dasatinib in Patients with Chronic Myeloid Leukemia in Blast Phase Whose Disease Is Resistant or Intolerant to Imatinib: 2-Year Follow-Up Data from the START Program.
|
Gambacorti, Carlo
|
|
|
110 |
11 |
p. 472
|
artikel
|
| 1590 |
Efficacy and Safety of Early Administration of Mycophenolate Mofetil to Steroid-Resistant Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation: A Single Institution Study.
|
Mori, Masaki
|
|
|
110 |
11 |
p. 4998
|
artikel
|
| 1591 |
Efficacy and Safety of Gemtuzumab-Based Regimens in Patients with CD33-Positive Refractory Leukemia.
|
Wu, Suijing
|
|
|
110 |
11 |
p. 4358
|
artikel
|
| 1592 |
Efficacy and Safety of ReFacto AF for Surgical Hemostasis in Previously Treated Patients with Severe Hemophilia A.
|
Windyga, Jerzy
|
|
|
110 |
11 |
p. 3960
|
artikel
|
| 1593 |
Efficacy and Safety of Rituximab+CHOP in IR and Maintenance Therapy with Rituximab vs Observation in De Novo Aggressive Non-Hodgkin Lymphoma.
|
Tripp, Francisco
|
|
|
110 |
11 |
p. 4489
|
artikel
|
| 1594 |
Efficacy and Safety of Rituximab in Post Transplant Lymphoproliferative Disorders (PTLD): Pooled Analysis and Review of Literature.
|
Ramanarayanan, Jeyanthi
|
|
|
110 |
11 |
p. 1084
|
artikel
|
| 1595 |
Efficacy and Safety of YM155 in Relapsed/Refractory Non-Hodgkin's Lymphoma Patients Enrolled in a Phase I Study.
|
Papadopoulos, Kyriakos
|
|
|
110 |
11 |
p. 3422
|
artikel
|
| 1596 |
Efficacy and Tolerability of Lenalidomide/Dexamethasone in Intensively Pretreated Myeloma Patients: Experiences from the German Named Patient Program.
|
Klein, Ulrike
|
|
|
110 |
11 |
p. 4834
|
artikel
|
| 1597 |
Efficacy and Tolerability of Pregabalin in Decreasing Pain Associated with High Dose of Imatinib in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase CML.
|
Iuliano, Francesco
|
|
|
110 |
11 |
p. 4570
|
artikel
|
| 1598 |
Efficacy Comparison of Oral Versus Intravenous Busulfan in a BuCy Conditioning Regimen for Allogeneic BMT.
|
Lee, Je-Hwan
|
|
|
110 |
11 |
p. 5042
|
artikel
|
| 1599 |
Efficacy of Allogeneic Stem-Cell Transplantation for T/NK-Cell Lymphomas in Adults.
|
Le Gouill, Steven
|
|
|
110 |
11 |
p. 3038
|
artikel
|
| 1600 |
Efficacy of Anagrelide Compared with Hydroxyurea in Patients with Essential Thrombocythemia.
|
Cacciola, Rossella Rosari
|
|
|
110 |
11 |
p. 4634
|
artikel
|
| 1601 |
Efficacy of Azacytidine (5-AC) Given as Maintenance or Salvage Therapy for Patients (pts) with Acute Leukemia Post Allogeneic Stem Cell Transplantation (HSCT).
|
Jabbour, Elias
|
|
|
110 |
11 |
p. 3013
|
artikel
|
| 1602 |
Efficacy of Cyclosporine Treatment in Patients with MDS.
|
Kokhno, Alina
|
|
|
110 |
11 |
p. 4608
|
artikel
|
| 1603 |
Efficacy of Dasatinib in Patients (pts) with Previously Untreated Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CML-CP).
|
Cortes, Jorge
|
|
|
110 |
11 |
p. 30
|
artikel
|
| 1604 |
Efficacy of Dasatinib in Patients with Accelerated-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-A (CA180-005).
|
Guilhot, Francois
|
|
|
110 |
11 |
p. 470
|
artikel
|
| 1605 |
Efficacy of Dasatinib in Patients with Chronic-Phase Chronic Myelogenous Leukemia with Resistance or Intolerance to Imatinib: 2-Year Follow-Up Data from START-C (CA180-013).
|
Stone, Richard M.
|
|
|
110 |
11 |
p. 734
|
artikel
|
| 1606 |
Efficacy of Dasatinib in Patients with Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukemia Who Are Resistant or Intolerant to Imatinib: 2-Year Follow-Up Data from START-L (CA180-015).
|
Porkka, Kimmo
|
|
|
110 |
11 |
p. 2810
|
artikel
|
| 1607 |
Efficacy of Dose-Dense R-CHOP-14 Chemoimmunotherapy Plus Pegfilgrastim for First-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) in Low Risk Patients: An Interim Analysis of an Open-Label Clinical Trial in Spain. On Behalf of GEL/TAMO (Spanish Group of Lymphoma).
|
Gonzalez-Barca, Eva
|
|
|
110 |
11 |
p. 3443
|
artikel
|
| 1608 |
Efficacy of Extracorporeal Photopheresis (ECP) Monotherapy in the Treatment of Cutaneous T Cell Lymphoma.
|
Geskin, Larisa
|
|
|
110 |
11 |
p. 2561
|
artikel
|
| 1609 |
Efficacy of FDG-PET/CT Imaging To Guide Biopsies in the Detection of Richter's Syndrome.
|
Le Gouill, Steven
|
|
|
110 |
11 |
p. 1390
|
artikel
|
| 1610 |
Efficacy of High-Dose Sequential Chemotherapy and Autograft for Transformed Non Hodgkin's B Cell Lymphoma: Results of a Retrospective Analysis from GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).
|
Di Nicola, Massimo
|
|
|
110 |
11 |
p. 3440
|
artikel
|
| 1611 |
Efficacy of Hydroxyurea To Prevent Organ Damage in Young Children with Sickle Cell Anemia.
|
Thornburg, Courtney D.
|
|
|
110 |
11 |
p. 3386
|
artikel
|
| 1612 |
Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.
|
Delaunay, Jacques
|
|
|
110 |
11 |
p. 4329
|
artikel
|
| 1613 |
Efficacy of Imatinib Mesylate Dose-Escalation in CML Patients Showing Suboptimal Response to Standard Dose.
|
Kim, D.Y.
|
|
|
110 |
11 |
p. 2967
|
artikel
|
| 1614 |
Efficacy of Lenalidomide for Treatment of Anemia in Secondary Myelodysplastic Syndrome (MDS) with Chromosome 5q Deletion.
|
Mintzer, David Michael
|
|
|
110 |
11 |
p. 4614
|
artikel
|
| 1615 |
Efficacy of Lenalidomide in Primary Plasma Cell Leukemia.
|
Pietrantuono, Giuseppe
|
|
|
110 |
11 |
p. 4835
|
artikel
|
| 1616 |
Efficacy of Mitoxantrone and Etoposide in Patients with Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy.
|
Sehgal, Rajesh
|
|
|
110 |
11 |
p. 4385
|
artikel
|
| 1617 |
Efficacy of Nilotinib (AMN107) in Patients (Pts) with Newly Diagnosed, Previously Untreated Philadelphia Chromosome (Ph)-Positive Chronic Myelogenous Leukemia in Early Chronic Phase (CML-CP).
|
Cortes, Jorge
|
|
|
110 |
11 |
p. 29
|
artikel
|
| 1618 |
Efficacy of ‘Off-the-Shelf', Commercially-Available, Third-Party Mesenchymal Stem Cells (MSC) in Ex Vivo Cord Blood (CB) Co-Culture Expansion.
|
Robinson, Simon N.
|
|
|
110 |
11 |
p. 4106
|
artikel
|
| 1619 |
Efficacy of Oral Ciprofloxacin Prophylaxis in BMT Recipients: A Case-Control Study.
|
Camacho, Pedro R.
|
|
|
110 |
11 |
p. 4987
|
artikel
|
| 1620 |
Efficacy of Panobinostat (LBH589) in CTCL Cell Lines and a Murine Xenograft Model: Defining Molecular Pathways of Panobinostat Activity in CTCL.
|
Shao, Wenlin
|
|
|
110 |
11 |
p. 1375
|
artikel
|
| 1621 |
Efficacy of Panobinostat (LBH589) in Multiple Myeloma Cell Lines and In Vivo Mouse Model: Tumor-Specific Cytotoxicity and Protection of Bone Integrity in Multiple Myeloma.
|
Growney, Joseph D.
|
|
|
110 |
11 |
p. 1510
|
artikel
|
| 1622 |
Efficacy of Recombinant Activated Factor VII (rFVIIa) vs. Activated Prothrombin Complex Concentrate (APCC) in Patients with Hemophilia with Inhibitors: A Bayesian Meta-Analysis.
|
Treur, Maarten Jacob
|
|
|
110 |
11 |
p. 3964
|
artikel
|
| 1623 |
Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera.
|
Wernig, Gerlinde
|
|
|
110 |
11 |
p. 556
|
artikel
|
| 1624 |
Efficacy of the “MarrowMiner” a Novel, Minimally Invasive Bone Marrow Harvesting Device in a Large Animal Model.
|
Kraft, Daniel
|
|
|
110 |
11 |
p. 1217
|
artikel
|
| 1625 |
Efficacy of the Novel Oral Iron Chelator Deferitrin in Metabolic Iron Balance Studies.
|
Grady, Robert W.
|
|
|
110 |
11 |
p. 2775
|
artikel
|
| 1626 |
Efficacy of 90Y-Ibritumomab Tiuxetan in Marginal-Zone Lymphoma (MZL).
|
Vanazzi, Anna
|
|
|
110 |
11 |
p. 4499
|
artikel
|
| 1627 |
Efficacy, Safety and Tolerability of a Novel High-Purity, Double Virus-Inactivated VWF/FVIII-Concentrate in the Treatment of Von Willebrand Disease (VWD) - Clinical Experience in the Treatment of Bleeding and Surgery.
|
Schwartz, B.A.
|
|
|
110 |
11 |
p. 2144
|
artikel
|
| 1628 |
Efficient Clonal Gene Delivery into Human Embryonic Stem Cells Via Active Transgenesis Using PiggyBac Transposition.
|
Zhang, Ting-Ting
|
|
|
110 |
11 |
p. 5149
|
artikel
|
| 1629 |
Efficient Delivery of the A-Gamma Globin Gene in Human Hematopoietic and Non-Hematopoietic Cells by Cationic Phosphonolipid- and Lipophosphoramide-Mediated Transfection.
|
Koumbi, Daphne
|
|
|
110 |
11 |
p. 5141
|
artikel
|
| 1630 |
Efficient Generation of Tumor-Specific, Cytotoxic T Cells by Genetic Transfer of allo-MHC.
|
Stronen, Erlend
|
|
|
110 |
11 |
p. 2755
|
artikel
|
| 1631 |
Efficient Induction and Isolation of CMV-Specific CD8+ T Cells from CMV Seronegative Donors for the Treatment of CMV Reactivation in CMV Seropositive Patients Transplanted with a CMV Seronegative Donor.
|
Jedema, Inge
|
|
|
110 |
11 |
p. 1053
|
artikel
|
| 1632 |
Efficient Lysis of Myeloma Cells by CD16 Positive Effector Cells with Recombinant Single Chain Bispecific Antibodies Targeting HM1.24.
|
Peipp, Matthias
|
|
|
110 |
11 |
p. 2752
|
artikel
|
| 1633 |
Efficient Transfer of CD40L mRNA into Mantle Cell Lymphoma for the Production of a Whole Tumor Cell Vaccine.
|
Brody, Joshua D.
|
|
|
110 |
11 |
p. 2591
|
artikel
|
| 1634 |
Eighty-Five Cases of Lymphoma in a Solid Organ Transplant (SOT) Population: Risk, Treatment, and Histologic Subtype.
|
Knight, Jason S.
|
|
|
110 |
11 |
p. 1367
|
artikel
|
| 1635 |
EKLF Is Recruited to the γ-Globin Gene Promoter as a Co-Activator and Is Required for γ-Globin Gene Induction by Short-Chain Fatty Acids.
|
Perrine, Susan P.
|
|
|
110 |
11 |
p. 1771
|
artikel
|
| 1636 |
Elderly Patients with Acute Myeloid Leukemia Are Not All the Same: Results of the Prospective DSIL AML96 Trial.
|
Schaich, Markus Andreas
|
|
|
110 |
11 |
p. 1840
|
artikel
|
| 1637 |
Electrocardiographic Screening for Cardiac Iron in Thalassemia Major.
|
Detterich, Jon A.
|
|
|
110 |
11 |
p. 2766
|
artikel
|
| 1638 |
Elements of a Chromatin Insulator Necessary for Consistent, High-Level Globin Gene Expression
|
Arumugam, Paritha I.
|
|
|
110 |
11 |
p. 3731
|
artikel
|
| 1639 |
Elevated CD56dimCD16neg NK Cells on Day 28 after HCT: Role in Immunity Against Viral Infections or Residual Tumor Cells?.
|
Khan, Faisal
|
|
|
110 |
11 |
p. 1977
|
artikel
|
| 1640 |
Elevated Fas Ligand and BA21 Serorecognition as Disease Correlates in Bone Marrow Failure Disorders: Taking Advantage of the LGL Leukemia Model.
|
Nyland, Susan B.
|
|
|
110 |
11 |
p. 4274
|
artikel
|
| 1641 |
Elevated Ferritin Is Associated with Poorer Survival Following Nonablative Allogeneic Transplantation.
|
Mahindra, Anuj
|
|
|
110 |
11 |
p. 1986
|
artikel
|
| 1642 |
Elevated Fibrinogen Predicts Atherosclerosis.
|
Green, David
|
|
|
110 |
11 |
p. 3188
|
artikel
|
| 1643 |
Elevated FoxM1 Expression Promotes Cell Cycle Progression by Induction of KIS Expression and Contributes to the Development of Leukemia Cells.
|
Keiji, Okinaka
|
|
|
110 |
11 |
p. 888
|
artikel
|
| 1644 |
Elevated Normal Immunoglobulins and Stable M-Protein Levels in Multiple Myeloma Patients on Erythropoietin Treatment.
|
Gadassi, Noa
|
|
|
110 |
11 |
p. 4747
|
artikel
|
| 1645 |
Elevated Pretransplant Serum Ferritin in Autologous Stem Cell Transplant.
|
Mahindra, Anuj
|
|
|
110 |
11 |
p. 606
|
artikel
|
| 1646 |
Elevated Red Cell Microparticles (RMP) as Risk Factor for Thrombosis in Patients with Renal Failure.
|
Fontana, Vincenzo
|
|
|
110 |
11 |
p. 1638
|
artikel
|
| 1647 |
Elevated Serum Interleukin-7 Levels Precede the Development of Acute Graft-Versus-Host Disease.
|
Dean, Robert M.
|
|
|
110 |
11 |
p. 1064
|
artikel
|
| 1648 |
Elevated Urinary Leukotriene E4 Levels Are Associated with Hospitalization for Pain in Children with Sickle Cell Disease.
|
Jennings, Jeanine E.
|
|
|
110 |
11 |
p. 3405
|
artikel
|
| 1649 |
Eltrombopag Decreases Proliferation of Human Leukemia and Lymphoma Cell Lines In Vitro.
|
Erickson-Miller, Connie L.
|
|
|
110 |
11 |
p. 4089
|
artikel
|
| 1650 |
Elucidating the Molecular Architecture of the FA-Core Complex Utilizing Biochemical Purification Approach.
|
Ali, Abdullah M.
|
|
|
110 |
11 |
p. 1683
|
artikel
|
| 1651 |
Embryonic Stem Cells Transplanted In Utero Survive and Produce Teratocarcinomas in a Murine Model.
|
Nedelcu, Elena
|
|
|
110 |
11 |
p. 4874
|
artikel
|
| 1652 |
Emergence of Rituximab-Fludarabine Resistance Is Associated with Changes in CD20 Antigen Expression and Improved Response to Almetuzumab Therapy in Patients with Chronic Lymphocytic Leukemia (CLL).
|
Ashraf, Umeer
|
|
|
110 |
11 |
p. 2054
|
artikel
|
| 1653 |
Emergency Blood Supply Planning: A Statewide Prospective Audit To Determine the Potential Benefits of Triaging Red Cells during a Critical Shortage.
|
Shortt, Jake
|
|
|
110 |
11 |
p. 2908
|
artikel
|
| 1654 |
Emerging Epidemics of Babesiosis in Hematology Consultation at a University Hospital.
|
Hosur, Srilatha
|
|
|
110 |
11 |
p. 3859
|
artikel
|
| 1655 |
Emodin Induces Leukemic HL-60 Cells Apoptosis by Inhibiting PI3K/Akt Signal Pathway.
|
Hu, Jian Da
|
|
|
110 |
11 |
p. 4296
|
artikel
|
| 1656 |
Empirical Antifungal Therapy for Patients with Neutropenia and Persitent Fever - Systematic Review and Meta-Analysis.
|
Goldberg, Elad
|
|
|
110 |
11 |
p. 4961
|
artikel
|
| 1657 |
Encouragement of Transplacental Stem Cell Transplantation.
|
Heldermon, Coy
|
|
|
110 |
11 |
p. 1202
|
artikel
|
| 1658 |
Encouraging Results of Reduced Intensity Conditioning (RIC) Umbilical Cord Blood (UCB) Transplantation for the Treatment of Advanced Lymphoid Malignancies.
|
Brunstein, Claudio G.
|
|
|
110 |
11 |
p. 2028
|
artikel
|
| 1659 |
Endogenous Elevations of Short Chain Fatty Acids (SCFAs) Can Up-Regulate Embryonic Globin Gene Expression.
|
Bhatia, Himanshu
|
|
|
110 |
11 |
p. 1770
|
artikel
|
| 1660 |
Endogenous Thrombin Potential (ETP) in Patients with Hereditary Antithrombin (AT) Deficiency or Carriers of the Prothrombin (PT) 20210A Gene Mutation.
|
Conard, Jacqueline
|
|
|
110 |
11 |
p. 1623
|
artikel
|
| 1661 |
Endothelial Cell Markers Kinetics Following Umbilical Cord Blood Transplantation in Adults.
|
Petropoulou, Anna D.
|
|
|
110 |
11 |
p. 4964
|
artikel
|
| 1662 |
Endothelial Cells Express No Detectable Erythropoietin Receptor Protein and Erythropoietin Does Not Induce Angiogenesis In Vivo.
|
Coxon, Angela
|
|
|
110 |
11 |
p. 4077
|
artikel
|
| 1663 |
Endothelial Cell Thiol Isomerases: Potential Role in Thrombus Formation.
|
Jasuja, Reema
|
|
|
110 |
11 |
p. 3709
|
artikel
|
| 1664 |
Endothelial Derived Microparticles Bind and Activate Platelets in a CD36 Dependent Manner.
|
Ghosh, Arunima
|
|
|
110 |
11 |
p. 418
|
artikel
|
| 1665 |
Endothelial Dysfunction in Autologous Hematopoietic Stem Cell Transplantation.
|
Diaz-Ricart, Maribel
|
|
|
110 |
11 |
p. 4855
|
artikel
|
| 1666 |
Endothelial Progenitor Cell Transplantation for Hematopoietic Regeneration.
|
Salter, Alice B.
|
|
|
110 |
11 |
p. 179
|
artikel
|
| 1667 |
Engraftment after Haematopoietic Stem Cell Transplantation: Which Predictors Are Most Important?.
|
Lioznov, Michael V.
|
|
|
110 |
11 |
p. 4947
|
artikel
|
| 1668 |
Engraftment Syndrome Is Common in Patients with POEMS Syndrome Undergoing PBSCT.
|
Dispenzieri, Angela
|
|
|
110 |
11 |
p. 2995
|
artikel
|
| 1669 |
Enhanced Anti-Breast Cancer Cytotoxicity after Autologous Peripheral Blood Stem Cell Transplant (PBSCT) by Boosting with Multiple Infusions of Activated T Cells (ATC) Armed with Anti-CD3 x Anti-Her2 Bispecific Antibody (Her2Bi) Prior to PBSCT.
|
Lum, Lawrence G.
|
|
|
110 |
11 |
p. 2748
|
artikel
|
| 1670 |
Enhanced Anticoagulant Activity of Factor VIII Inhibitors Due to Positive Cooperativity between Two Classes of Anti-Factor VIII C2 Antibodies.
|
Meeks, Shannon L.
|
|
|
110 |
11 |
p. 784
|
artikel
|
| 1671 |
Enhanced Efficacy of Recombinant Factor VIII in Non-Covalent Complex with PEGylated Liposome in Hemophilia A Mice.
|
Pan, Junliang
|
|
|
110 |
11 |
p. 3149
|
artikel
|
| 1672 |
Enhanced Erythroblast Mobilization in Nix-Deficient Mice Confers Resistance to Phenylhydrazine-Induced Anemia Despite Accelerated Erythrocyte Turnover.
|
Diwan, Abhinav
|
|
|
110 |
11 |
p. 3659
|
artikel
|
| 1673 |
Enhanced HDAC (Histone Deacetylase) Enzyme Activities in Blood CD 34 + Cells in Patients with Myeloid Metaplasia Myelofibrosis (MMM).
|
Wang, Jen-Chin
|
|
|
110 |
11 |
p. 4657
|
artikel
|
| 1674 |
Enhanced Natural Killer (NK) and NK T Cell Activation, Expansion and Cytokine Protein Production Following Ex-Vivo Engineering (EvE) of Cryopreserved Umbilical Cord Blood (UCB): Potential Role of CB NK and NKT Cells in Adoptive Cellular Immunotherapy (ACI).
|
Ayello, Janet
|
|
|
110 |
11 |
p. 1206
|
artikel
|
| 1675 |
Enhanced Phosphatidylserine Scrambling in Oxidatively Challenged Red Blood Cells.
|
DeJong, Kitty
|
|
|
110 |
11 |
p. 1718
|
artikel
|
| 1676 |
Enhanced Phosphorylation and Altered Localization Lead to Impairment of p27kip Activity in CML Progenitor Cells Despite Enhanced Protein Translation and Expression.
|
Chu, Su
|
|
|
110 |
11 |
p. 999
|
artikel
|
| 1677 |
Enhanced Serum Complement Activation on Platelets Is Associated with Arterial Thrombosis in Patients with Systemic Lupus Erythematosus (SLE) and Antiphospholipid Antibodies(aPL).
|
Peerschke, Ellinor I.B.
|
|
|
110 |
11 |
p. 1637
|
artikel
|
| 1678 |
Enhanced T Cell Function in Patients with Hematological Malignanicies Undergoing Mobilization for Autologous Stem Cell Transplantation.
|
Colovai, Adriana I.
|
|
|
110 |
11 |
p. 3288
|
artikel
|
| 1679 |
Enhancement of Cytogenetic Diagnosis of Myeloid Disorders through Application of SNP-Array-Based Karyotyping.
|
Gondek, Lukasz P.
|
|
|
110 |
11 |
p. 108
|
artikel
|
| 1680 |
Enhancement of the Antigen-Presenting Cell Function of Mantle Cell Lymphomas (MCL) by Novel Molecularly Based Immunotherapeutic Strategies.
|
Wang, Hongwei
|
|
|
110 |
11 |
p. 2315
|
artikel
|
| 1681 |
ENMD-1198 in Combination with Vincristine Shows Synergistic Activity in Leukemia Cells and Prolonged Mouse Survival in Human Leukemia Xenografts.
|
Liaw, Tracy T.Y.E.
|
|
|
110 |
11 |
p. 859
|
artikel
|
| 1682 |
α-Enolase Is the c-myc Promoter-Binding Protein.
|
Miller, Donald M.
|
|
|
110 |
11 |
p. 4075
|
artikel
|
| 1683 |
Enrichment of CD34+ Hematopoietic Stem and Progenitor Cells from Human Bone Marrow Using a P-Selectin-Coated Microtube.
|
Narasipura, Srinivas D.
|
|
|
110 |
11 |
p. 1219
|
artikel
|
| 1684 |
Enrichment of Hematopoietic Stem Cells from Normal and Trp53 Null Mice Using SLAM Receptor CD150 as a Positive Selection Marker.
|
Chen, Jichun
|
|
|
110 |
11 |
p. 2235
|
artikel
|
| 1685 |
Enrichment of Mesenchymal Progenitor Cells from Mouse Compact Bone.
|
Short, Brenton
|
|
|
110 |
11 |
p. 4105
|
artikel
|
| 1686 |
Enucleation of Primitive Erythroid Cells Generates a Transient Population of “Pyrenocytes” in the Mammalian Fetus.
|
McGrath, Kathleen E.
|
|
|
110 |
11 |
p. 425
|
artikel
|
| 1687 |
Environmental Factors Determine Lineage Fate in a Human Model of MLL-AF9 Leukemia.
|
Wei, Junping
|
|
|
110 |
11 |
p. 3374
|
artikel
|
| 1688 |
Environmental Mediated-Immune Resistance (EM-IR) to APO2L/TRAIL Mediated Apoptosis.
|
Perez, Lia E.
|
|
|
110 |
11 |
p. 3521
|
artikel
|
| 1689 |
Epac Is Involved in cAMP-Mediated Exocytosis of Weibel-Palade Bodies in Endothelial Cells through the Activation of the Small GTPase Rap1.
|
Voorberg, Jan
|
|
|
110 |
11 |
p. 2157
|
artikel
|
| 1690 |
Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.
|
Kuang, Shao-qing
|
|
|
110 |
11 |
p. 2128
|
artikel
|
| 1691 |
Epidemiology and Clinical Outcomes of the M-Component Immunoglobulin Types of Multiple Myeloma in an Inner City Hispanic Population.
|
Batty, George Nicolas
|
|
|
110 |
11 |
p. 4736
|
artikel
|
| 1692 |
Epidemiology of Plasma Cell Disorders in a General Hospital: A Retrospective Study of 102 Patients.
|
Ricca, Irene
|
|
|
110 |
11 |
p. 4754
|
artikel
|
| 1693 |
Epidemiology of S pneumoniae Infection in Hematology Patients in Ile de France: Serotypes Covered by the Polysaccharide 23-Valent (PS23) and the Heltavalent Conjugate Vaccine.
|
Debbache, Karima
|
|
|
110 |
11 |
p. 4963
|
artikel
|
| 1694 |
(−)-Epigallocatechin-3-Gallate (EGCG), Green Tea Component, Antagonize the Anti-Myeloma Activity of Proteasome Inhibitor PS-341 by Direct Chemical Interaction.
|
Kim, Tae Young
|
|
|
110 |
11 |
p. 4850
|
artikel
|
| 1695 |
Epigenetic Inactivation of the Secreted Frizzled-Related Protein Gene Family in Multiple Myeloma.
|
Jost, Edgar
|
|
|
110 |
11 |
p. 2131
|
artikel
|
| 1696 |
Epigenetic Profiling Identifies EGLN3 as a Frequent Target for Transcriptional Silencing in Plasma Cell Neoplasias.
|
Shah, Reshma
|
|
|
110 |
11 |
p. 2132
|
artikel
|
| 1697 |
Epigenetic Regulation of CD20 Protein Expression in B-Cell Lymphoma Cells after Rituximab-Containing Chemotherapy.
|
Tomita, Akihiro
|
|
|
110 |
11 |
p. 3423
|
artikel
|
| 1698 |
Epigenetic Repression of the Adaptor Molecule LAT2 by the Leukemic Fusion Protein AML1/ETO.
|
Duque-Afonso, Jesus
|
|
|
110 |
11 |
p. 987
|
artikel
|
| 1699 |
Epistatic Interaction between Fibrinogen alpha and gamma Genes and Factor V Leiden in Children with Venous Thrombosis: Results from a Family-Based Association Study.
|
Nowak-Gottl, Ulrike
|
|
|
110 |
11 |
p. 1640
|
artikel
|
| 1700 |
Epitope Identification and Generation of an Antigen-Specific T-Cell Clone in a Mild Hemophilia A Inhibitor Subject with Missense Genotype R593C.
|
James, Eddie A.
|
|
|
110 |
11 |
p. 1159
|
artikel
|
| 1701 |
Epoetin Beta (Neorecormon®) Treatment for Anemia of Patients with Non-Myeloid Hematological Malignancy under Chemotherapy: Results of a Large Prospective Cohort Study.
|
Haïoun, Corinne
|
|
|
110 |
11 |
p. 3777
|
artikel
|
| 1702 |
Epoetin Beta with Intravenous Iron Results in Overall Cost Savings in a Population of Anemic Patients with Lymphoid Malignancies Not Receiving Chemotherapy.
|
Hedenus, Michael
|
|
|
110 |
11 |
p. 5179
|
artikel
|
| 1703 |
EPO Receptor Overexpression in Breast Cancer Cells Enhances EPO Sensitivity, Induces ERK and AKT Phosphorylation and Promotes Cellular Proliferation and Migration through a JNK-Dependent Pathway.
|
Fu, Ping
|
|
|
110 |
11 |
p. 4083
|
artikel
|
| 1704 |
Epstein-Barr Virus: Main Pathogenic Agent in Hodgkin Lymphoma Associated Hemophagocytic Syndrome?.
|
Menard, Fanny
|
|
|
110 |
11 |
p. 2272
|
artikel
|
| 1705 |
Epstein-Barr Virus Status Correlates with Poor Outcome and Is an Independent Prognostic Variable in De Novo Nodal Diffuse Large B Cell Lymphoma in Peru.
|
Beltran, Brady
|
|
|
110 |
11 |
p. 4391
|
artikel
|
| 1706 |
Eradication and Reduction of the Abnormal Chromosome 7 Clone with Azacitidine (AZA C) Is Achievable for One-Third of Patients (pts) with Myelodysplastic Syndrome (MDS).
|
Najfeld, Vesna
|
|
|
110 |
11 |
p. 5181
|
artikel
|
| 1707 |
Eradication of B Cell Malignancies by Anti-3rd Party CTLs: A Novel Role for MHC Class I.
|
Lask, Assaf
|
|
|
110 |
11 |
p. 2759
|
artikel
|
| 1708 |
Eradication of Minimal Residual Disease with Alemtuzumab in Chronic Lymphocytic Leukemia Is Associated with Prolonged Survival and Is an Appropriate Theraputic Endpoint for Relapsed CLL.
|
Sayala, Hazem A.
|
|
|
110 |
11 |
p. 3114
|
artikel
|
| 1709 |
ERG Deletions Define a Novel Subtype of B-Progenitor Acute Lymphoblastic Leukemia.
|
Mullighan, Charles G.
|
|
|
110 |
11 |
p. 691
|
artikel
|
| 1710 |
Erythrocytosis Caused by Mutations in the PHD2 and VHL Genes.
|
Percy, Melanie J.
|
|
|
110 |
11 |
p. 3663
|
artikel
|
| 1711 |
Erythroid Development in the Absence of Hemoglobin.
|
Liu, Shan-Run
|
|
|
110 |
11 |
p. 1262
|
artikel
|
| 1712 |
Erythroid-Lineage Specific Engraftment in Patients with Severe Hemoglobinopathy Following Allogeneic Hematopoietic Stem Cell Transplantation.
|
Armistead, Paul M.
|
|
|
110 |
11 |
p. 2996
|
artikel
|
| 1713 |
Erythroid Precursors from Patients with Low-Risk Myelodysplasia Demonstrate Ultrastructural Features of Autophagy.
|
Houwerzijl, Ewout
|
|
|
110 |
11 |
p. 2444
|
artikel
|
| 1714 |
Erythroid Response to Epoetin alfa (EPO) 120,000 Units (U) Every Three Weeks (Q3W) Initiated Early or at a Standard Threshold in Chemotherapy-Induced Anemia (CIA).
|
Charu, Veena
|
|
|
110 |
11 |
p. 3770
|
artikel
|
| 1715 |
Erythropoiesis in Polycythemia Vera Is Hyper-Proliferative and Has Accelerated Differentiation during In Vitro Erythroid Expansion and Is Associated with Higher Expressions of cMYB and EPOR at Early Erythroid Progenitors
|
Bruchova, Hana
|
|
|
110 |
11 |
p. 1549
|
artikel
|
| 1716 |
Erythropoiesis Stimulating Agents and the Risk of Leukemic Transformation in Primary Myelofibrosis.
|
Huang, Jocelin
|
|
|
110 |
11 |
p. 554
|
artikel
|
| 1717 |
Erythropoiesis-Stimulating Agents for Chemotherapy Induced Anemia: Analysis of an Electronic Medical Record Database within a Large Oncology/Hematology Practice.
|
Feinberg, Bruce
|
|
|
110 |
11 |
p. 963
|
artikel
|
| 1718 |
Erythropoietin (Epo) Secreting Mesenchymal Stromal Cells and Autocrine Signalling Via the Epo Receptor. A Novel, Cell-Based Paracrine Epo Delivery System for Cardiovascular Therapy.
|
Copland, Ian B.
|
|
|
110 |
11 |
p. 1198
|
artikel
|
| 1719 |
Erythropoietin Lacking Hypoxia Responsive Element in 3′ Untranslated Region Stimulates Hepatic Erythropoiesis in Anemic Xenopus.
|
Aizawa, Youichi
|
|
|
110 |
11 |
p. 4057
|
artikel
|
| 1720 |
Erythropoietin Signaling and Response in Vascular Smooth Muscle Cells.
|
Beleslin-Cokic, Bojana B.
|
|
|
110 |
11 |
p. 3724
|
artikel
|
| 1721 |
Erythropoietin Supplementation in Patients with Refractory Anemia and Mild Renal Insufficiency - MDS Meets Renal Anemia.
|
Korte, Wolfgang C.
|
|
|
110 |
11 |
p. 3771
|
artikel
|
| 1722 |
Erythropoietin Therapy Does Not Benefit Transfusion-Dependent Primary Myelofibrosis Patients and Treatment Response Is Infrequent with a Baseline Hemoglobin Level ≥ 10 g/dL.
|
Huang, Jocelin
|
|
|
110 |
11 |
p. 3555
|
artikel
|
| 1723 |
Escape of Minor Histocompatibility Antigen-Restricted Anti-Leukemia Immunity Associated with Loss of Specific HLA-I Locus Expression in a Leukemia Patient after an Intensive Immunotherapy.
|
Chang, Lung-Ji
|
|
|
110 |
11 |
p. 4895
|
artikel
|
| 1724 |
Essential Role for Rbm15 (Ott1) in the Maintenance of Hematopoietic Stem Cell Function and Cell Cycle Control.
|
Niu, Chao
|
|
|
110 |
11 |
p. 1223
|
artikel
|
| 1725 |
Essential Role of Gab2 in CSF-1 Dependent Macrophage Development in the Bone Marrow.
|
Lee, Angel W.
|
|
|
110 |
11 |
p. 2197
|
artikel
|
| 1726 |
Essential Role of Pro-Apoptotic Mechanisms for Production of Normal Erythrocytes and Prevention of Hemolysis.
|
Chen, Min
|
|
|
110 |
11 |
p. 426
|
artikel
|
| 1727 |
Essential Roles for Mef2c in Lymphoid Commitment and B-Cell Function.
|
Stehling-Sun, Sandra
|
|
|
110 |
11 |
p. 377
|
artikel
|
| 1728 |
Essential Thrombocythemia: A Prospective Analysis of Efficacy and Safety of Anagrelide for Long Term Treatment in Patients Below and Above the Age of 60 Years.
|
Gisslinger, Heinz
|
|
|
110 |
11 |
p. 3561
|
artikel
|
| 1729 |
Establishment and Characterization of a tel/abl Rearrangement Responsible for Imatinib Sensitivity in bcr/abl Negative Acute Lymphoblastic Leukemia.
|
Bäumler, Jörg
|
|
|
110 |
11 |
p. 4280
|
artikel
|
| 1730 |
Establishment of a Labeling System for Hematopoietic Stem Cells by Nucleostemin Enhancer/Promoter-GFP Transgenic Mice.
|
Naka, Kazuhito
|
|
|
110 |
11 |
p. 2240
|
artikel
|
| 1731 |
Establishment of a Metastasizing Human Cell Line Based Multiple Myeloma Model in Immunodeficient Mice.
|
Schueler, Julia B.
|
|
|
110 |
11 |
p. 4784
|
artikel
|
| 1732 |
Establishment of an International Registry of Patients with Inherited FXIII Deficiency.
|
Ivaskevicius, Vytautas
|
|
|
110 |
11 |
p. 2149
|
artikel
|
| 1733 |
Establishment of Cell Lines Stably Expressing HNA-1A, -1B, -2A, -4A, -4B, -5A and -5B Antigen with Low Background Reactivity in Flow Cytometric Analysis.
|
Yasui, Kazuta
|
|
|
110 |
11 |
p. 4015
|
artikel
|
| 1734 |
Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rgnull Mouse.
|
Iwamoto, Chika
|
|
|
110 |
11 |
p. 2797
|
artikel
|
| 1735 |
Establishment of Stroma-Free Cultures for Human B Lymphopoiesis: Roles of High Cell Density Condition and Mesenchymal Stem Cell-Secreted Factors.
|
Ichii, Michiko
|
|
|
110 |
11 |
p. 1420
|
artikel
|
| 1736 |
Etanercept Plus Methylprednisolone as Initial Therapy for Acute GVHD.
|
Levine, John E.
|
|
|
110 |
11 |
p. 39
|
artikel
|
| 1737 |
Ethical Reasoning About Allogeneic Bone Marrow Transplantation and Patient Eligibility Based on Psychosocial Criteria.
|
Foster, Larry
|
|
|
110 |
11 |
p. 635
|
artikel
|
| 1738 |
Etoposide Sensitivity Does Not Predict MLL Rearrangements or Risk of Therapy-Related Acute Myeloid Leukemia.
|
Yang, Jun
|
|
|
110 |
11 |
p. 1829
|
artikel
|
| 1739 |
ETP in the Discrimination of Liver Disease from DIC.
|
Tran, Minh H.
|
|
|
110 |
11 |
p. 3932
|
artikel
|
| 1740 |
ETS2 and ERG1 Promote Megakaryopoiesis and Immortalize GATA1 Knockdown (ΔneoΔHS) Fetal Liver Progenitors: Implications for Leukemogenesis in Down Syndrome.
|
Stankiewicz, Monika J.
|
|
|
110 |
11 |
p. 824
|
artikel
|
| 1741 |
ETV6: Its Role in Mouse Development and Leukaemogenesis Using Knock-Out and Knock-In Models.
|
Hart, Stephen
|
|
|
110 |
11 |
p. 461
|
artikel
|
| 1742 |
European MCL Network: An Update on Current First Line Trials.
|
Dreyling, Martin H.
|
|
|
110 |
11 |
p. 388
|
artikel
|
| 1743 |
Evaluating Mortality with Erythropoietic Stimulating Agents (ESAs) in the Nephrology Setting: The Distinction between Evaluating Trials That Measure Survival as a Primary or Secondary Efficacy Endpoint Versus a Safety Endpoint.
|
Barnato, Sara E.
|
|
|
110 |
11 |
p. 962
|
artikel
|
| 1744 |
Evaluating the Role of a New Dilute Prothrombin Time Assay ACTICLOT dPT in Lupus Anticoagulant Testing.
|
Dlott, Jeffrey S.
|
|
|
110 |
11 |
p. 3629
|
artikel
|
| 1745 |
Evaluating the Safety of Erythropoiesis-Stimulating Agents (ESAs) in Patients with Breast Cancer, Lung Cancer, and Hematologic Malignancies: A Meta-Analysis of Randomized, Controlled Trials.
|
Glaspy, J.
|
|
|
110 |
11 |
p. 3669
|
artikel
|
| 1746 |
Evaluation of a Dye Binding Method for Determining the Solution Concentration of Low Molecular Weight Heparins.
|
Kim, Yumi
|
|
|
110 |
11 |
p. 3928
|
artikel
|
| 1747 |
Evaluation of a Method for Removal and Determination of Thrombogenic Microparticles.
|
Vetr, Helga
|
|
|
110 |
11 |
p. 3626
|
artikel
|
| 1748 |
Evaluation of AMG 531 Efficacy in Nonsplenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.
|
Kuter, David J.
|
|
|
110 |
11 |
p. 565
|
artikel
|
| 1749 |
Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.
|
Gernsheimer, Terry B.
|
|
|
110 |
11 |
p. 2
|
artikel
|
| 1750 |
Evaluation of AMG 531 Safety in Splenectomized (S) and Nonsplenectomized (NS) Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in Two Randomized Placebo-Controlled Phase 3 Studies
|
Lyons, Roger
|
|
|
110 |
11 |
p. 1300
|
artikel
|
| 1751 |
Evaluation of an Automated Ficoll Procedure To Enrich for Mononuclear Cells for Use in Clinical Trials.
|
Sepulveda, Carmen A.
|
|
|
110 |
11 |
p. 1216
|
artikel
|
| 1752 |
Evaluation of a Powered Intraosseous Device for Bone Marrow Sampling.
|
Cohen, Stephen C.
|
|
|
110 |
11 |
p. 5150
|
artikel
|
| 1753 |
Evaluation of Children with Suspected Bleeding Disorder Applying the Impact-R [Cone and Plate(let) Analyzer].
|
Revel-Vilk, Shoshana
|
|
|
110 |
11 |
p. 3962
|
artikel
|
| 1754 |
Evaluation of Clinical Judgement at Initiation of AML-Therapy in Elderly Patients - A Prospective Randomized Trial.
|
Schuler, Ulrich S.
|
|
|
110 |
11 |
p. 2863
|
artikel
|
| 1755 |
Evaluation of Deferasirox (Exjade®, ICL670) Therapy in Patients with Transfusional Iron Overload Who Achieve Serum Ferritin (SF) ≤1000 ng/mL in Long-Term Studies.
|
Cappellini, Maria Domenica
|
|
|
110 |
11 |
p. 3795
|
artikel
|
| 1756 |
Evaluation of Immune Responses to Seasonal Influenza Vaccination in Healthy Volunteers and in Patients after Stem Cell Transplantation.
|
Avetisyan, Gayane
|
|
|
110 |
11 |
p. 2993
|
artikel
|
| 1757 |
Evaluation of Inherited Prothrombotic Risk Factors in Children with Acute Lymphoblastic Leukemia.
|
Te, Valerie Li Thiao
|
|
|
110 |
11 |
p. 3953
|
artikel
|
| 1758 |
Evaluation of Microsatellite Instability and Loss of Heterozygosity in Defining the Instability Phenotype of Myelodysplastic Syndromes.
|
Vazquez, Maria Lorena
|
|
|
110 |
11 |
p. 4620
|
artikel
|
| 1759 |
Evaluation of Minimal Residual Disease Based on NPM1 Mutations in AML with Intermediate Risk Cytogenetics: A Prospective Study of 36 Patients.
|
Renneville, Aline
|
|
|
110 |
11 |
p. 2847
|
artikel
|
| 1760 |
Evaluation of Prospective Detection of PML-RARA and RARA-PML Fusion Transcripts by Real-Time Quantitative PCR (RQ-PCR) To Direct Pre-Emptive Therapy with Arsenic Trioxide (ATO) in Acute Promyelocytic Leukemia (APL) Patients Treated in the UK MRC AML15 Trial.
|
Grimwade, David J.
|
|
|
110 |
11 |
p. 541
|
artikel
|
| 1761 |
Evaluation of the Cytogenetic Aberration Pattern in AL Amyloidosis Compared to Monoclonal Gammopathies Not Requiring Treatment: Translocation t(11;14) Is More Frequent in AL Amyloidosis.
|
Bochtler, Tilmann
|
|
|
110 |
11 |
p. 2500
|
artikel
|
| 1762 |
Evaluation of the Expression of MDM2 & CD44v6 in Hodgkin's Lymphoma.
|
El-Sebaaie, Amr Farag
|
|
|
110 |
11 |
p. 4389
|
artikel
|
| 1763 |
Evaluation of the Impact of Myelosuppression on Treatment Response and Health-Related Quality of Life (HRQoL) in Patients with Chronic Myeloid Leukemia (CML).
|
Rosa, K.
|
|
|
110 |
11 |
p. 4584
|
artikel
|
| 1764 |
Evaluation of the REG1 Anticoagulant System Using Thrombelastography and Thrombin Generation Assay.
|
Tanaka, Kenichi A.
|
|
|
110 |
11 |
p. 4010
|
artikel
|
| 1765 |
Evaluation of the Spectrin Compartment Size in Normal and Diseased Red Blood Cells by Single Particle Tracking.
|
Kodippili, Gayani C.
|
|
|
110 |
11 |
p. 143
|
artikel
|
| 1766 |
Evaluation of TW-37, a pan Bcl-2 Proteins Small-Molecule Inhibitor, Against Spectrum of Human B-Cell Lines and Patient-Derived Samples.
|
Mohammad, Ramzi M.
|
|
|
110 |
11 |
p. 4521
|
artikel
|
| 1767 |
Evaluation of XL999, a Potent Inhibitor of FGFR3, for the Potential Treatment of t(4;14) Positive Multiple Myeloma.
|
Trudel, Suzanne
|
|
|
110 |
11 |
p. 2515
|
artikel
|
| 1768 |
Event-Free Survival in Patients (pts) with Chronic Myeloid Leukemia (CML) Treated with 2nd Generation Tyrosine Kinase Inhibitors (TKI) after Imatinib Failure Is Dependent on the In Vitro Sensitivity of BCR-ABL Kinase Domain (KD) Mutations.
|
Jabbour, Elias
|
|
|
110 |
11 |
p. 1941
|
artikel
|
| 1769 |
Everolimus and Cyclosporine in Combination with 2Gy TBI as Pre- and Posttransplant Immunosuppression in a Canine Transplantation Model.
|
Lange, Sandra
|
|
|
110 |
11 |
p. 4861
|
artikel
|
| 1770 |
Evidence-Based Medicine (EBM) Order Set Improves the Management of Patients with Sickle Cell Disease (SCD) Presenting with Severe Acute Pain Episode to the Emergency Room (ER): A Single Center Experience.
|
Winslow, Laura
|
|
|
110 |
11 |
p. 3811
|
artikel
|
| 1771 |
Evidence for a Metabolic Stem Cell Niche.
|
Cross, Michael
|
|
|
110 |
11 |
p. 4046
|
artikel
|
| 1772 |
Evidence for an Environmental Influence Leading to the Development of JAK2V617F-Positive Polycythemia Vera: A Molecular Epidemiological Study.
|
Hoffman, Ronald
|
|
|
110 |
11 |
p. 264
|
artikel
|
| 1773 |
Evidence for HLA Class II Susceptible and Protective Haplotypes for Osteomyelitis in Pediatric Patients with Sickle Cell Anemia.
|
Almawi, Wassim Y.
|
|
|
110 |
11 |
p. 3784
|
artikel
|
| 1774 |
Evidence for QTLs Influencing the Endogenous Thrombin Potential (ETP) and Protein C Concentrations in a Dutch Family with Unexplained Thrombophilia.
|
Tanck, Michael W.T.
|
|
|
110 |
11 |
p. 132
|
artikel
|
| 1775 |
Evidence of Pre-Diagnostic Monoclonality in Blood Obtained up to 6.4 Years Preceding Diagnosis of Chronic Lymphocytic Leukemia (CLL).
|
Landgren, Ola
|
|
|
110 |
11 |
p. 3082
|
artikel
|
| 1776 |
Evidence That Heme Export Via the Feline Leukemia Virus, Subgroup, C Receptor (FLVCR) Is Carrier Dependent and Its Physiological Implications.
|
Yang, Zhantao
|
|
|
110 |
11 |
p. 2659
|
artikel
|
| 1777 |
EVI1 Is a Transcriptional Repressor Able To Recruit SUV39H1 Histone Methylation Activity.
|
Cattaneo, Francesca
|
|
|
110 |
11 |
p. 1235
|
artikel
|
| 1778 |
Evi-1 Promotes Para-Aortic Splanchnopleural Hematopoiesis through Up-Regulation of GATA-2 and Repression of TGF-β Signaling.
|
Sato, Tomohiko
|
|
|
110 |
11 |
p. 1236
|
artikel
|
| 1779 |
Examination of Point Mutations within the ABL Kinase Domain of Bcr-Abl Fusion Gene in Chinese Patients with Chronic Myeloid Leukemia Who Develop Imatinib Resistance.
|
Yang, Dongguang
|
|
|
110 |
11 |
p. 4573
|
artikel
|
| 1780 |
Examining Decision Making Styles in Patients with Lymphoma and Multiple Myeloma Considering Autologous Stem Cell Transplantation.
|
Agboola, Olabunmi A.
|
|
|
110 |
11 |
p. 3322
|
artikel
|
| 1781 |
Excessive Isolated Erythrocytosis Linked to Induction of SCL/Tal1 and Erythropoietin Receptor Expression.
|
Rogers, Heather M.
|
|
|
110 |
11 |
p. 1244
|
artikel
|
| 1782 |
Exchange of microRNAs between Breast Cancer Cells and Bone Marrow Stroma: Potential for Avenues To Revisit Hematopoietic Stem Cell Transplantation for Breast and Other Cancers That Show Preference for Bone Marrow.
|
Taborga, Marcelo
|
|
|
110 |
11 |
p. 1199
|
artikel
|
| 1783 |
Exclusion from Acute Myeloid Leukemia (AML) Clinical Trials of Patients Unlikely To Respond.
|
Tsimberidou, Apostolia-Maria
|
|
|
110 |
11 |
p. 2867
|
artikel
|
| 1784 |
Exjade® Reduces Cardiac Iron Burden in Chronically Transfused β-Thalassemia Patients: An MRI T2* Study.
|
Wood, J.
|
|
|
110 |
11 |
p. 2781
|
artikel
|
| 1785 |
Exogenous Nucleic Acids - A Potential Source of Resistance to Nucleoside Analogues in Cancer and Antiviral Therapy.
|
Buhmann, Raymund
|
|
|
110 |
11 |
p. 4207
|
artikel
|
| 1786 |
Expanded Natural Killer Cells for Cellular Therapy of Acute Myeloid Leukemia.
|
Fujisaki, Hiroyuki
|
|
|
110 |
11 |
p. 2743
|
artikel
|
| 1787 |
Expanding Nilotinib Access in Clinical Trials (ENACT) Study in Adult Patients (Pts) with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) in Blast Crisis (BC), Accelerated Phase (AP), or Chronic Phase (CP): Preliminary Safety Analysis.
|
Nicolini, Franck
|
|
|
110 |
11 |
p. 2960
|
artikel
|
| 1788 |
Expansion of BCR-ABL Positive Leukemic Stem Cells Is Dependent on Hedgehog Pathway Activation.
|
Dierks, Christine
|
|
|
110 |
11 |
p. 3379
|
artikel
|
| 1789 |
Expansion of CD38+ Activated B Cells in Circulation as a Manifestation of Early Onset EBV Associated Post-Transplant Lymphoproliferative Disease.
|
Chaganti, Sridhar
|
|
|
110 |
11 |
p. 5013
|
artikel
|
| 1790 |
Expansion of Immature/Transitional B-Lymphocytes in Patients with Active Chronic Graft-Versus-Host Disease.
|
Kouba, Michal
|
|
|
110 |
11 |
p. 1065
|
artikel
|
| 1791 |
Expansion of Umbilical Cord Blood Hematopoietic Stem Cells for Clinical Use.
|
Peters, Rowayda
|
|
|
110 |
11 |
p. 4049
|
artikel
|
| 1792 |
Experience with a Modified Nijmegen-Bethesda Method for Measurement of Inhibitors in Hemophilia Patients: The CDC Inhibitor Surveillance Pilot Project.
|
Miller, Connie H.
|
|
|
110 |
11 |
p. 1156
|
artikel
|
| 1793 |
Experience with Autologous HSC Transplant in Therapy-Related MDS/AML Using Cells Harvested Prior to the Development of the Secondary Malignancy.
|
Costa, Luciano J.
|
|
|
110 |
11 |
p. 5099
|
artikel
|
| 1794 |
Experiment Therapy of Aplastic Anemia Using Cyclosporin A Combined with IDO Agonist.
|
Huang, Lifang
|
|
|
110 |
11 |
p. 1695
|
artikel
|
| 1795 |
Expert Second Opinion Pathology Review of Lymphoma in the Era of the World Health Organization Classification.
|
Matasar, Matthew J.
|
|
|
110 |
11 |
p. 3317
|
artikel
|
| 1796 |
Exploitation of Novel Hyperdiploid and Nonhyperdiploid Myeloma Cell Lines for Studying Innovative Interventions for Myeloma and Its Associated Bone Disease.
|
Pennisi, Angela
|
|
|
110 |
11 |
p. 548
|
artikel
|
| 1797 |
Exploring Genetic Basis of GVHD by Whole-Genome Association Studies in a Large Series from the Japan Marrow Donation Program (JMDP).
|
Nannya, Yasuhito
|
|
|
110 |
11 |
p. 3232
|
artikel
|
| 1798 |
Expressing N-RasG12D from the Endogenous Promoter Induces Myeloproliferative Disease (MPD) and Cooperates with Retroviral Insertional Mutagenesis (RIM) To Generate Acute Myeloid Leukemia (AML).
|
Li, Qing
|
|
|
110 |
11 |
p. 1616
|
artikel
|
| 1799 |
Expression Analysis and Prognostic Significance of the PHLPP Gene in Acute Leukemias and Myelodysplastic Syndromes.
|
Ono, Takaaki
|
|
|
110 |
11 |
p. 4234
|
artikel
|
| 1800 |
Expression and Prognostic Impact of Candidate Suppressor Sequence-Specific Single-Stranded DNA Binding Protein (SSBP2) in AML Using Reverse Phase Proteins Arrays (RPPA).
|
Kornblau, Steven M.
|
|
|
110 |
11 |
p. 2394
|
artikel
|
| 1801 |
Expression and Role of hERG1 Channels in Pediatric Acute Lymphoblastic Leukemias: Shortcoming of Drug Resistance by hERG1 Channel Inhibitors in Stoma-Supported Leukaemia Cell Cultures In Vitro.
|
Pillozzi, Serena
|
|
|
110 |
11 |
p. 724
|
artikel
|
| 1802 |
Expression Level, and Prognostic Impact of Vascular Endothelial Growth Factor (VEGF) in Non-Hodgkin Lymphoma (NHL).
|
Li, Yiqing
|
|
|
110 |
11 |
p. 4422
|
artikel
|
| 1803 |
Expression Level of Granulocyte-Colony Stimulating Factor Receptor and Effect of Two Forms of G-CSF to in AML1/ETO+ Acute Myelogenous Leukemia.
|
Moon, Heewon
|
|
|
110 |
11 |
p. 4298
|
artikel
|
| 1804 |
Expression Levels of a Single Gene, Lymphoid Enhancer Binding Factor 1, Discriminates CLL B-Cells from Other B-Cell Malignancies.
|
McCarthy, Brian A.
|
|
|
110 |
11 |
p. 1113
|
artikel
|
| 1805 |
Expression of a Glyco-Optimized Anti-CD20 Antibody in the Aquatic Plant Lemna with Enhanced ADCC Activity.
|
Gasdaska, John R.
|
|
|
110 |
11 |
p. 2358
|
artikel
|
| 1806 |
Expression of Alternative CALM-AF10 Fusions Causes Different Hematological Malignancies in Mice.
|
Stoddart, Angela
|
|
|
110 |
11 |
p. 2640
|
artikel
|
| 1807 |
Expression of Bruton's Tyrosine Kinase in Multiple Myeloma.
|
Zhou, Guangbiao
|
|
|
110 |
11 |
p. 4751
|
artikel
|
| 1808 |
Expression of CD38 and High Levels of CD5 Identifies Members of CLL Clones That Have Progressed beyond G1 and Proliferated.
|
Calissano, Carlo
|
|
|
110 |
11 |
p. 1114
|
artikel
|
| 1809 |
Expression of Coagulation FVIII and FIX in Human Adipose Stromal Cells (hASC) and hASC-Derived Cells - Potential Autologous Cell Therapy for Hemophilia.
|
Rosen, Elliot D.
|
|
|
110 |
11 |
p. 767
|
artikel
|
| 1810 |
Expression of Complement Regulatory Protein CD55 on Tumor Cells Has an Adverse Effect on the Outcome of Follicular Lymphoma Patients Treated with Immunochemotherapy
|
Sommarhem, Antti
|
|
|
110 |
11 |
p. 1297
|
artikel
|
| 1811 |
Expression of Endothelial Protein C Receptor Confines Hematopoietic Stem Cell in Murine Fetal Liver.
|
Iwasaki, Hiroko
|
|
|
110 |
11 |
p. 1260
|
artikel
|
| 1812 |
Expression of Functional B7-H1 Molecules on Blasts from Myelodysplastic Syndromes.
|
Kondo, Asaka
|
|
|
110 |
11 |
p. 2429
|
artikel
|
| 1813 |
Expression of G-CSF Receptor during Embryonic Development in a Csf3r-Cre Knock-In Mouse Model.
|
Touw, Ivo P.
|
|
|
110 |
11 |
p. 2233
|
artikel
|
| 1814 |
Expression of Genes Regulating Iron Metabolism in Hepatocyte Cell-Line HepG2 Induced by Sera from MDS Patients.
|
Breda, Laura
|
|
|
110 |
11 |
p. 4612
|
artikel
|
| 1815 |
Expression of γ-Globin Is Reactivated by a Novel Mechanism in Baboon CD34+ Erythroid Progenitor Cell Cultures.
|
Lavelle, Donald
|
|
|
110 |
11 |
p. 1768
|
artikel
|
| 1816 |
Expression of High Levels of Human γ-Globin in Adult Mice Carrying a Transgene of the Brazilian Type of Hereditary Persistence of Fetal Hemoglobin.
|
Cunha, Anderson F.
|
|
|
110 |
11 |
p. 3831
|
artikel
|
| 1817 |
Expression of HLA-G1 and G5 Enables Human Mesenchymal Stem Cells To Engraft at High Levels across Xenogeneic Barriers Following Transplantation into Immunocompetent Recipients.
|
Yamagami, Takashi
|
|
|
110 |
11 |
p. 1195
|
artikel
|
| 1818 |
Expression of Hyperactivable NFAT1 from the ROSA26 Locus Leads to Detrimental Effects during Embryonic Development.
|
Mueller, Martin R.
|
|
|
110 |
11 |
p. 2296
|
artikel
|
| 1819 |
Expression of MAGE-A1 and MAGE-A3 in Bone Marrow from Monoclonal Gammapathy to Myeloma Patients.
|
Necasova, Jana
|
|
|
110 |
11 |
p. 4752
|
artikel
|
| 1820 |
Expression of Midkine(MDK) and Sensitivity to Anti-Leukemic Drugs in Pediatric Acute Lymphoblastic Leukemia (ALL).
|
Zeng, Weihua
|
|
|
110 |
11 |
p. 1432
|
artikel
|
| 1821 |
Expression of miR-188 and 362 Induced by Erythropoietin Stimulation in a Human Erythrocytic Leukemia Cell Line.
|
Sugiura, Keiichi
|
|
|
110 |
11 |
p. 2210
|
artikel
|
| 1822 |
Expression of Nuclear Factor-kappa B Pathway Genes and Their Correlation with Clinical Features in Multiple Myeloma.
|
Almeida, Manuella S.S.
|
|
|
110 |
11 |
p. 4735
|
artikel
|
| 1823 |
Expression of p14ARF in De Novo AML with Normal Karyotype. Implication on Drug Resistance and Survival.
|
Paul, Esbjorn O.
|
|
|
110 |
11 |
p. 4261
|
artikel
|
| 1824 |
Expression of Phosphorylated mTOR (p-mTOR) Correlates with Advanced Stage in Diffuse Large B-Cell Lymphomas.
|
Patel, Raina A.
|
|
|
110 |
11 |
p. 1573
|
artikel
|
| 1825 |
Expression of ROR1 in Chronic Lymphocytic Leukemia Cells Enhances Cells Survival by Wnt5a Signaling.
|
Chen, Liguang
|
|
|
110 |
11 |
p. 340
|
artikel
|
| 1826 |
Expression of the Cancer-Testis Antigens, SEMG 1 and Protamine 1, in Early CLL: Their Relationship to Disease Stage and Zap 70 Expression.
|
Meklat, Farouk
|
|
|
110 |
11 |
p. 4680
|
artikel
|
| 1827 |
Expression of the Human Concentrative Nucleotide Transporter (hCNT1) Gene Correlates with Clinical Response in Patients Affected by Waldenstrom's Macroglobulinemia (WM), Undergoing a Combination Treatment with Cladribine (2-CdA) and Rituximab.
|
Laszlo, Daniele
|
|
|
110 |
11 |
p. 1357
|
artikel
|
| 1828 |
Expression of the Human PIM-2 (hPIM-2) Gene in Patients with Acute Myeloblastic Leukaemia (AML) and Acute Lymphoblastic Leukaemia (ALL).
|
Kapelko-Slowik, Katarzyna L.
|
|
|
110 |
11 |
p. 4288
|
artikel
|
| 1829 |
Expression of the 67-kDa Laminin Receptor Is Associated with Increased AML Cells through the Enhanced GM-CSF/Stat5 Signaling.
|
Ando, Koji
|
|
|
110 |
11 |
p. 2845
|
artikel
|
| 1830 |
Expression of Transmembrane Adaptors Is Specific in Distinct Childhood Acute Lymphoblastic Leukaemia Subgroups and Indicates Early Treatment Response in T-ALL.
|
Svojgr, Karel
|
|
|
110 |
11 |
p. 1433
|
artikel
|
| 1831 |
Expression of V617F JAK2 in Mice Leads to MPD Mimicking Human ET, Idiopahtic Myelofibrosis, and PV.
|
Shide, Kotaro
|
|
|
110 |
11 |
p. 2531
|
artikel
|
| 1832 |
Expression Pattern and Prognostic Impact of Vascular Endothelial Growth Factors VEGF and VEGF-C and Their Receptors Flt-1, KDR and Flt-4 in Peripheral T-Cell Lymphomas.
|
Jørgensen, Judit M.
|
|
|
110 |
11 |
p. 689
|
artikel
|
| 1833 |
Expression Pattern of TCR-zeta Chain in Patients with Aplastic Anemia and Polycythemia Vera.
|
Yang, Lijian
|
|
|
110 |
11 |
p. 3763
|
artikel
|
| 1834 |
Expression Profile Analysis of Genes Related to Resistance/Sensibility to Prednisolone, Daunorubicin, L-Asparaginase and Vincristine in Childhood Acute Lymphoblastic Leukemia.
|
Silveira, Vanessa S.
|
|
|
110 |
11 |
p. 3463
|
artikel
|
| 1835 |
Expression Profiles in Chronic Lymphoid Leukemia by Hematochip Analysis.
|
Alvarez, Patricia
|
|
|
110 |
11 |
p. 4676
|
artikel
|
| 1836 |
Expression Profiling Identifies Novel Genetic Subgroups with Distinct Clinical Features and Outcome in High-Risk Pediatric Precursor B Acute Lymphoblastic Leukemia (B-ALL). A Children's Oncology Group Study.
|
Harvey, Richard C.
|
|
|
110 |
11 |
p. 1430
|
artikel
|
| 1837 |
Extended-Duration Enoxaparin for Venous Thromboembolism Prophylaxis in Acutely Ill Medical Patients: An Evaluation of the EXCLAIM Study Based on a Recently Recommended Composite Efficacy Endpoint.
|
Schellong, Sebastian M.
|
|
|
110 |
11 |
p. 1870
|
artikel
|
| 1838 |
Extended, Flexible Program Matching Red Cell Antigens for Patients with Sickle Cell Anemia Provides for Both Chronic and Intermittent Transfusions.
|
Ambruso, Daniel R.
|
|
|
110 |
11 |
p. 2899
|
artikel
|
| 1839 |
Extended Follow-Up of Reduced Intensity Transplantation with an Alemtuzumab-Containing Regimen for Follicular Lymphoma.
|
Thomson, Kirsty
|
|
|
110 |
11 |
p. 1666
|
artikel
|
| 1840 |
Extended Matching of Red Cell Antigens for Patients with Sickle Cell Anemia Decreases the Rate of Alloimmunization.
|
Ambruso, Daniel R.
|
|
|
110 |
11 |
p. 3389
|
artikel
|
| 1841 |
Extended Thromboprophylaxis with Rivaroxaban Compared with Short-Term Thromboprophylaxis with Enoxaparin after Total Hip Arthroplasty: The RECORD2 Trial.
|
Kakkar, Ajay K.
|
|
|
110 |
11 |
p. 307
|
artikel
|
| 1842 |
External PS in Sickle RBC: Relationships among Aminophospholipid Translocase (APLT), Phospholipid Scramblase (PLSCR), Cell Maturity, and Cell Density.
|
Arnold, Latorya E.
|
|
|
110 |
11 |
p. 148
|
artikel
|
| 1843 |
Extracorporeal Photopheresis Diminishes Graft-Versus-Host-Disease and Modulates Dendritic Cell Cytokine Production.
|
Davis, Jessica P.
|
|
|
110 |
11 |
p. 2177
|
artikel
|
| 1844 |
Extranodal NK/T-Cell Lymphoma: A Comparative Clinicopathological Study According to Survival Outcome.
|
Choi, Yong Won
|
|
|
110 |
11 |
p. 4413
|
artikel
|
| 1845 |
Extravascular Clotting Factor Activity within Joint Tissues Protects Against Progression of Hemophilic Arthropathy.
|
Sun, Junjiang
|
|
|
110 |
11 |
p. 496
|
artikel
|
| 1846 |
Ex Vivo Activity of Bortezomib and Dexamethasone Combinations Against Childhood Acute Leukemia Cells.
|
Franke, Niels E.
|
|
|
110 |
11 |
p. 4205
|
artikel
|
| 1847 |
Ex Vivo Expansion of Cord Blood NK Cell Have In Vivo Efficacy Against Leukemia.
|
Xing, Dongxia
|
|
|
110 |
11 |
p. 2741
|
artikel
|
| 1848 |
Ex Vivo Glycan Engineering of Membrane CD44 To Create HCELL Programs Human Mesenchymal Stem Cell Trafficking to Bone.
|
Sackstein, Robert
|
|
|
110 |
11 |
p. 218
|
artikel
|
| 1849 |
Ex Vivo Graft Purging and Expansion of Autologous Mobilized Peripheral Blood Progenitor Cell (PBPC) Products from Patients with Multiple Myeloma (MM).
|
Yang, Hong
|
|
|
110 |
11 |
p. 770
|
artikel
|
| 1850 |
Ex Vivo Treatment of Human Cord Blood with dmPGE2 Can Safely Increase the Potential for Hematopoietic Engraftment.
|
North, Trista E.
|
|
|
110 |
11 |
p. 1190
|
artikel
|
| 1851 |
Factors Affecting Allogeneic Peripheral Blood Stem Cell Mobilization in a Large, Ethnically, Diverse Population.
|
Vasu, Sumithira
|
|
|
110 |
11 |
p. 3283
|
artikel
|
| 1852 |
Factors Affecting Long-Term Survival in Non-Transplanted Acute Myeloid Leukemia Patients.
|
Lof, Anna H.
|
|
|
110 |
11 |
p. 4371
|
artikel
|
| 1853 |
Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.
|
Yanada, Masamitsu
|
|
|
110 |
11 |
p. 2813
|
artikel
|
| 1854 |
Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.
|
Al-Ali, Haifa K.
|
|
|
110 |
11 |
p. 1654
|
artikel
|
| 1855 |
Factors Predicting Long Term Survival after Reduced Intensity Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia.
|
Craddock, Charles F.
|
|
|
110 |
11 |
p. 326
|
artikel
|
| 1856 |
Factors Predicting PBPC Collections in Healthy Adolescents and Children with Solid Tumours.
|
Roncon, Susana
|
|
|
110 |
11 |
p. 5119
|
artikel
|
| 1857 |
Factors Predictors of Vascular Events with Antiphospholipids Antibodies.
|
Kassis, Jeannine
|
|
|
110 |
11 |
p. 128
|
artikel
|
| 1858 |
Factors That Determine Overall Survival among Patients (Pts) with Multiple Myeloma (MM) Treated with Zoledronic Acid (ZOL): Lack of Skeletal-Related Events (SREs) and Occurrence of Osteonecrosis of the Jaw (ONJ) Predict Improved Survival.
|
Berenson, James R.
|
|
|
110 |
11 |
p. 4842
|
artikel
|
| 1859 |
Factor Va Cofactor Activity Is Dependent on the Interaction of Prothrombin with the Membrane Surface.
|
Bukys, Michael A.
|
|
|
110 |
11 |
p. 2702
|
artikel
|
| 1860 |
Factor VIII, a Cofactor for Accelerating Proteolytic Cleavage of von Willebrand Factor by ADAMTS13 Metalloprotease.
|
Cao, Wenjing
|
|
|
110 |
11 |
p. 766
|
artikel
|
| 1861 |
Factor Xa Inhibitors Can Be Differentiated in Xa, IIa and Microparticle Generation and Other Whole Blood Based Assays.
|
Iqbal, Omer
|
|
|
110 |
11 |
p. 931
|
artikel
|
| 1862 |
Factor XI Homodimer Formation Is Mediated by Electrostatic (Lys331 with Glu287) and Hydrophobic (Ile290 with Leu284 and Tyr329 with Tyr329) Interactions in the Apple 4 Domain and Is Essential for Normal Proteolytic Activation of Factor XI by Factor XIIa, Thrombin and Factor XIa.
|
Wu, Wenman
|
|
|
110 |
11 |
p. 2706
|
artikel
|
| 1863 |
Factor XIII Supports Metastatic Potential through a Mechanism Coupled to Natural Killer Cell Function.
|
Palumbo, Joseph S.
|
|
|
110 |
11 |
p. 1753
|
artikel
|
| 1864 |
Failure of Asparagine (ASN) Depletion, Not Inadequate Asparaginase (ASNase) Activity, Predicts Relapse in Standard Risk (SR) Childhood Acute Lymphoblastic Leukemia (ALL): A Children's Oncology Group (COG) Report.
|
Avramis, Vassilios I.
|
|
|
110 |
11 |
p. 588
|
artikel
|
| 1865 |
Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.
|
Milone, Giuseppe
|
|
|
110 |
11 |
p. 2849
|
artikel
|
| 1866 |
Familial Essential Thrombocythemia Showing Spontaneous Megakaryocyte Colony Formation and Acquired JAK2 Mutations without a Germline Mutation in C-MPL or TPO.
|
Higgs, Jillian R.
|
|
|
110 |
11 |
p. 4655
|
artikel
|
| 1867 |
FANCD2 Purification and Identification of a Functionally Important Phosphorylation Event at Serine 331.
|
Zhi, Gang
|
|
|
110 |
11 |
p. 1676
|
artikel
|
| 1868 |
FANCF Co-Localizes with Nonerythroid Alpha Spectrin in Nuclear Foci and Shows Enhanced Binding to It in Normal but Not Fanconi Anemia, Group A, Cells after Damage with a DNA Interstrand Cross-Linking Agent.
|
Sridharan, Deepa M.
|
|
|
110 |
11 |
p. 838
|
artikel
|
| 1869 |
Fanconi-Like Syndrome with Negative Chromosomal Breakages Test and High Incidence of Myelodysplasia.
|
Gupta, Sunil
|
|
|
110 |
11 |
p. 1681
|
artikel
|
| 1870 |
Fas-Dependent Apoptosis in Early MDS Erythroid Precursors Involves Endoplasmic Reticulum.
|
Gyan, Emmanuel
|
|
|
110 |
11 |
p. 3346
|
artikel
|
| 1871 |
Fatal Complication of Transfusion of No Irradiated Blood Product in an Immunocompetent Recipient.
|
Campos-Cabrera, Gregorio
|
|
|
110 |
11 |
p. 4016
|
artikel
|
| 1872 |
Fate of Membrane-Bound Reactants and Products during Prothrombin Activation by Prothrombinase.
|
Kamath, Parvathi
|
|
|
110 |
11 |
p. 2692
|
artikel
|
| 1873 |
Favourable Outcome of Pregnancy in Essential Thrombocythemia (ET) Patients Treated with Interferon Alpha. A Report from the Registro Italiano Trombocitemia (RIT).
|
Melillo, Lorella
|
|
|
110 |
11 |
p. 2549
|
artikel
|
| 1874 |
Favourable Treatment Outcome in Childhood AML Is Determined by Intact Apoptosis Signalling in Myeloid Leukaemia Cells.
|
Meyer, Lüder H.
|
|
|
110 |
11 |
p. 2842
|
artikel
|
| 1875 |
FBW7 E3-Ligase Mutations Are Associated with T Cell Leukemia.
|
Buonamici, Silvia
|
|
|
110 |
11 |
p. 4284
|
artikel
|
| 1876 |
FCgamma Receptor Polymorphisms Do Not Influence the Outcome of Treatment with Rituximab Followed by Active Immunotherapy with Mitumprotimut-T (FavId®, Id-KLH).
|
Maloney, David G.
|
|
|
110 |
11 |
p. 3416
|
artikel
|
| 1877 |
FcγRIIa and the Integrin β3 Cytoplasmic Domain: Two Prerequisites for Thrombocytopenia and Thrombosis Following Administration of the Fibrinogen Receptor Antagonist, Eptifibatide.
|
Gao, Cunji
|
|
|
110 |
11 |
p. 282
|
artikel
|
| 1878 |
FcγRIIa Is Required for Outside-In β3 Integrin Signaling in Human Platelets.
|
Boylan, Brian
|
|
|
110 |
11 |
p. 3637
|
artikel
|
| 1879 |
FCRL2 Expression Is Predictive of IgV
H Mutation Status and Clinical Progression in Chronic Lymphocytic Leukemia.
|
Li, Fu Jun
|
|
|
110 |
11 |
p. 488
|
artikel
|
| 1880 |
FCyIIIa Gene Polymorphisms as Response Predictor in Patients with Non-Hodgkin Lymphoma after Treatment with Anti-CD 20 Monoclonal Antibody (Rituximab).
|
Molnar, Soledad
|
|
|
110 |
11 |
p. 4487
|
artikel
|
| 1881 |
FDG-PET/CT Is Superior to Anatomic Imaging for the Staging and Follow Up of Bony Involvement in Patients with Lymphoma.
|
Elstrom, Rebecca L.
|
|
|
110 |
11 |
p. 2330
|
artikel
|
| 1882 |
FDG-PET for Assessment of Residual Tissue after Completion of Chemotherapy in Hodgkin Lymphoma - Report on the 2nd Interim Analysis of the PET Investigation in the Trial HD15 of the GHSG.
|
Diehl, Volker
|
|
|
110 |
11 |
p. 212
|
artikel
|
| 1883 |
FDG-PET Guided Consolidative Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma with Residual Abnormalities on Post Chemotherapy CT Scan.
|
Savage, Kerry J.
|
|
|
110 |
11 |
p. 213
|
artikel
|
| 1884 |
FDG-PET in the Serial Assessment of Patients with Lymphoma in Complete Remission.
|
Zinzani, Pier Luigi
|
|
|
110 |
11 |
p. 216
|
artikel
|
| 1885 |
Feasibility and Safety Profile of Intensive Consolidation with Clofarabine and Intermediate-Dose Cytarabine (CLARA) in Younger Patients with AML in First Complete Remission (AML-CR1).
|
Lobe, Ida
|
|
|
110 |
11 |
p. 1853
|
artikel
|
| 1886 |
Feasibility of Rapidly Generating Sufficient Autologous Human Marrow Stromal Cells for Cellular Therapy.
|
Lane, Thomas A.
|
|
|
110 |
11 |
p. 1218
|
artikel
|
| 1887 |
Feasibility Study of Temozolomide Maintenance Therapy in Elderly Patients with AML Following Induction Therapy with High Dose Mitoxantrone and High Dose Ara-C.
|
Ponce, Doris
|
|
|
110 |
11 |
p. 4383
|
artikel
|
| 1888 |
Feasiblity and Implication of Bidirectional Sequencing Using a Multiplex Framework 2 Region Primer for Somatic Mutation Analysis of the Immunoglobulin (IgH) Heavy Chain in Chronic Lymphocytic Leukemia (CLL).
|
Nelson, Adin
|
|
|
110 |
11 |
p. 4706
|
artikel
|
| 1889 |
Females with Severe or Moderate Hemophilia A or B: A U.S. Study.
|
DiMichele, Donna M.
|
|
|
110 |
11 |
p. 2146
|
artikel
|
| 1890 |
Fetal Hemoglobin Induction in Baboons (P. Anubis) Following Admistration of a Novel Decitabine Dinucleotide (S110) Compound.
|
Lavelle, Donald
|
|
|
110 |
11 |
p. 571
|
artikel
|
| 1891 |
Fetal Immune Responses Post In Utero Transplantation of Embryonic Stem Cells, Bone Marrow and Fetal Liver Hematopoietic Stem Cells.
|
Nedelcu, Elena
|
|
|
110 |
11 |
p. 4058
|
artikel
|
| 1892 |
FGFR3 Tyrosine Kinase Inhibitor AB1010 as Treatment of t(4;14) Multiple Myeloma.
|
Arnulf, Bertrand
|
|
|
110 |
11 |
p. 413
|
artikel
|
| 1893 |
Fibrinolytic Activity in Patients with Essential Thrombocythemia.
|
Sokolowska, Bozena
|
|
|
110 |
11 |
p. 3223
|
artikel
|
| 1894 |
Fibrinolytic Agents for Restoration of Central Venous Catheter Patency: A Systematic Review.
|
Wang, Myra
|
|
|
110 |
11 |
p. 971
|
artikel
|
| 1895 |
Fifth Succesfully Retreatment with Alemtuzumab in Patient with Chronic Lymphocytic Leukemia.
|
Egyed, Miklos
|
|
|
110 |
11 |
p. 4713
|
artikel
|
| 1896 |
Final Analysis of a Multicenter, Randomised Study Comparing Zoledronate vs Observation in Patients with Asymptomatic Myeloma.
|
Musto, Pellegrino
|
|
|
110 |
11 |
p. 534
|
artikel
|
| 1897 |
Final Analysis of Phase II Study of CHOP/CHOEP-14 Followed by Consolidation with Alemtuzumab in Untreated Aggressive T-Cell Lymphomas (DSHNHL 2003–1).
|
Binder, Claudia
|
|
|
110 |
11 |
p. 3431
|
artikel
|
| 1898 |
Final Results of a Dose Escalation Study of Flavopiridol in Acute Leukemias Using a Novel Treatment Schedule.
|
Blum, William
|
|
|
110 |
11 |
p. 890
|
artikel
|
| 1899 |
Final Results of a Phase I Trial of Oral Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) in Patients with Advanced Multiple Myeloma.
|
Richardson, Paul G.
|
|
|
110 |
11 |
p. 1179
|
artikel
|
| 1900 |
Final Results of Lower Dose Fludarabine (F) and Cyclophosphamide (C), and High Dose Rituximab (R), (FCR-Lite) for Patients with Untreated Chronic Lymphocytic Leukemia (CLL).
|
Tarhini, Ahmad A.
|
|
|
110 |
11 |
p. 2037
|
artikel
|
| 1901 |
Final Update of Phase I-II Study of the Farnesyltransferase Inhibitor Tipifarnib in Combination with Idarubicin and Cytarabine for Patients with Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome.
|
Delmonte Jr., John
|
|
|
110 |
11 |
p. 441
|
artikel
|
| 1902 |
FIP1L1/PDGFRa Synergizes with SCF/c-Kit Signaling To Induce Systemic Mastocytosis in a Chronic Eosinophilic Leukemia Murine Model
|
Yamada, Yoshiyuki
|
|
|
110 |
11 |
p. 1540
|
artikel
|
| 1903 |
FIP1L1/PDGFRα Imposes Commitment towards Eosinophil Lineage on Hematopoietic Stem/Progenitor Cells by Modifying the Expression and Function of Lineage Specific Transcription Factors.
|
Fukushima, Kentaro
|
|
|
110 |
11 |
p. 988
|
artikel
|
| 1904 |
First Clinical Report of Tipifarnib for the Treatment of T-Large Granular Lymphocyte (LGL) Leukemia.
|
Epling-Burnette, P.K.
|
|
|
110 |
11 |
p. 3132
|
artikel
|
| 1905 |
First Isolated Extramedullary Relapse in Children with B-Cell Acute Lymphoblastic Leukemia: Results of the Coprall-97 Study.
|
Domenech, Carine
|
|
|
110 |
11 |
p. 853
|
artikel
|
| 1906 |
First Report of a Phase II Clinical Trial of Lenalidomide Oral Therapy for Peripheral T-Cell Lymphoma.
|
Reiman, Tony
|
|
|
110 |
11 |
p. 2579
|
artikel
|
| 1907 |
First Successful Allogeneic Hematopoietic Stem Cell Transplantation in Children with Chronic Myeloid Leukemia, Preceded by Imatinib Prior Transplantation.
|
Wu, Kang-Hsi
|
|
|
110 |
11 |
p. 4565
|
artikel
|
| 1908 |
FISH-Analyses of Cirulating CD34+ Cells in MDS-Patients - A Suitable Method To Measure and Predict Response to 5-Azacytidine.
|
Braulke, Friederike
|
|
|
110 |
11 |
p. 2466
|
artikel
|
| 1909 |
FISH Analysis of IgH Rearrangement by 4 Kinds of Probes Involving IgH Genes in Multiple Myeloma: Improved Sensitivity for the Detection by Use of IGH Break-Apart Probe.
|
Chung, Hye Yoon
|
|
|
110 |
11 |
p. 4134
|
artikel
|
| 1910 |
Five Novel Mutations in F13B Gene Resulting in FXIII Deficiency.
|
Ivaskevicius, Vytautas
|
|
|
110 |
11 |
p. 2150
|
artikel
|
| 1911 |
Five-Year Experience of Early Enteral Feeding in Patients Undergoing Allogeneic Stem Cell Transplantation Following Myeloablative Conditioning.
|
Seguy, David
|
|
|
110 |
11 |
p. 3004
|
artikel
|
| 1912 |
FLAG-IDA Regimen (Fludarabine, Cytarabine, Idarubicin and G-CSF) in the Treatment of Patients with High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes.
|
Montesinos, Pau
|
|
|
110 |
11 |
p. 2866
|
artikel
|
| 1913 |
FLAG-IM (Fludarabine, Ara-C, G-CSF, Idarubicin, Mylotarg) Is an Effective Salvage Regimen Producing High Rates of Remission (CR+CRi) in Relapsed/Refractory AML.
|
Goyal, Sagun D.
|
|
|
110 |
11 |
p. 1855
|
artikel
|
| 1914 |
FLAMSA Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation in High Risk Myeloid Malignancies Is Also Feasible with Partially Mismatched Donors.
|
Stadler, Michael
|
|
|
110 |
11 |
p. 3068
|
artikel
|
| 1915 |
Flow Cytometric Analysis of Donor-Recipient Chimerism Using Anti-HLA Antibody after HLA-Mismatched Cord Blood Transplantation.
|
Takahashi, Satoshi
|
|
|
110 |
11 |
p. 2008
|
artikel
|
| 1916 |
Flow Cytometric Determination of ZAP-70 Expression by SBZAP Antibody: Impact of Type of Data Analysis on Correlation with IgVH Mutation Status, Cytogenetics, and Level of ZAP-70 mRNA Expression in 351 Patients with Chronic Lymphocytic Leukemia (CLL).
|
Kern, Wolfgang
|
|
|
110 |
11 |
p. 4682
|
artikel
|
| 1917 |
Flow Cytometric Examination of Non-Hematic Body Fluids in Hematologic Malignancies: A Comparison with Cytology.
|
Cesana, Clara
|
|
|
110 |
11 |
p. 4237
|
artikel
|
| 1918 |
Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.
|
Buccisano, Francesco
|
|
|
110 |
11 |
p. 3498
|
artikel
|
| 1919 |
Flow Cytometry Analysis of Peripheral Blood CD4+/CD25+/FOXP3+ T Regulator Cells from 11 Patients Treated with Ipilimumab Following Relapse of Malignancy after Allogeneic Hematopoietic Stem Cell Transplantation.
|
Zhou, Jiehua
|
|
|
110 |
11 |
p. 3240
|
artikel
|
| 1920 |
FLT3 Is Up-Regulated in Blast Crisis of Chronic Myeloid Leukemia and Combination of Small Interference RNA of FLT3 and Gleevec (STI571) Synergistically Induces the Apoptosis in K562 Cells.
|
Lee, Young Y.
|
|
|
110 |
11 |
p. 4532
|
artikel
|
| 1921 |
FLT3-ITD but Not FLT3-TKD Mutations Have Major Prognostic Impact in Normal Karyotype AML.
|
Schneider, Stephanie
|
|
|
110 |
11 |
p. 3486
|
artikel
|
| 1922 |
Flt3-Ligand Plays a Critical Role in Restoring Function of NOD Facilitating Cells.
|
Huang, Yiming
|
|
|
110 |
11 |
p. 1186
|
artikel
|
| 1923 |
FLT3 Mediated MAPK Activation Participates in the Control of Megakaryopoiesis in Primary Myelofibrosis
|
Desterke, Christophe
|
|
|
110 |
11 |
p. 1532
|
artikel
|
| 1924 |
FLT3 Mutation in Patients with Acute Promyelocytic Leukemia Has No Effect on Therapy Response.
|
Xue, Meng Xing
|
|
|
110 |
11 |
p. 4239
|
artikel
|
| 1925 |
Flt3 Mutations in Proximity to an Ubiquitin Dependent Endocytosis Motif Suspend Its Hdm2 Modulation.
|
Wergeland, Line
|
|
|
110 |
11 |
p. 4320
|
artikel
|
| 1926 |
Flt3 Receptor Inhibition Abolishes Constitutive NFκB Activation in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
|
Grosjean, Jennifer
|
|
|
110 |
11 |
p. 2434
|
artikel
|
| 1927 |
Fludarabine, Amsacrine, High-Dose Cytarabine and Total Body Irridation Followed by Allogeneic Stem Cell Transplantation for the Treatment of High Risk or Relapsed Acute Lymphoblastic Leukemia.
|
Zohren, Fabian
|
|
|
110 |
11 |
p. 5086
|
artikel
|
| 1928 |
Fludarabine and Melphalan Conditioning Regimen in Young Patients with Acute Myeloid Leukemia in CR1 Undergoing a Matched Related Allogeneic Stem Cell Transplant: A Single Center Experience.
|
Chandy, Mammen
|
|
|
110 |
11 |
p. 5049
|
artikel
|
| 1929 |
Fludarabine, Cyclophosphamide and Rituximab in Waldenström's Macroglobulinemia: An Effective Regimen Requiring a New Category of Response Criteria and a Delayed Assessment of Results
|
Tedeschi, Alessandra
|
|
|
110 |
11 |
p. 1290
|
artikel
|
| 1930 |
Fluorescence Activated Cell Sorting (FACS) Followed by Fluorescence In Situ Hybridization (FISH) To Determine Clonal Origins of Cells in Myelodysplastic Syndrome (MDS) with Paroxysmal Nocturnal Hemoglobinuria (PNH).
|
Battiwalla, Minoo
|
|
|
110 |
11 |
p. 4623
|
artikel
|
| 1931 |
Fluorophore Conjugated Iron Oxide Nanoparticle Labeling and Analysis of Engrafting Human Hematopoietic Stem Cells.
|
Maxwell, Dustin
|
|
|
110 |
11 |
p. 1213
|
artikel
|
| 1932 |
Focal Adhesion Kinase Regulates Critical Functions in Hematopoiesis.
|
Vemula, Sasidhar
|
|
|
110 |
11 |
p. 1407
|
artikel
|
| 1933 |
Fog1 and Cebpa Are DNA Targets of GATA-1/PU.1 Antagonism during Leukemia Differentiation.
|
Burda, Pavel
|
|
|
110 |
11 |
p. 4121
|
artikel
|
| 1934 |
Folicular and Diffuse Large B Cell Lymphoma Can Be Distinguished by 1H -Magnetic Resonance Spectroscopy.
|
Sanz, Carolina
|
|
|
110 |
11 |
p. 3584
|
artikel
|
| 1935 |
Follicular Lymphomas with and without Translocation t(14;18) Differ in Gene Expression Profiles and Genetic Alterations.
|
Leich, Ellen
|
|
|
110 |
11 |
p. 360
|
artikel
|
| 1936 |
For CML Patients in Chronic Phase Who Achieve a Cytogenetic Response to Imatinib the Finding of a BCR-ABL Mutation Predicts for Progression to Advanced Phase but It Has No Such Significance in Primary Resistance.
|
de Lavallade, Hugues
|
|
|
110 |
11 |
p. 323
|
artikel
|
| 1937 |
Four Novel Mutations in the Ferrochelatase (FECH) Gene in Patients with Erythropoietic Protoporphyria (EPP).
|
Di Pierro, Elena
|
|
|
110 |
11 |
p. 3688
|
artikel
|
| 1938 |
FOXC1, a New Prognostic Marker in Adult Acute Myeloid Leukemia (AML).
|
Blanchet, Odile
|
|
|
110 |
11 |
p. 2387
|
artikel
|
| 1939 |
Foxo3 Modulation of ATM and Oxidative Stress Mediates Distinct Functions in the Regulation of Hematopoietic Stem and Progenitor Cell Fate.
|
Yalcin, Safak
|
|
|
110 |
11 |
p. 1272
|
artikel
|
| 1940 |
FoxO Transcription Factor Is Delocalized and Inactivated in Acute Myeloid Leukaemia Patients.
|
Cilloni, Daniela
|
|
|
110 |
11 |
p. 1251
|
artikel
|
| 1941 |
FoxO Transcription Factor Is Delocalized in CML Patients by Bcr-Abl Induced PI3K/AKT Activation and IKK Pathway and Can Be Reactivated by Imatinib Treatment.
|
Cilloni, Daniela
|
|
|
110 |
11 |
p. 1010
|
artikel
|
| 1942 |
Free Light Chains, Monoclonal Proteins, and Chronic Lymphocytic Leukemia.
|
Ruchlemer, Rosa
|
|
|
110 |
11 |
p. 4697
|
artikel
|
| 1943 |
Frequency of JAK2 Exon 12 Mutations in JAK2 Exon 14 V617F-Negative Patients: High Frequency in ET Patients.
|
Duke, Veronique M.
|
|
|
110 |
11 |
p. 2539
|
artikel
|
| 1944 |
Frequent CD7 Antigen Loss in Aggressive Natural Killer-Cell Leukemia Can Be a Useful Diagnostic Marker.
|
Kim, Sun-Hee
|
|
|
110 |
11 |
p. 2400
|
artikel
|
| 1945 |
Frequent Mitochondrial DNA Mutations and Polymorphisms in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
|
Lipshultz, Steven E.
|
|
|
110 |
11 |
p. 2800
|
artikel
|
| 1946 |
Frequent Molecular Aberrations in Normal Karyotype (NC) Precursor B-Cell Acute Lymphoblastic Leukemia (pB-ALL) Detected by Comparative Genomic Hybridization.
|
Zeidan, Amer
|
|
|
110 |
11 |
p. 4270
|
artikel
|
| 1947 |
Frequent Occurrence of Aberrant Pax5 Splice Variants in Philadelphia Chromosome-Positive Lymphoblastic Leukemia.
|
Okawara, Akemi
|
|
|
110 |
11 |
p. 4287
|
artikel
|
| 1948 |
Front-Line Brief Chemo-Immunotherapy Rituximab (R)-FND + Rituximab Consolidation ± Rituximab Maintenance in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): First Interim Analysis of a Prospective Randomized Study (ML17638)
|
Vitolo, Umberto
|
|
|
110 |
11 |
p. 1278
|
artikel
|
| 1949 |
Front-Line Treatment of Low-Grade Non-Follicular Non-Hodgkin Lymphoma (Final Report of Gisl LL02 Trial).
|
Goldaniga, Maria
|
|
|
110 |
11 |
p. 2332
|
artikel
|
| 1950 |
Fucosylation of Cord Blood CD34+ Cells Improves the Rate of Engraftment without Compromising Long-Term Engraftment.
|
Robinson, Simon N.
|
|
|
110 |
11 |
p. 1187
|
artikel
|
| 1951 |
Functional Alterations of Lin−CD34+CD38+ Progenitors in Chronic Myelomonocytic Leukaemia and on Progression to Acute Leukaemia.
|
Sun, Qian
|
|
|
110 |
11 |
p. 4119
|
artikel
|
| 1952 |
Functional Analysis of Cyclin D1 in Mantle Cell Lymphoma (MCL) by Specific Lentiviral shRNA Mediated Knockdown.
|
Klier, Margit
|
|
|
110 |
11 |
p. 1584
|
artikel
|
| 1953 |
Functional and Numerical T Cell Abnormalities in Chronic Lymphocytic Leukemia.
|
Lanasa, Mark C.
|
|
|
110 |
11 |
p. 3085
|
artikel
|
| 1954 |
Functional and Structural Characterization of Factor Xa Dimer in Solution.
|
Chattopadhyay, Rima
|
|
|
110 |
11 |
p. 2698
|
artikel
|
| 1955 |
Functional Assay of VWF Measured by Its Interaction with Platelet GPIb without the Use of Ristocetin.
|
Montgomery, Robert R.
|
|
|
110 |
11 |
p. 3158
|
artikel
|
| 1956 |
Functional Characterisation of Alloreactive T-Cells Identifies CD25 and CD71 as the Optimal Targets for Allodepletion Strategies.
|
Samarasinghe, Sujith R.
|
|
|
110 |
11 |
p. 2183
|
artikel
|
| 1957 |
Functional Effects of the Bcl-2/Bcl-xL Inhibitor ABT-737 on Primary Cells from Smoldering Multiple Myeloma.
|
Ricciardi, Maria Rosaria
|
|
|
110 |
11 |
p. 4782
|
artikel
|
| 1958 |
Functional Interaction of c-Kit Receptor and Interleukin-3 Receptor.
|
Ye, Zhijia
|
|
|
110 |
11 |
p. 2228
|
artikel
|
| 1959 |
Functional Microparticles Are up Regulated in Patients with Anti-Heparin/Platelet Factor 4 Antibodies: A Potential Mechanism of Thrombogenesis in the Heparin-Induced Thrombocytopenia Syndrome.
|
Cunanan, Josephine
|
|
|
110 |
11 |
p. 2105
|
artikel
|
| 1960 |
Functional Outcomes of Children with Sickle Cell Disease Treated for Vaso-Occlusive Painful Events.
|
Brandow, Amanda M.
|
|
|
110 |
11 |
p. 82
|
artikel
|
| 1961 |
Functional Platelet Counting in Patients with Renal, Haematological and Cardiological Disease Using Blood Collecting Bottles Coated with Collagen, Ristocetin and Arachidonic Acid.
|
Smith, Graham
|
|
|
110 |
11 |
p. 3207
|
artikel
|
| 1962 |
Functional Polymorphisms of Notch 4 and the Risk of Aplastic Anemia.
|
Kim, Hee Nam
|
|
|
110 |
11 |
p. 1732
|
artikel
|
| 1963 |
Functional Regulation of TEL through MOZ-Induced Acetylation.
|
Maki, Kazuhiro
|
|
|
110 |
11 |
p. 2647
|
artikel
|
| 1964 |
Functional Regulation of the GPIb-IX-V Complex by 14-3-3ζ: Role of Protein Kinase A Phosphorylation of Multiple GPIbα Cytoplasmic Residues.
|
Munday, Adam D.
|
|
|
110 |
11 |
p. 3654
|
artikel
|
| 1965 |
Function and Therapeutic Potential of In Vitro-Expanded Natural Killer T (NKT) Cells from Patients with Hematopoietic Malignancies.
|
Rogers, Paul R.
|
|
|
110 |
11 |
p. 2742
|
artikel
|
| 1966 |
Function of Nucleophosmin in Zebrafish Hematopoiesis.
|
Payne, Elspeth M.
|
|
|
110 |
11 |
p. 2644
|
artikel
|
| 1967 |
Fungal and Bacterial Infections in Acute Myeloid Leukemia Patients Treated with Induction Regimens Including Fludarabine: A Retrospective Analysis of 224 Cases.
|
Malagola, Michele
|
|
|
110 |
11 |
p. 4351
|
artikel
|
| 1968 |
Further Evidence That MDS and AML Cells Exhibit a Differential Capacity To Activate the DNA-Damage Response (DDR) Pathways.
|
Boehrer, Simone
|
|
|
110 |
11 |
p. 2438
|
artikel
|
| 1969 |
Further Investigation of the Role of Factor XIII in Priapism Associated with SCD.
|
Khatib, Aya El
|
|
|
110 |
11 |
p. 3407
|
artikel
|
| 1970 |
FVIII Tolerance Following Nonmyeloablative Transplantation of Hematopoietic Stem Cells Engineered To Encode a High-Expression Factor VIII Transgene in Hemophilia A Mice.
|
Ide, Lucienne M.
|
|
|
110 |
11 |
p. 2599
|
artikel
|
| 1971 |
GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Exhibits Superior Anti-Tumor Efficacy and Superior Tissue B Cell Depletion In Vivo.
|
Umana, Pablo
|
|
|
110 |
11 |
p. 2348
|
artikel
|
| 1972 |
GA101, a Novel Humanized Type II CD20 Antibody with Glycoengineered Fc and Enhanced Cell Death Induction, Mediates Superior Efficacy in a Variety of NHL Xenograft Models in Comparison to Rituximab.
|
Friess, Thomas
|
|
|
110 |
11 |
p. 2338
|
artikel
|
| 1973 |
Gab1 Is Involved in Erythropoietin Receptor-Mediated Survival Signal through Activation of the Erk Pathway.
|
Fukumoto, Tetsuya
|
|
|
110 |
11 |
p. 2207
|
artikel
|
| 1974 |
GABP Transcription Factor Is Required for Myeloid Cell Development In Vivo.
|
Yang, Zhong-fa
|
|
|
110 |
11 |
p. 374
|
artikel
|
| 1975 |
Gadd45a Behaves as a Tumor Suppressor and Gadd45b Behaves as an Oncogene in myc-Mediated Block in Myeloid Differentiation.
|
Mohamed-Hadley, Alisha
|
|
|
110 |
11 |
p. 4163
|
artikel
|
| 1976 |
Gadd45 Genes Participate in Myeloid Cell Fate Determination.
|
Gibbs, John D.
|
|
|
110 |
11 |
p. 4043
|
artikel
|
| 1977 |
Gain-of-Function Mutations and Copy Number Increases of Notch2 in Diffuse Large B-Cell Lymphoma.
|
Lee, Suk Young
|
|
|
110 |
11 |
p. 695
|
artikel
|
| 1978 |
Gain-of-Function Mutations of GATA-2 in Acute Myeloid Transformation of Chronic Myeloid Leukemia.
|
Zhang, Su-Jiang
|
|
|
110 |
11 |
p. 1022
|
artikel
|
| 1979 |
Gain of the Short Arm of Chromosome 2 Is a New Recurring Chromosome Aberration in CLL Which Is Significantly Associated with an Unmutated IgGVH Status and a Complex Aberrant Karyotype and Leads to a Higher Expression of Genes Located on 2P.
|
Haferlach, Claudia
|
|
|
110 |
11 |
p. 2075
|
artikel
|
| 1980 |
Galiximab Sensitizes Malignant Human B Cell Lines to Apoptosis by Chemotherapeutic Drugs.
|
Baritaki, Stravroula
|
|
|
110 |
11 |
p. 3591
|
artikel
|
| 1981 |
Gamma-Retroviral and Lentiviral Vectors Have Different Preferences for Specific Classes of Genes and Specific Genomic Features in Human Hematopoietic Cells
|
Recchia, Alessandra
|
|
|
110 |
11 |
p. 3732
|
artikel
|
| 1982 |
Ganoderma lucidum Polysaccharides Can Induce Human Monocytic Leukemia Cells into Dendritic Cells with Immunotolerogenic Function.
|
Chan, Wing Keung
|
|
|
110 |
11 |
p. 4906
|
artikel
|
| 1983 |
Gas6 and Its Receptors Are Implicated in Sepsis as Modulators of Innate Immunity.
|
Burnier, Laurent
|
|
|
110 |
11 |
p. 2409
|
artikel
|
| 1984 |
GATA and BCLxl Downregulation in Erythropoiesis during In Vitro Lineage Specific Differentiation of MDS Hematopoietic Progenitor Cells Is Not Induced by Activated Notch Pathway.
|
Hopfer, Olaf J.
|
|
|
110 |
11 |
p. 4118
|
artikel
|
| 1985 |
GATA-1 Interferes with Monopoiesis by Blocking a Positive Regulatory Circuit Involving VDR and PU.1 - Results from a Retroviral Dominant Effector Screen.
|
Taschner, Sabine
|
|
|
110 |
11 |
p. 1229
|
artikel
|
| 1986 |
GATA-1 Is Functionally Involved in the Human CD11b+ Interstitial/Dermal Dendritic Cell Pathway.
|
Gobel, Florian
|
|
|
110 |
11 |
p. 4072
|
artikel
|
| 1987 |
GATA1 Is Over-Expressed in Essential Thrombocytemia
|
Rinaldi, Ciro R.
|
|
|
110 |
11 |
p. 1534
|
artikel
|
| 1988 |
GATA-1 Represses PU.1/Sfpi-1 Gene Transcription in Erythro-Megakaryocytic Progenitors.
|
Chou, Stella T.
|
|
|
110 |
11 |
p. 1226
|
artikel
|
| 1989 |
G-CSF Induces Expression of Both Hepatocyte Growth Factor (HGF) and Its Receptor (c-Met) in Human Hematopoietic Stem/Progenitor Cells and Mature Myeloid Cells - Novel Evidence That during Mobilization the HGF-c-Met Axis Counterbalances G-CSF-Induced Attenuation of the SDF-1-CXCR4 Axis.
|
Jalili, Ali
|
|
|
110 |
11 |
p. 2203
|
artikel
|
| 1990 |
G-CSF Primed Bone Marrow Is Not Superior to Unprimed Bone Marrow as a Source of Stem Cells in HLA Matched Related Allogeneic SCT for β Thalassaemia Major.
|
Rajasekar, Reena
|
|
|
110 |
11 |
p. 5052
|
artikel
|
| 1991 |
G-CSFSR Mutations Present in Patients with Severe Congenital Neutropenia Cooperate with PML-RARα To Induce Acute Myeloid Leukemia in Mice.
|
Woloszynek, Jill R.
|
|
|
110 |
11 |
p. 2193
|
artikel
|
| 1992 |
G-CSF Stimulates Expression of Non-Phosphorylated Stathmin (Oncoprotein, Op18) in Hematopoietic Stem Cells.
|
Lannert, Heinrich
|
|
|
110 |
11 |
p. 2215
|
artikel
|
| 1993 |
GD2+ Selected Mesenchymal Stromal Cells (MSCs) Demonstrate a More Robust Proliferation and Differentiation Potential Compared to Unselected Cells.
|
Martinez, Caridad
|
|
|
110 |
11 |
p. 1919
|
artikel
|
| 1994 |
Gemtuzumab Ozagamicin Is Well Tolerated as Post-Consolidation Therapy in Childhood AML.
|
Hasle, Henrik
|
|
|
110 |
11 |
p. 4367
|
artikel
|
| 1995 |
Gemtuzumab Ozogamicin as Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Patients with Acute Myeloid Leukemia (AML).
|
Cascavilla, Nicola
|
|
|
110 |
11 |
p. 4380
|
artikel
|
| 1996 |
Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning in Patients with Relapsed or Refractory Acute Myeloid Leukemia - Results of a Phase I/II Trial.
|
Bornhaeuser, Martin
|
|
|
110 |
11 |
p. 1997
|
artikel
|
| 1997 |
Gender Differences in Bleeding Problems and Implications for the Assessment of a Bleeding Disorder.
|
Pai, Menaka
|
|
|
110 |
11 |
p. 2148
|
artikel
|
| 1998 |
Gender Differences in Iron Overload and Left Ventricular Function in a Cohort of Thalassemia Major Patients: A Prospective Study of a Single Italian Center Using Cardiovascular Magnetic Resonance.
|
Volpato, Elisabetta
|
|
|
110 |
11 |
p. 3819
|
artikel
|
| 1999 |
Gene and microRNA (miRNA) Expression Signatures and Prognostic Significance of CEBPA Mutations in Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML) with High-Risk Molecular Features: A Cancer and Leukemia Group B (CALGB) Study.
|
Marcucci, Guido
|
|
|
110 |
11 |
p. 104
|
artikel
|
| 2000 |
Gene Conversion Is a Late Event in Evolution of High Risk AML.
|
Meshinchi, Soheil
|
|
|
110 |
11 |
p. 207
|
artikel
|
Tijdschrift beschrijving